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Spatiotemporal control of cellular events is key to developmental progression in all 
organisms. Accordingly the abundance of regulatory proteins must be tightly controlled in a 
highly time- and tissue-specific manner. Pioneering work in the small roundworm 
Caenorhabditis elegans (C. elegans) has uncovered a network of genes, termed the 
heterochronic loci, which govern temporal coordination of developmental processes. 
Importantly this heterochronic network is remarkably conserved across species. There are 
currently over 30 identified heterochronic loci, which encode various transcriptional, 
translational and post-translational regulators including the first discovered microRNAs lin-4 
and let-7.  
In 2007 our laboratory discovered a novel heterochronic gene, dre-1, which specifies late 
larval development in the C. elegans epidermis and gonad. Interestingly dre-1 encodes a 
highly conserved F-box protein; F-box proteins typically function as substrate recognition 
components of SCF E3-ubiquitin ligase complexes, thus conferring substrate specificity to the 
ubiquitin proteasome system (UPS). The initial analysis of DRE-1 and its mammalian 
homolog FBXO11 revealed their interaction with SCF complex components, suggesting 
conservation also on the functional level. Mutation of C. elegans dre-1 leads to a diverse 
array of developmental alterations including precocious terminal differentiation of epidermal 
blast cells, molting defects and alterations in gonadal outgrowth. Likewise, haploinsuffiency 
of Fbxo11 has been linked to craniofacial malformations such as cleft palates, as well as otitis 
media, an inflammation of the middle ear, in both mice and men. Furthermore, FBXO11 was 
recently shown to function as a tumor suppressor in lymphoid malignancies by controlling 
turnover of the oncoprotein BCL6. However, the DRE-1/FBXO11 substrate(s) coordinating 
developmental progression still remain to be elucidated. Thus the central questions of my 
thesis are: what are the substrates of DRE-1/FBXO11 in the heterochronic circuit, and how do 
they illuminate developmental timing events? 
 
In an effort to identify novel substrates of the SCFDRE-1/FBXO11 E3-ubiquitin ligase complex 
involved in developmental timing, I pursued an RNAi-based suppressor approach in C. 
elegans. I reasoned that client substrates should aberrantly accumulate in dre-1 mutants and 
cause developmental alterations across tissues. If so, then knockdown of such substrates 
would ameliorate related phenotypes. Here, I identified the highly conserved zinc-finger 
transcriptional repressor BLMP-1 as a new substrate of the SCFDRE-1 complex. Several lines of 
evidence reveal that BLMP-1 is a substrate of the SCFDRE-1 complex in developmental timing 
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circuits. First, blmp-1 loss of function strongly suppressed dre-1 heterochronic phenotypes in 
epidermis and gonad and blmp-1 mutation itself exhibited developmental timing defects 
opposite to dre-1. blmp-1 also opposed dre-1 for other life history traits such as entry into the 
dauer diapause and adult longevity. Second, BLMP-1 protein was strikingly elevated upon 
depletion of dre-1 and other SCF complex components, as well as by inhibition of the 
proteasome. Moreover, BLMP-1 was regulated in a time- and tissue-specific manner by dre-
1, consistent with corresponding phenotypes. Third, DRE-1 and BLMP-1 physically 
interacted in vivo in C. elegans and in vitro in a cell-based system. Importantly the role of 
DRE-1 in regulating BLMP-1 stability is evolutionary conserved, as direct protein interaction 
and degradation function was also observed for the human counterparts FBXO11 and 
BLIMP-1.  
 
In addition to blmp-1, I also investigated genetic interactions of dre-1 and cdt-2 in C. elegans, 
since CDT2 was recently identified as a FBXO11 substrate in mammalian systems. I found 
cdt-2 to genetically interact with dre-1 for specific processes in the epidermis. In particular 
gaps in an adult-specific cuticular structure occurring in dre-1 mutants could arise from 
elevated CDT-2 levels and a subsequent failure of cell cycle exit of epidermal blast cells, 
which synthesize these structures. My findings are in line with mammalian studies that 
established CDT2, which itself is part of an E3-ubiqitin ligase complex, as a critical cell cycle 
regulator by targeting substrates such as the CDK inhibitor p21 for proteasomal degradation. 
 
Altogether I conclude that dre-1 mutants’ diverse developmental alterations arise from 
aberrant accumulation of distinct target proteins. In particular, my work shows that 
spatiotemporal control of BLMP-1 protein by DRE-1 coordinates developmental timing and 
other life history traits in C. elegans. DRE-1, on the one hand, restrains BLMP-1 abundance 
in the epidermis to prevent precocious terminal differentiation and, on the other hand, triggers 
BLMP-1 degradation in distal tip cells to initiate dorso-ventral migratory events. The notion 
that DRE-1/BLMP-1 work together for multiple processes suggests these proteins comprise a 
two-protein module that may mediate related metazoan maturation processes. Taken together, 
my work fundamentally contributes to the understanding of developmental timing 
coordination by DRE-1/FBXO11 in C. elegans and might help to shed light on related 




Die zeitliche und räumliche Koordination zellulärer Ereignisse ist in allen Organismen 
essentiell für die optimale Entwicklung von Geweben und des gesamten Organismus. Im 
Besonderen muss dabei die Menge regulatorischer Proteine strikt kontrolliert und reguliert 
werden. Pionierarbeit im Fadenwurm Caenorhabditis elegans (C. elegans) führte zur 
Entdeckung eines genetischen Netzwerkes bestehend aus so genannten ‚heterochronen 
Genen’, die die zeitliche Anordnung zellulärer Ereignisse steuern. Dieses ‚heterochrone 
Netzwerk’ ist evolutionär weitgehend konserviert und beinhaltet über 30 Gene, die 
transkriptionelle, translationale und post–translationale Regulatoren codieren.  
2007 wurde in unserem Labor ein neues ‚heterochrones Gen’ entdeckt, dre-1. dre-1 reguliert 
die Entwicklung der Epidermis und der Gonade in späten C. elegans Larvenstadien und 
codiert ein hoch konserviertes F-box Protein. F-box Proteine agieren generell als 
Substraterkennungskomponenten von so genannten SCF E3-Ubiquitin Ligase Komplexen und 
sind somit maßgeblich an der Spezifität des Ubiquitin-Proteasom-Systems beteiligt. Erste 
Analysen von DRE-1 und seinem Säugetierortholog FBXO11 haben gezeigt, dass beide 
Proteine Teil eines solchen SCF Komplexes sind. Punktmutationen im dre-1 Gen führen zu 
multiplen Entwicklungsveränderungen im Fadenwurm: verfrühte Ausdifferenzierung 
epidermaler Stammzellen (seam cells), Störung der Häutungsprozesse und ein verändertes 
Migrationsmuster der Gonade. Analog sind auch Punktmutationen in murinem und humanem 
FBXO11 mit Entwicklungsstörungen wie der Ausbildung einer Lippen-Kiefer-Gaumenspalte 
oder einer chronischen Mittelohrentzündung (Otitis Media) assoziiert. Zusätzlich wurde 
FBXO11 kürzlich als Tumorsuppressorgen eingestuft, da es den Abbau des onkogenen 
Proteins BCL6 kontrolliert und häufig in malignen Lymphomen mutiert ist. 
Interessanterweise sind die Substrate von DRE-1 und FBXO11, die möglicherweise zur 
Ausbildung von Entwicklungsstörungen führen könnten, noch nicht bekannt. Somit stellen 
sich folgende fundamentale Fragen, die in dieser Doktorarbeit adressiert werden: Was sind 
die Substrate von DRE-1/FBXO11, die die zeitliche Abfolge entwicklungsbiologischer 
Prozesse koordinieren? Wie erfolgt diese Regulation auf molekularer Ebene? 
Mittels eines RNAi-basierten Ansatzes habe ich versucht Substrate des SCFDRE-1/FBXO11-
Komplexes zu identifizieren, die die Entwicklungsstörungen in dre-1 Mutanten auslösen 
könnten. Dies basierte auf der Hypothese, dass Substrate in dre-1 Mutanten nicht mehr 
abgebaut werden und somit in zu hohen Konzentrationen vorliegen, welche die Koordination 
der Gewebeentwicklung negative beeinflussen könnten. Folglich sollte eine Reduktion dieser 
Substrate mittels RNAi, zu einer Linderung der Entwicklungsstörungen führen. Mit diesem 
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Ansatz identifizierte ich den Zink-Finger-Tranksriptionsfaktor BLMP-1 als neues Substrat des 
SCFDRE-1/FBXO11-Komplexes: Erstens führte eine Reduktion der BLMP-1 Menge zu einer 
Milderung der dre-1 Phänotypen in Epidermis und Gonade und blmp-1 Mutanten selbst 
zeigten entgegengesetzte Phänotypen in beiden Geweben. Weiterhin beeinflussten dre-1 und 
blmp-1 auch den Prozess der dauer Diapause, so wie die Lebensspanne des Fadenwurms in 
entgegengesetzte Richtungen. Zweitens war die BLMP-1-Proteinkonzentration in dre-1 
Mutanten und nach Inhibition des 26S Proteasoms deutlich erhöht. Interessanterweise 
unterlag der BLMP-1-Spiegel einer strikten zeitlichen Regulation, die in dre-1 Mutanten 
gestört war und eng verknüpft mit den entsprechenden Phänotypen war. Drittens konnte ich 
eine direkte Interaktion zwischen DRE-1 und BLMP-1 in vivo in C. elegans und in vitro in 
kultivierten Säugerzellen nachweisen. Schließlich konnte ich zeigen, dass auch die humanen 
Orthologe FBXO11 und BLIMP-1 direkt interagieren und FBXO11 den Abbau von humanem 
BLIMP-1 kontrolliert.  
Zusätzlich zu BLMP-1 charakterisierte ich ein weiteres FBXO11 Substrat im Fadenwurm, 
CDT2, welches erst kürzlich entdeckt wurde. Dabei fand ich eine genetische Interaktion 
zwischen dre-1 und cdt-2 für die Bildung spezifischer, extrazellulärer Strukturen der 
Fadenwurmepidermis. Lücken dieser Struktur, die von epidermalen Stammzellen synthetisiert 
wird, treten häufig in dre-1 Mutanten auf. Meine Daten deuten darauf hin, dass diese Lücken 
durch eine Dysregulation von CDT-2 verursacht sein könnte, die in epidermalen Stammzellen 
zu Defekten im Zellzyklus führt. Unsere Ergebnisse unterstützen Forschungsergebnisse aus 
Säugerzellen, in denen FBXO11-abhängigem CDT2 Abbau regulatorische Funktionen im 
Zellzyklus zugesprochen werden.  
Insgesamt zeigt meine Arbeit, dass den diversen Phänotypen in dre-1 Mutanten nicht die 
aberrante Akkumulation eines bestimmten Proteins, sondern vielmehr die Anhäufung 
multipler Substrate zugrunde liegt. Im Besonderen konnte ich zeigen das DRE-1 den BLMP-
1-Proteinspiegel kontrolliert, was für die zeitliche Abfolge gewebespezifischer 
Entwicklungsprozesse von zentraler Bedeutung ist. Weiterhin koordinieren DRE-1 und 
BLMP-1 Prozesse, die den gesamten Organismus betreffen, wie Häutungsvorgänge, dauer 
Diapause und die Regulation der Lebensspanne. Analog könnten die orthologen Proteine 
FBXO11 und BLIMP-1 zusammen verwandte Prozesse in Säugetieren regulieren. 
Zusammenfassend erweitert meine Arbeit das Verständnis über die Koordination zeitlicher 
Entwicklungsabläufe durch DRE-1/FBXO11 im Fadenwurm C. elegans, Erkenntnisse, die 
möglicherweise direkt auf verwandte Prozesse in Säugetieren übertragbar sind. 








Life itself is adamantly intertwined with the passing of time. During a life cycle metazoans 
develop through successive stages and mature to reproductive adults. At the organismal level, 
development is often marked by dramatic transitions such as metamorphosis and puberty. At 
the cellular level, temporal and positional fates are precisely regulated to coordinate 
proliferative, morphogenetic and differentiation events. Molecularly, transcriptional, 
translational and post-translational mechanisms must act in concert to control rates of 
protein synthesis, activity and degradation, thereby ensuring sequential action of 
differentiation and maturation factors.  
How do organisms keep track of time and in turn coordinate the proper chronology of distinct 
developmental events on a molecular level?  
1.1 Temporal Control of C. elegans Development 
1.1.1 The Concept of Heterochrony 
Heterochrony denotes a change in the relative timing of developmental events in evolution 
and its definition has varied since its introduction in 1860. The term heterochrony (from 
Greek: heteros different, changed; khronos timing) was first introduced by Ernst Haeckel to 
describe cases in which an ontogenetic sequence of events does not recapitulate the 
evolutionary stages of phylogeny and thus constitutes an exception from the biogentic law 
(Russell, 1916). In the 1950ies Gavin de Beer (De Beer, 1951) and later Gould redefined the 
scope of heterochrony for the next decades (Gould, 1977; Alberch et al., 1979): In contrast to 
Haeckel, Gould described heterochrony as the mechanism that produces parallels between 
ontogeny and phylogeny. Thereby he distinguished between acceleration and retardation of 
maturation versus body development, also shifting the focus of heterochrony from the relative 
timing of developmental events to changes in the relation between size and shape (growth 
heterochrony or allometry). More recently, Smith untangled the different histological 
meanings of heterochrony by differentiating growth- and sequence heterochrony (Smith, 
2001; 2002; 2003). The latter refers to changes in the order of developmental events, extended 
to the cellular level, and often induced by experimental intervention (e.g. genetically). Such 
developmental events include cell proliferation, cell differentiation, the appearance of 
structures, or even the induction of specific genes.  
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The paradigm for heterochrony is the Mexican axolotl Ambystoma mexicanum: this 
salamander reaches sexual maturity without undergoing metamorphosis, such that its somatic 
tissue retains larval features of its ancestors and other salamanders. Interestingly, 
metamorphosis in salamanders is triggered by thyroid hormones, which highly vary in 
abundance and activity between different axolotl species, indicating that rather few genetic 
changes in endocrine signaling can alter organismal developmental timing (Frieden, 1981).  
Notably, in the last decades the nematode C. elegans became the major tool to dissect 
heterochronic phenomena, amongst others due its genetic tractability, the ability to follow cell 
fates in living animals and its essentially invariant and entirely determined cell lineage 
(Brenner, 1974; Sulston and Horvitz, 1977). 
1.1.2 C. elegans Life Plan 
Under favorable environmental conditions (abundant food, low population density and 
moderate temperature) Caenorhabdidtis elegans (from Greek: caeno new, recent; rhabditis 
rod-like and Latin: elegans elegant) develops from egg through four larval stages to reach 
reproductive maturity within 3-5 days.  
 After hatching young larvae consist of 558 cells and rapidly develop through the larval 
stages, each marked by ecdysis and characterized by stage-specific patterns of cellular events. 
These basically invariant patterns include cell divisions, mostly in neuronal, epidermal, and 
gonadal cell lineages as well as morphogenetic events such as gonad and vulval formation 
that lead to the final 959 somatic cells in hermaphrodite adults. Hermaphrodite animals are 
reproductive for a 5-day period and live for another two to three weeks post-reproductively.  
In unfavorable conditions such as food scarcity, elevated temperature, and high population 
density indicated by ascaroside pheromones (Golden and Riddle, 1984; Butcher et al., 2007), 
C. elegans can arrest development at certain checkpoints and run alternative life plan 
programs. First, in the absence of food L1 larvae arrest and survive for several days, and can 
return to continuous development upon re-feeding, demonstrating that food availability is key 
to the initiation of postembryonic development (Johnson et al., 1984). Second, C. elegans can 
enter an alternative third larval stage called dauer diapause, characterized by stress resistance, 
longevity and multiple metabolic and morphological changes including the synthesis of a 
thick stress and desiccation resistant cuticle, which contains characteristic cuticular threads 
called dauer alae (Cassada and Russell, 1975). When returned to favorable conditions dauer 
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larvae resume reproductive development even after periods of over 4 months without food 
(Wood, 1988). Finally, starvation of larvae at the mid L4 stage, induces the adult reproductive 
diapause (ARD) (Angelo and Van Gilst, 2009), which is a quiescent state of extended 
survival thought to be analogous to overwintering in the fruitfly Drosophila melanogaster 
(Tatar and Yin, 2001; Saunders et al., 1989). In C. elegans arrested adults can survive for 
weeks without food while they harbor one or two arrested embryos inside the uterus and halt 
reproductive development and growth. When returned to food, they regenerate their germline, 
give rise to normal broods and live a normal adult lifespan (Gerisch, unpublished). 
1.1.3 Dauer Diapause Signaling 
The dauer diapause is the best-characterized developmental arrest in C. elegans, and allows 
worms to survive extended periods of food scarcity in the wild. The dauer decision is 
governed by a molecular switch (Figure 1): environmental cues are transduced through an 
endocrine signaling network and converge on the nuclear hormone receptor DAF-12, a key 
regulator of reproductive vs. arrested development (Fielenbach and Antebi, 2008; Antebi et 
al., 1998; 2000). DAF-12 contains an N-terminal DNA-binding- and a C-terminal ligand-
binding domain (DBD and LBD). Similar to its mammalian homologs, the Vitamin-D (VDR), 
Liver-X (LXR) and Farnesoid-X (FXR) receptors DAF-12 drives transcription upon binding 
of its ligands, the cholesterol-derived bile-acid-like dafachronic acids (DAs) (Antebi et al., 
2000; Motola et al., 2006). The presence of DAs in young larvae reflects a healthy metabolic 
state and, then liganded DAF-12 leads to reproductive development (Figure 1). Conversely, 
the absence of DAs reflects an unfavorable metabolic state. In this case unliganded DAF-12 
binds its corepressor DIN-1 and triggers developmental arrest, dauer diapause, and longevity 
(Ludewig et al., 2004). Besides daf-12, genetic screens have revealed more than 30 Daf 
(abnormal dauer formation) loci that modulate dauer diapause formation and comprise the 
endocrine network upstream of DAF-12 (Riddle et al., 1981; Albert and Riddle, 1988; 
Gerisch et al., 2001; Fielenbach and Antebi, 2008). Dauer defective (Daf-d) mutants fail to 
form dauer largely independent of the environmental triggers, while dauer constitutive (Daf-
c) mutants enter the dauer stage even under normal or low stress conditions. These Daf loci 
include components of the sensory neuronal circuits, cGMP signaling (Birnby et al., 2000), 
and serotonergic neurotransmission (Sze et al., 2000) that under favorable conditions 
stimulate TGF-β (Ren et al., 1996) and Insulin/IGF signaling (Figure 1) (Kimura et al., 1997). 
In turn, both signaling cascades impinge on rate limiting enzymes within the DA biosynthetic 
pathway leading to increased DA levels that enforce the reproductive fate (Figure 1) (Gerisch 
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and Antebi, 2004). Therein, daf-9/CYP27A1 catalyzes the last step in the biosynthesis of the 
most potent DAF-12 ligand, Δ7-DA and thus acts directly upstream of DAF-12 within the 
dauer signaling circuits (Figure 1) (Gerisch et al., 2001; Jia et al., 2002; Motola et al., 2006). 
Interestingly, both feedforward and feedback loops modulate the activity of DA biosynthetic 
enzymes to assure this binary organismal fate choice.  
 
Figure	  1:	  Dauer	  Diapause	  Signaling	  
Simplified	  schematic	  representation	  of	  the	  signaling	  cascade	  governing	  the	  dauer	  decision.	  Under	  favorable	  environmental	  
conditions	   upstream	   signaling	   cascades	   such	   as	   TGF-­‐β-­‐	   and	   Insulin/IGF	   signaling	   trigger	   DA	   biosynthesis	   leading	   to	  
reproductive	   growth	   via	   ligand-­‐bound	   DAF-­‐12.	   Conversely	   unliganded	   DAF-­‐12	   forms	   a	   repressor	   complex	   together	   with	  
DIN-­‐1	  and	  induces	  dauer	  diapause	  upon	  unfavorable	  environmental	  conditions.	  	  
	  
1.1.4 C. elegans Landmarks of Developmental Time  
1.1.4.1 Molt Cycle 
Invertebrate species with exoskeletons often undergo the process of molting as part of growth 
and maturation. Across molting species, hatching and ecdysis (the shedding of the cuticle) 
function as major landmarks to define the chronological age of individual animals.  
In the fruitfly Drosophila melanogaster molting events are triggered by hormonally driven 
transcriptional cascades. In a cyclic behavior ecdysteroid hormones such as 20-
hydroxiecdysone trigger downstream target gene expression including DHR-3, FTZ-F1, and 
others, through the ecdysone receptor and its coreceptor ultraspiracle/RXR (Riddiford, 1993; 
sensory neuronal circuits, cGMP 
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Riddiford et al., 2000; 2003; King-Jones and Thummel, 2005; Thummel, 1996; Koelle et al., 
1992; 1991). 
In C. elegans regulation of the molt cycle is less understood, but initial studies suggest that it 
is also controlled by an endocrine mechanism. The orphan nuclear hormone receptors nhr-23 
and nhr-25, homologs of Drosophila DHR3 and FTZ-F1, respectively, have been implicated 
in regulating the molts. Their expression oscillates with the molt cycle and their mutation 
leads to severe molting defects (Asahina et al., 2000; Gissendanner and Sluder, 2000; 
Kostrouchova et al., 1998; 2001; Kouns et al., 2011). However, neither ecdysone nor its 
receptor have been identified in C. elegans. 
Although chronological age is a very convenient measure for C. elegans temporal boundaries, 
close inspection indicates that the molt itself is only the termination of a process that was 
initiated during the intermolts by synthesizing collagens (Johnstone and Barry, 1996). 
Similarly seam cells, which are lateral epidermal blast cells, divide around the molts, but the 
cell cycle entry was triggered during intermolts, suggesting developmental programs to run 
from intermolt to intermolt (Ambros and Horvitz, 1984; Antebi et al., 1998). Based on the 
description of the entire C. elegans cell lineage I will refer to developmental age as hours 
post-hatching as staged by specific landmarks of developmental progression described in 
Sulston and Horvitz’s landmark work (Sulston and Horvitz, 1977).  
1.1.4.2 Tissue- and Stage-Specific Developmental Programs 
Each larval stage is characterized by a highly invariant pattern of traceable cellular events 
including cell proliferation, differentiation and migration in various tissues. C. elegans 
epidermis consists of the hypodermal syncytium and the seam cells, which collectively 
synthesize and secrete new collagenous cuticles before shedding the old (Singh and Sulston, 
1978; Edwards and Wood, 1983; Chisholm and Hsiao, 2012). Seam cells, named H0–H2, 
V1–V6, and T, are situated along the lateral midline on each side of the worm and display the 
most conspicuous and best studied temporal patterning events (Figure 2A and 2B). During 
post-embryonic development they undergo stem cell divisions once during each larval stage 
roughly coinciding with the molts. These divisions give rise to an anterior hypodermal 
daughter, which fuses to the hypodermal syncytium, whereas the posterior seam cell retains 
its stem cell character. Uniquely during the L2 stage subsets of seam cells undergo an 
additional proliferative division, thus increasing the number of seam cells from 10 to 16 on 
each side of adult worms. Finally, early in the L4 stage seam cells exit the cell cycle, fuse into 
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a syncytium and synthesize a continuous ridged cuticular structure called adult alae, a 
hallmark of the adult cuticle (Figure 2B) (Singh and Sulston, 1978; White, 1988). 
 
Figure	  2:	  Stage-­‐Specific	  Developmental	  Programs	  in	  Epidermis	  and	  Gonad	  
(A)	   Schematic	   representation	   of	   an	   adult	   worm,	   showing	   seam	   cell	   nuclei	   (grey),	   which	   comprise	   the	   left	   seam-­‐cell	  
syncytium	   (grey	   line).	   The	   nuclei	   are	   indicated	   by	   the	   name	   of	   the	   blast	   cell	   from	   which	   they	   were	   derived,	   with	   the	  
exception	  of	  H0,	  which	  does	  not	  divide	  post-­‐embryonically.	  Distal	  tip	  cells	  (dtcs),	  which	  lead	  gonad	  migration,	  are	  shown	  in	  
green,	  the	  whole	  gonad	  in	  purple.	  (B) Seam	  cell	  lineages	  (V1-­‐V4,	  V6)	  from	  WT	  worms	  and	  two	  representative	  heterochronic	  
mutants.	   Terminal	   differentiation	   is	   indicated	  by	   fusion	  of	   the	   seams	   (eye-­‐shaped	   cells)	   and	   adult	   alae	   formation	   (three	  
horizontal	  bars).	   (C)	  Gonad	  migration	  program	  of	  WT	  worms	  and	  retarded	  mutants	  such	  as	  daf-­‐12(rh61),	  where	  gonadal	  
arms	  fail	  to	  reflex.	  Arrowheads	  indicate	  positions	  of	  the	  dtcs.	  Figure	  modified	  from	  (Rougvie,	  2001).	  
 
Temporal development not only manifests in epidermal blast cells, but also emerges in other 
tissues: Similar to seam cell programs, intestinal nuclei undergo repetitive endoreplications 
during each larval stage, with a modification during L2 that gives rise to binucleate cells. 
Moreover, linear non-repetitive patterns exist that also exhibit strict temporal control such as 
neuronal remodeling, vulval formation, and gonadal outgrowth. The hermaphrodite gonad 
undergoes a stereotyped morphogenesis during the larval stages that is readily visible by 
microscopy (Figure 2C): In L1 larvae the gonad primordium consists of just four cells Z1-Z4, 
whereby Z2 and Z3 are the germ cell precursors and Z1 and Z4 the somatic gonadal precursor 
cells. The latter give rise to the distal tip cells (dtcs), which remain located at the distal ends 
of the two gonadal arms throughout development (Hedgecock et al., 1987). Led by these two 




















































In the L3 stage, dtcs reflex dorsally and centripetally back toward the midbody to form two 
U-shaped gonadal arms in adult animals (Figure 2C). 
1.1.5 Heterochronic Genes 
A rich signaling network of temporal selector genes, the heterochronic genes, orchestrate C. 
elegans stage- and tissue-specific cellular patterns. Forward genetic screens identified a class 
of mutants called lin (cell lineage abnormal) mutants. A handful of these, including lin-4, lin-
14, lin-28, and lin-29, were further classified into a subgroup termed heterochronic mutants 
due to their alteration of cellular developmental timing events (Ambros and Horvitz, 1984; 
Chalfie et al., 1981). Heterochronic genes work in a highly tissue- and stage-specific manner 
to coordinate developmental progression throughout the whole organism. Mutations in these 
genes cause stage-specific cellular events to be expressed earlier (precocious) or later 
(retarded) than normal, which often manifests as a deletion or repetition of such temporal 
patterns. Currently, there are over 30 identified heterochronic loci which encode various 
highly conserved transcriptional, translational and post-translational regulators including the 
first discovered microRNAs lin-4 and let-7 (Table 1) (Reinhart et al., 2000; Lee et al., 1993; 
Resnick et al., 2010). The hierarchy of the heterochronic circuitry has been built on genetic 
epistasis and synergy experiments as well as the study of molecular interactions and 
expression profiles. Although affecting multiple tissues, developmental timing mechanisms 
have been most extensively studied in C. elegans epidermis. 
1.1.6 Seam Cell Heterochronic Circuitry 
Despite the extensive complexity of the C. elegans developmental timing regulatory network, 
its basic framework relies on three microRNA-mediated switches shutting down previous 
developmental programs to allow for subsequent ones (Figure 3 and Table 1) (Ambros, 2011; 
Rougvie and Moss, 2013). microRNAs, which encode 21-25 nucleotide RNA stretches, bind 
to partially complementary sequences in the 3’UTR of a target mRNA to specifically inhibit 
translation or induce mRNA degradation (Olsen and Ambros, 1999; Pillai et al., 2007; 
Ambros, 2004). Ultimately they control levels of key regulatory components, which connect 




Figure	  3:	  Seam	  Cell	  Heterochronic	  Circuitry	  
Schematic	   representation	   of	   the	   seam	   cell	   heterochronic	   circuitry	   that	   is	   organized	   around	   three	   microRNA-­‐mediated	  
switches	  indicated	  in	  orange,	  red	  and	  green	  color.	  Under	  favorable	  conditions	  heterochronic	  genes	  catalyze	  developmental	  
progression	  toward	  terminal	  differentiation,	  while	  adverse	  environment	  induces	  dauer	  diapause	  via	  the	  nuclear	  hormone	  
receptor	  DAF-­‐12.	  
	  
The canonical heterochronic network can be divided into three phases (Figure 3). First, lin-
4/mir-125b microRNA accumulates toward the end of the L1 stage to downregulate the novel 
nuclear protein lin-14/nuclear protein, which specifies the L1 fate (Chalfie et al., 1981; 
Ambros and Horvitz, 1984; Ruvkun and Giusto, 1989; Arasu et al., 1991; Lee et al., 1993; 
Wightman et al., 1993). lin-4 transcriptional activation requires the abundance of food, as 
well as multiple components of Insulin/IGF signaling and various microRNAs (Arasu et al., 
1991; Feinbaum and Ambros, 1999; Baugh and Sternberg, 2006; Fukuyama et al., 2006; Karp 
et al., 2011; Kasuga et al., 2013). Recent studies suggest timely lin-4 accumulation also relies 
on auto-regulatory action of the lin-4 microRNA itself to lock the fate decision (Turner et al., 
2014). lin-4 loss of function results in a strong retarded phenotype where L1 stage patterns are 
incessantly reiterated and seam cell terminal differentiation never occurs. Likewise, lin-14 
recessive mutation causes L1 patterns to be skipped and all subsequent patterns to advance 
precociously, such that seam cells undergo the proliferative division already in the L1 stage 
and seam terminal differentiation occurs late in L3. Intriguingly, lin-14 gain-of-function 
alleles were identified, which lack lin-4 binding sites in the 3’UTR and thus aberrantly 
stabilize lin-14 through withdrawal from lin-4 mediated degradation (Ambros and Horvitz, 
1987; Wightman et al., 1991). This observation was key to the discovery of microRNAs.  
The RNA-binding protein lin-28/LIN28 and the homolog of the Drosophila hunchback 
transcription factor, hbl-1/ZnF specify second larval stage fates (Fay et al., 1999; Moss et al., 
1997). lin-28(lf) results in precocious phenotypes whereby L2 programs are skipped and L3 
stage and subsequent programs are expressed one stage ahead of schedule (Ambros and 



























Horvitz, 1984). Like lin-14, lin-28 is also targeted by lin-4 microRNA, but slightly later in 
development to initiate the L2-to-L3 transition (Moss et al., 1997). In addition to the 
sequential downregulation of lin-14 and lin-28 by lin-4, a positive feedback loop between lin-
14 and lin-28 reinforces early larval fate specifications (Arasu et al., 1991; Moss et al., 1997; 
Seggerson et al., 2002). The second switch is mediated by the redundant let-7-familiy 
microRNA members mir-48, -84, and -241, termed let-7s. During L2, hbl-1 is stabilized by 
lin-28, but just as lin-28 is downregulated by lin-4, hbl-1 too, becomes targeted by let-7s 
microRNAs. (Vadla et al., 2012; Abrahante et al., 2003; Abbott et al., 2005). hbl-1 mutants 
skip L2-specific patterns whereas let-7s triple mutants show misexpression of hbl-1 within the 
L3 stage, causing reiteration of the L2-specific proliferative seam cell division (Abrahante et 
al., 2003; Abbott et al., 2005).  
Finally, the third phase is initiated by derepression of let-7 microRNA, which ultimately 
results in seam cell terminal differentiation. During early larval stages, lin-28 recruits a 
poly(U) polymerase pup-2 to stimulate let-7 precursor degradation (Lehrbach et al., 2009; 
Moss et al., 1997; Vadla et al., 2012; Van Wynsberghe et al., 2011). At later stages, during 
which lin-28 is repressed, let-7 accumulates to downregulate its major target lin-41/TRIM71, 
which results in expression of the terminal transcription factor lin-29/EGR (Reinhart et al., 
2000; Slack et al., 2000; Vella et al., 2004; Rougvie and Ambros, 1995). Thus LIN-28 on the 
one hand drives L2 programs by stabilizing hbl-1 and on the other hand inhibits microRNA 
biogenesis to prevent execution of subsequent programs (Vadla et al., 2012). 
let-7 mutants are lethal. However temperature sensitive (ts) let-7 alleles such as let-7(n2853ts) 
display retarded heterochronic phenotypes, as seam cells fail to exit the cell cycle and adult 
alae are not formed until an additional fifth molt. Evidence suggests that rather than repeating 
L4 programs, let-7 mutants might reiterate L3-specific programs (Vadla et al., 2012). 
lin-41/TRIM71 encodes a highly-conserved TRIM-NHL-family RNA binding protein that 
affects mRNA function across species (Ecsedi and Grosshans, 2013). lin-41(gf) mutants 
display retarded phenotypes, largely resembling let-7 ts alleles (Slack et al., 2000). Likewise, 
in lin-41(lf) mutants seam cells terminally differentiate precociously in L3 larvae due to early 
elevated LIN-29 levels (Slack et al., 2000). However the concrete mechanism of lin-29 
inhibition by lin-41 remains poorly understood. Although LIN-41 harbors a RING domain 
and few studies reported mammalian LIN-41/TRIM-71 to act as ubiquitin ligase on the 
microRNA machinery component AGO2 (Duchaine et al., 2006; Rybak et al., 2009; Loedige 
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et al., 2013), its ubiquitin ligase activity seems to be highly context-specific and was reported 
to be dispensable for repression of mRNA function (Chen et al., 2012; Chang et al., 2012; 
Loedige et al., 2013). 
Finally, increasing LIN-29 levels drive an adult-specific transcriptional pattern including the 
expression of several collagens, such as col-7 and col-19, which serve as markers of the adult 
fate (Rougvie and Ambros, 1995; Liu et al., 1995). The Krüppel family zinc-finger 
transcription factor lin-29 functions as the most downstream gene in C. elegans heterochronic 
pathways and consequentially is epistatic to all known heterochronic genes affecting seam 
cell development (Rougvie and Ambros, 1995; Resnick et al., 2010). In other words, all 
known heterochronic genes directly or indirectly affect the temporal control of lin-29 
expression to specify the timing of seam cell terminal differentiation. 
1.1.7 Additional Layers of Seam Cell Fate Coordination - a Link Between 
Developmental Timing, the Molt Cycle and Environmental Cues 
The components of the canonical heterochronic pathway described above constitute key 
players, which when mutated result in strong and penetrant heterochronic phenotypes. In 
addition to these genes a large number of heterochronic genes has been identified that fine-
tune temporal progression in the epidermis and link it to environmental cues and the molting 
timer. Most of them affect the second and the last of the three microRNA-mediated switches 
(Figure 3 and Table 1). 
1.1.7.1 Additional Modulators of the Second microRNA Switch (L2-to-L3 Transition): 
The scaffold protein lin-46/Gephyrin, as well as the nematode-specific transcription factor 
sel-7 have been reported to act in parallel to the let-7s microRNAs to downregulate hbl-1 and 
allow developmental progression to L3 (Pepper et al., 2004; Xia et al., 2009). Consistent with 
LIN-46 levels peaking once in each larval stage, lin-46 mutation also affects developmental 
timing at later stages (Pepper et al., 2004; Moss, 2007). Not surprisingly, also mutations in 
components of the microRNA biogenesis machinery including the Argonaute homologs alg-
1/2, the GW182 homologs ain-1/2, and the Dicer homolog, dcr-1, affect C. elegans 
developmental timing as corresponding mutants reiterate L2-specific patterns, most likely 
through impaired regulation of hbl-1 by let-7s (Morita and Han, 2006; Grishok et al., 2001). 
DAF-12 functions as a molecular switch between reproductive vs. dauer development and 
thereby links environmental cues to developmental timing and progression. One of DAF-12’s 
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major and direct transcriptional outputs includes the let-7s microRNAs (Antebi et al., 1998; 
2000; Fielenbach and Antebi, 2008; Bethke et al., 2009). In favorable environmental 
conditions ligand-bound DAF-12 moderately activates let-7s expression, which in turn 
downregulate hbl-1 to allow reproductive growth and developmental progression. In contrast, 
ligand-free DAF-12 is a potent repressor of these microRNAs. In the daf-12 null mutant allele 
daf-12(rh61rh411), which harbors point mutations in both the DBD and the LBD, let-7s 
microRNAs are slightly reduced and accordingly, these mutants exhibit only weak 
developmental timing alterations (Bethke et al., 2009; Hammell et al., 2009a; Antebi et al., 
1998; 2000). In contrast, daf-12 LBD mutants such as daf-12(rh61) show a striking decrease 
in let-7s microRNAs resulting in aberrantly high HBL-1 levels in L3 larvae. Consequentially, 
LBD mutants repeat L2-specific seam cell programs leading to delayed or impaired terminal 
differentiation (e.g. adult alae formation) later in life (Antebi et al., 2000; 1998; Motola et al., 
2006). Multiple studies suggest that these allele-specific daf-12 phenotypes are based on the 
loss-of-activation and repression function in the daf-12(null) mutants, whereas the LBD 
mutant only impairs daf-12-depedent activation, still allowing potent suppression of 
microRNA expression (Antebi et al., 2000; Bethke et al., 2009). In particular, DAF-12 is a 
potent repressor of the let-7s microRNAs during dauer formation. Of note, the daf-12-
dependent regulation of let-7s is not a linear relation, but fine-tuned by negative feedback 
loops to lock fate decisions based on environmental stimuli in a cell-autonomous fashion 
(Hammell et al., 2009a; Grosshans et al., 2005; Bethke et al., 2009). Recently, Chip on Chip 
analysis suggests a global role for daf-12 in regulating heterochronic genes at various stages, 
as daf-12 resides at the promoters of the heterochronic loci alg-2, lin-46, lin-14, lin-66, lin-28, 
lin-41, dre-1, and lin-42 (Hochbaum et al., 2011). In sum, DAF-12 functions as key 
modulator of the second microRNA-mediated switch, which is directly linked to the 
perception of environmental conditions. 
1.1.7.2 Additional Modulators of the Third microRNA Switch (Larval-to-Adult 
Transition): 
In addition to its function at the L2-to-L3 transition the transcription factor hbl-1 works in 
parallel to lin-41 to redundantly specify L4-specific cellular fates by preventing lin-29 
expression (Abrahante et al., 2003). hbl-1 is not only targeted by let-7s microRNAs, but also 
by let-7 itself, whose accumulation initiates late larval and finally adult-specific programs 
(Abrahante et al., 2003; Lin et al., 2003). Both lin-41 and hbl-1 are epistatic to let-7, as the 
double mutants display precocious seam phenotypes, consistent with their role downstream of 
the microRNA (Slack et al., 2000; Abrahante et al., 2003).  
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Moreover, the C. elegans polycomb-group-like (PcG-like) gene sop-2 specifies spatial and 
temporal identities of the seams (Cai et al., 2008; Zhang et al., 2003). Null mutants arrest 
early in L1, whereas ts alleles of sop-2 show various developmental alterations at permissive 
temperatures: e.g. seam cells undergo precocious terminal differentiation at the L3- or even 
the L2 molt. Furthermore, sop-2 genetically interacts with heterochronic loci controlling early 
and late developmental programs, acting presumably largely in parallel to the ‘canonical’ 
pathways. Initial evidence suggests that sop-2(+) might generally hamper microRNA-
mediated gene repression, consistent with a role at multiple steps in C. elegans developmental 
timing (Cai et al., 2008).  
mab-10/NAB encodes a NAB (NGFI-A-binding protein) transcriptional cofactor and was 
recently shown to regulate the larval-to-adult transition in concert with lin-29. In mab-10 loss-
of-function mutants seam cells fail to exit the cell cycle and worms undergo supernumerary 
molts. MAB-10 protein directly binds to LIN-29 via a conserved motif to promote its activity, 
including downregulation of nhr-25 and nhr-23 to prevent extra molts and induction of the 
CDK inhibitor cki-1 to trigger exit from the cell cycle (Harris and Horvitz, 2011; Hong et al., 
1998).  
nhr-25/SF1, the homolog of Drosophila β-FTZ-F1 and mammalian SF1, encodes a nuclear 
hormone receptor not only regulating C. elegans molting, embryogenesis and reproduction, 
but also epidermal developmental timing (Gissendanner and Sluder, 2000; Gissendanner et 
al., 2004; Silhánková et al., 2005; Hada et al., 2010; Chen et al., 2004). In contrast to many 
other heterochronic genes that are expressed for continuous temporal blocks working in a 
sequential manner, NHR-25 levels oscillate with the molt cycle, with peaks around the molts 
(Gissendanner et al., 2004). Intriguingly, nhr-25 mutants show inconclusive phenotypes 
regarding their role in epidermal timing regulation: Although these mutants exhibit 
precocious expression of the adult-specific collagen col-19, seam cells do not fuse, undergo 
an extra division and fail to synthesize adult alae (Hada et al., 2010).  
Similar to NHR-25, LIN-42/Period levels oscillate in a 8-10 hour period synchronized with 
the molt cycle (25°C) (Jeon et al., 1999; Tennessen et al., 2006). lin-42 encodes the C. 
elegans homolog of the Drosophila circadian rhythm gene Period, a PAS domain containing 
protein that cycles in a daily pattern (Jeon et al., 1999). In C. elegans, lin-42 acts as a global 
regulator of life history, affecting dauer formation, molting, and epidermal developmental 
timing (Tennessen et al., 2006; 2010). Loss-of-function mutants are hypersensitive to dauer 
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formation (Tennessen et al., 2010) and exhibit precocious seam cell fusion and adult alae 
formation, suggesting lin-42(+) to specify late larval development in the epidermis 
(Tennessen et al., 2006; Abrahante et al., 1998). Genetic epistasis experiments place lin-42 in 
close proximity to hbl-1 and lin-41, as it mutually suppresses retarded let-7 phenotypes 
(Tennessen et al., 2006). Further, lin-42 acts in opposition to daf-12 for multiple phenotypes 
in seam and gonadal heterochrony, as well as dauer formation (Tennessen et al., 2010). lin-42 
also genetically interacts with lin-14, lin-46, and others, suggesting lin-42 works at multiple 
steps of C. elegans development consistent with its cycling expression (Abrahante et al., 
1998; Pepper et al., 2004; Ren and Zhang, 2010). 
Also other key circadian rhythm regulators affect C. elegans developmental timing. tim-1 and 
kin-20 are C. elegans homologs of the Drosophila circadian clock genes timeless and 
doubletime, respectively and prevent premature terminal differentiation in the seams (Jeon et 
al., 1999; Banerjee and Slack, 2002).  
Strikingly, multiple heterochronic genes not only have homologs regulating circadian rhythms 
in vertebrates, but they also directly affect C. elegans molting. Besides nhr-23 and -25, the 
heterochronic gene lin-42 is a key player within the molt cycle. Its misregulation elicits 
molting defects at all four molts (Monsalve et al., 2011). Interestingly, heterochrony in C. 
elegans is directly linked to the molt cycle as precocious heterochronic mutants cease the molt 
cycle at earlier stages than wild type and conversely, retarded mutant animals frequently 
undergo supernumerary molts, e.g. in let-7 or mab-10 mutants. In particular, let-7/let-7s 
microRNAs, as well as lin-29 together with mab-10 were shown to directly downregulate 
NHR-25 levels to trigger exit from the molt cycle at the larval-to-adult transition (Hayes et 
al., 2006; Harris and Horvitz, 2011). Taken together, molecular pathways governing circadian 
rhythms in vertebrates and C. elegans developmental timing and molting show striking 
parallels and interactions, suggesting a conserved molecular mechanism to be applied for 
various types of biological timing control. Intriguingly, then iterant cycling modules are 
coordinated with molecular switches to ensure proper succession of cellular temporal fates. 
Table	  1:	  Heterochronic	  Genes	  Affecting	  Developmental	  Timing	  in	  C.	  elegans	  Epidermis	  
Summary	  of	  known	  heterochronic	  genes,	  including	  the	  phenotype	  in	  seam	  cells	  upon	  loss	  of	  function,	  as	  well	  as	  the	  closest	  
mammalian	  homolog.	  
 
Gene Seam phenotype Mammalian homolog References 
Switch 1 




lin-14	   Precocious, Skip L1	   Novel nuclear protein	   (Ambros and Horvitz, 1987; 1984; 
Ruvkun and Giusto, 1989) 
Switch 2 
hbl-1 Precocious, Skip L2 ZnF (Lin et al., 2003; Abrahante et al., 
2003)  
lin-28 Precocious, Skip L2 LIN28 (Moss et al., 1997) 
mir-48,84,241 Retarded, Repeat L2 let-7s (Abbott et al., 2005) 
lin-46 Retarded, Repeat L2 Gephyrin (Pepper et al., 2004) 
nhl-2 Retarded, Repeat L2 Trim2/nhl Ring finger (Hammell et al., 2009b) 
sel-7 Retarded, Repeat L2 not conserved (Xia et al., 2009) 
daf-12 Retarded, Repeat L2 FXR/LXR/VDR (Antebi et al., 1998; 2000) 
lin-66 Retarded, Repeat L2 not conserved (Morita and Han, 2006) 
Switch 3 
lin-29 Retarded seam fusion ZnF362/EGR (Rougvie and Ambros, 1995) 
let-7 Retarded seam fusion let-7 (Reinhart et al., 2000) 
dre-1 Precocious seam fusion FBXO11 (Fielenbach et al., 2007)  
lin-41 Precocious seam fusion Trim71/nhl Ring finger (Slack et al., 2000) 
lin-42 Precocious seam fusion Period (Jeon et al., 1999; Tennessen et al., 
2006) 
tim-1 Precocious seam fusion Timeless (Banerjee et al., 2005) 
kin-20 Precocious seam fusion  Doubletime kinase (Banerjee et al., 2005) 
sop-2 Precocious seam fusion Polycomb-group-like (Cai et al., 2008) 
nhr-25 Retarded seam fusion SF1 (Gissendanner and Sluder, 2000; 
Hada et al., 2010) 
apl-1 Let-7 suppressor APP homolog (Niwa et al., 2008) 
Wingless Signaling 
pop-1 Synthetic Precocious TCF/LEF Tcf factor (Ren and Zhang, 2010) 
wrm-1 Synthetic Precocious β-catenin (Ren and Zhang, 2010) 
MicroRNA Biogenesis 
dcr-1 Retarded Repeat L2 Dicer (Grishok et al., 2001) 
alg1/2 Retarded, Repeat L2 Argonaute (Grishok et al., 2001) 
ain1/2 Retarded, Repeat L2 GW182 protein (Ding et al., 2005) 
 
1.1.8 Gonadal Heterochronic Circuitry 
Heterochronic genes have been demonstrated to coordinate developmental timing across 
tissues, but their timing, circuitry, and outcome can be highly tissue-specific (Hallam and Jin, 
1998; Antebi et al., 1998; Ambros and Horvitz, 1984). The molecular network underlying 
temporal control of gonadal migration is poorly understood, except for some key regulators. 
Similar to the situation in the seams, daf-12 null mutants show a near WT-like gonadal 
migration pattern, whereas daf-12 LBD mutants, which render daf-12 a constitutive repressor, 
exhibit a penetrant gonadal migration defect (mig): dtcs fail to turn, repeat L2-stage specific 
linear ventral movement and migrate straight into head and tail (Figure 2) (Antebi et al., 
1998). As in the epidermis, these developmental alterations are partly suppressed by mutation 
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of the DAF-12 corepressor DIN-1 (Ludewig et al., 2004). Interestingly, mutations in the DA 
biosynthetic pathway, e.g. daf-36/Rieske or daf-9/CYP27A1 (previously termed mig-8) also 
cause gonadal migration defects, supporting the idea that ligand-free DAF-12 prevents the 
dorsal gonadal turn (Antebi et al., 1998; Rottiers et al., 2006; Gerisch et al., 2001). 
Furthermore, daf-12 null mutants exhibit synthetic gonadal migration defects in sensitized 
backgrounds, such as lin-29(lf), indicating daf-12-parallel functions to redundantly activate 
gonadal L3 programs, which could be thwarted by a constitutive DAF-12 repressor (Antebi et 
al., 1998; Fielenbach et al., 2007). In contrast to retarded migration defects, lin-42 depletion 
precedes the dorsal gonadal turn (Tennessen et al., 2006). Thereby genetic epistasis 
experiments place lin-42 upstream or parallel to lin-29 and daf-12 (Fielenbach et al., 2007; 
Tennessen et al., 2006). Finally, evidence suggests that temporal signals in the dtcs 
collectively trigger expression of the netrin receptor unc-5/UNC5 to ultimately initiate the 
dorsal migratory fate (Su et al., 2000).  
1.1.9 Dauer Diapause - a Reset of Developmental Timing 
An unexpected phenomenon was discovered about 25 years ago, which suggests that temporal 
fates can be reprogrammed. Heterochronic mutants that affect early larval stages show wild 
type epidermal fates when they developed through dauer diapause (Liu and Ambros, 1991; 
Abrahante et al., 2003; Euling and Ambros, 1996). Most strikingly, precocious formation of 
the adult vulva is prevented by reprogramming a subset of vulval precursor cells to reset them 
to their ancestral fates. The molecular mechanisms underlying the reset of developmental 
timing are currently investigated, but still very poorly understood (Hochbaum et al., 2011; 
Karp and Ambros, 2012).  
1.1.10  Heterochronic Genes – Parallels in Higher Organisms 
Importantly, most heterochronic genes are remarkably conserved throughout evolution and 
fulfill essential functions in plants, flies, and mammals directing proliferation, differentiation, 
and stem cell dynamics (Geuten and Coenen, 2013; Ambros, 2003; Sokol, 2012). Some 
extraordinary examples of structural and functional conservation are depicted in the 
following, highlighting the importance of C. elegans heterochronic genes in vertebrate 
biology. 
DAF-12 is homologous to the mammalian nuclear hormone receptors FXR, LXR, and VDR 
and works at the interface of dauer diapause and heterochronic pathways in C. elegans 
epidermis and gonad. Similar to DAF-12, its mammalian homologs bind steroid ligands to 
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read out the metabolic state and in turn regulate metabolism homeostasis and developmental 
progression. For example ligand-bound LXR promotes keratinocyte differentiation in the 
epidermis (Kömüves et al., 2002). Likewise, lack of VDR prevents skin stem cell 
differentiation (Xie et al., 2002; Cianferotti et al., 2007; Zhang et al., 2011), indicating that 
cellular fate decisions are coordinated by a hormone-dependent switch, similar to C. elegans. 
Even more striking, microRNAs, as well as genes involved in their biogenesis, are highly 
conserved up to humans. Both lin-4/mir-125b and let-7/let-7 have been demonstrated to direct 
proliferation and differentiation in various tissues across species (Zhang et al., 2011; Caygill 
and Johnston, 2008; Yu et al., 2007a). let-7 is fully conserved throughout all major taxa and 
has been shown to function as a maturation factor in C. elegans, Drosophila, and mice (Sokol 
et al., 2008; Caygill and Johnston, 2008; Büssing et al., 2008; Reinhart et al., 2000). Across 
species, let-7 levels are low early in undifferentiated tissues and rise during development to 
direct differentiation (Pasquinelli et al., 2000). In the fruitfly, let-7 accumulation triggers 
terminal maturation of neuronal and abdominal muscles (Sokol et al., 2008; Caygill and 
Johnston, 2008). Interestingly, the steroid hormone 20-hydroxiecdysone, which pulses before 
each molt, has been shown to activate let-7 expression (Chawla and Sokol, 2012). This 
hormone-driven switch in Drosophila shows remarkable similarities to the regulation of 
developmental progression by DAF-12 and let-7s microRNAs in C. elegans.  
In mammals, let-7 levels increase during embryogenesis, brain development, and upon 
differentiation of mouse embryonic stem cells and levels are maintained in various adult 
tissues (Wulczyn et al., 2007; Thomson et al., 2006; Sempere et al., 2004). Not surprisingly, 
decreased let-7 levels have been found to be a hallmark of a variety of different cancers, 
including lung cancer, breast cancer, hematopoietic cancers, and others (Takamizawa et al., 
2004; Thornton and Gregory, 2012). These tumor cells are characterized by a low 
differentiation state, harboring a high proliferative and self-renewal potential. Likewise, let-7 
deregulation has been demonstrated to significantly contribute to the determination of breast 
cancer stem cell populations, which have a high proliferative capacity allowing cancers to 
repopulate after cancer therapy (Yu et al., 2007a). These findings largely reflect the situation 
in the nematode, where lack of let-7 results in impaired terminal differentiation and aberrantly 
ongoing cell divisions, reflecting a cancer-cell-like state (Reinhart et al., 2000). Interestingly, 
also let-7 target genes show a substantial overlap between worms and mammals. Amongst 
them, the oncogene Ras (homolog of let-60) provides a link between reduced let-7 levels and 
tumor formation, establishing let-7 as a tumor suppressor (Grosshans et al., 2005; Johnson et 
Introduction 
18 
al., 2005; Jérôme et al., 2007). Furthermore, TRIM71 (homolog of lin-41) is targeted by let-7 
and involved in a feedback-loop regulating let-7 activity in stem cells (Rybak et al., 2009). 
Although the hypothesis that LIN-41/TRIM-71 acts as ubiquitin ligase to AGO2 to regulate 
microRNA and mRNA function has recently been challenged (Loedige et al., 2013; Chen et 
al., 2012; Chang et al., 2012), still LIN-41/TRIM-71 action has been demonstrated to prevent 
terminal differentiation in mammals – analogous to the situation in C. elegans epidermis 
(Slack et al., 2000; Ecsedi and Grosshans, 2013). 
In addition to let-7, lin-28 is highly conserved and is of extraordinary importance to human 
stem cell biology. First in mammals LIN28 was shown to inhibit let-7 maturation by distinct 
mechanisms, thereby preventing (precocious) stem cell terminal differentiation (Viswanathan 
et al., 2008; Rybak et al., 2008; Nam et al., 2011; Piskounova et al., 2011). In worms and 
mammals lin-28 is highly expressed early in undifferentiated cells and then decreases to allow 
let-7 accumulation and cell differentiation. Importantly, mammalian LIN28 works as 
pluripotency factor, which when overexpressed together with OCT4, SOX2 and NANOG can 
even dedifferentiate terminally differentiated cells to give rise to induced pluripotent stem 
cells (Yu et al., 2007b). This activity might in part depend on the decrease of let-7 levels to 
re-induce pluriotency (Shyh-Chang et al., 2013). Not surprisingly, mammalian LIN28 
overexpression has been demonstrated to drive cancer progression and metastasis in a variety 
of tumors (Zhou et al., 2013; Thornton and Gregory, 2012). Thereby strong repression of let-7 
shifts transformed cells toward self-renewal and a high proliferative capacity, hallmarks of 
these tumors (Thornton and Gregory, 2012; Murray et al., 2013). However, the regulation of 
let-7 by lin-28 is not unidirectional, but comprises an autoregulatory feedback as lin-
28/LIN28 belongs to the conserved let-7 targets (Rybak et al., 2008; Grosshans et al., 2005). 
Notably also the lin-4 homolog mir-125b has a conserved role in regulating lin-28/LIN28 
levels and consequentially affects differentiation across tissues (Rybak et al., 2008; Zhang et 
al., 2011; Wu and Belasco, 2005).  
Finally, in addition to the pivotal role of LIN-28 in stemness and tumorigenesis, LIN-28 
polymorphisms have recently been associated with the precocious onset of puberty in 
humans, revealing a remarkable degree of functional conservation not only on the molecular, 
but also on the organismal level (Park et al., 2012; Zhu et al., 2010; Ong et al., 2009).  
In sum, C. elegans and mammalian developmental timing mechanisms show many analogies 
on a cellular and a molecular level, although their life histories are apparently different. Thus 
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studying developmental timing mechanisms in lower organisms might further inform 
temporal control of developmental progression and differentiation in mammals, and might 
lead to the discovery of novel molecular timing devices. Across species, the specific and 
precise regulation of protein abundance is key to coordinated developmental progression, but 




1.2 Ubiquitin-Mediated Proteolysis 
1.2.1 Ubiquitin Proteasome System (UPS) 
Already more than 70 years ago, Schoenheimer and coworkers discovered the dynamic state 
of cellular proteins (Schoenheimer, 1942). They found that isotope-labeled amino acids fed to 
rats were not entirely excreted, but isotopes were present in extracted proteins, indicating their 
partial or full renewal. However, the biochemical mechanisms underlying protein homeostasis 
and in particular protein turnover have begun to be uncovered only decades later. 
Notably, the discovery of the canonical ubiquitin-dependent proteolysis pathway early in the 
1980s was honored with a Nobel prize in chemistry in 2004 (Ciechanover et al., 1980; 
Hershko et al., 1980; Wilkinson, 2005). The 76 amino acid polypeptide ubiquitin was initially 
purified from bovine thymus, but later shown to be ubiquitously expressed and extremely 
conserved among all eukaryotes (Goldstein et al., 1975; Hershko and Ciechanover, 1998). It 
constitutes the most prominent member of a class of ubiquitin-like modifiers, which change 
the properties of a target protein upon post-translational covalent linkage (Komander and 
Rape, 2012; Vertegaal, 2007). Today we know that thousands of proteins get modified by 
ubiquitination, which most predominantly triggers their subsequent proteasomal degradation, 
but also can induce a variety of alternative fates, including lysosomal degradation, as well as 
non-proteolytic fates such as regulation of protein interactions, activity, and localization 
(Figure 4) (Komander and Rape, 2012; Pickart and Fushman, 2004). 
 
Figure	  4:	  Mechanism	  and	  Cellular	  Fates	  of	  Protein	  Ubiquitination	  
Target	   proteins	   are	   ubiquitinated	   by	   an	   enzymatic	   cascade	   of	   E1,	   E2	   and	   E3	   enzymes.	   Number	   and	   linkage	   of	   ubiquitin	  
moieties	   can	   direct	   the	   target	   protein	   to	   distinct	   cellular	   fates.	   Poly-­‐ubiquitination	   (mainly	   Lys48	   linked)	   predominantly	  
triggers	   degradation	   of	   the	   target	   protein	   via	   the	   26S	   proteasome.	   Deubiquitinating	   enzymes	   (DUBs)	   antagonize	   the	  




















Covalent ligation of ubiquitin to a target protein is catalyzed by a 3-step enzymatic cascade 
(Figure 4): ubiquitin-activating enzymes (E1) form a thioester bond between the C-terminal 
Gly of ubiquitin and a Cys residue of the E1 enzyme in an ATP-dependent reaction. Activated 
ubiquitin is then transferred to a Cys residue in the active site of an ubiquitin-conjugating 
enzyme (E2). In the final step an ubiquitin ligase (E3) links the ubiquitin C-terminus via an 
isopeptide bond to the ε-amino group of a target proteins Lys residue. The attachment of a 
single ubiquitin to a target protein (monoubiquitination) is commonly though to regulate 
protein interaction or localization (Hicke, 2001). Repetitive action of an E3 ligase results in 
polyubiquitin chains through conjugation of ubiquitin to one of the seven Lys residues of a 
preceding ubiquitin (Lys6, -11, -27, -29, -33, -48, or -63) (Hershko and Ciechanover, 1998). 
Notably, ubiquitin chain elongation can be supported by a 4th class of enzymes (E4 ligases), 
which specifically promote polyubiquitination of short ubiquitin chains (Koegl et al., 1999; 
Hoppe et al., 2004; Hoppe, 2005). Depending on the linkage between the ubiquitin molecules, 
the chain on a target protein can be recognized by linkage-specific adapters, which couple the 
chain topology to a particular outcome (Dikic et al., 2009; Dikic and Dötsch, 2009; Komander 
and Rape, 2012; Pickart and Fushman, 2004; Thrower et al., 2000). While Lys63 linkages 
predominantly affect DNA damage responses and protein trafficking (Spence et al., 1995; 
Galan and Haguenauer-Tsapis, 1997; Hicke and Dunn, 2003), polyubiquitin chains linked via 
Lys11, Lys29, and Lys48 mainly label target proteins for subsequent degradation via the 26S 
proteasome (Chau et al., 1989; Finley et al., 1994; Komander and Rape, 2012).  
The 26S proteasome is a multi-subunit complex present in cytosol and nucleus, consisting of 
a multi-catalytic core subunit (20S) and two regulatory caps (19S) on each site of the barrel-
shaped core (Bedford et al., 2010; Wójcik and DeMartino, 2003). Proteins labeled for 
proteasomal degradation are recognized by ubiquitin binding domain-containing receptors 
exposed on the proteasome surface, then get unfolded, deubiquitinated, and proteolyzed to 
small polypeptides. Deubiquitination is carried out by C-terminal hydrolases (deubiquitinases, 
DUBs), which function as natural counterparts to the ubiquitination machinery and constantly 
recycle ubiquitin molecules (Figure 4) (Komander et al., 2009). Recent studies unraveled a 
major role, in particular for linkage-specific DUBs, in the sophisticated process of ubiquitin 
chain editing (Komander and Rape, 2012). Although extensive research on the ubiquitin code 




In sum, posttranslational modification by ubiquitin, and in particular ubiquitin-dependent 
proteolysis of regulatory proteins, such as cyclins, transcription factors, oncoproteins, and 
tumor suppressors directs distinct cellular fates in health and disease. Therefore the UPS is a 
key contributor to the control of intracellular protein homeostasis and acts in an active and 
highly time- and substrate-specific manner. The diversity of ubiquitin’s biological targets and 
functional outcomes of ubiquitination raises the question of how specificity is ensured within 
the ubiquitination pathway. 
1.2.2 Specificity of the Canonical UPS Pathway – E3-Ubiquitin Ligases 
The large protein superfamily of E3-ubiquitin ligases selects target proteins and directly or 
indirectly determines the topology of conjugated ubiquitin moieties by recruiting specific E2 
enzymes and mediating the terminal ubiquitin transfer. 
Across species, the number of E3 ligases largely exceeds the number of E1 and E2 enzymes. 
For example in humans, there are only two E1 enzymes (1 in C. elegans), about 38 E2 
enzymes (20 in C. elegans), but more than 600 E3 ligases (about 170 in C. elegans) (Kipreos, 
2005; Skaar et al., 2009b; Deshaies and Joazeiro, 2009). One distinguishes two major classes 
of E3 ligases in eukaryotes depending on the presence of either a HECT (Homologous to the 
E6-AP Carboxyl Terminus) or a RING (Really Interesting New Gene) domain, which both 
are involved in the recruitment of the E2-conjugating enzyme. Interestingly, these two classes 
also catalyze ubiquitin-transfer by distinct mechanisms: While HECT domain E3-ligases 
contain a conserved Cys-residue that forms and intermediate thioester bond with the ubiquitin 
C-terminus, RING domain E3 ligases facilitate the direct transfer of ubiquitin from the 
conjugating E2 enzyme to the target’s Lys by bringing them in close spatial proximity 
(Passmore and Barford, 2004; Scheffner et al., 1995). In addition to these two major classes 
there is a third, small family of E3-ubiquitin ligases, containing a U-box domain, a specified 
RING finger (Fang et al., 2003). 
Given the substrate diversity, additional mechanisms must exist to ensure target specificity. 
While HECT E3s and many RING E3 ligases act as monomers, some RING E3 ligases form 
multimeric complexes (Feldman et al., 1997; Deshaies and Joazeiro, 2009). Pioneering work 
in C. elegans and yeast uncovered this large class of E3 ligases termed Cullin-RING ubiquitin 
ligases (CRL) which are built on different Cullin scaffolds (8 in humans, 6 in C. elegans) and 
can incorporate an enormous variety of substrate-recognition subunits (SRS) (Petroski and 
Deshaies, 2005; Deshaies and Joazeiro, 2009; Sarikas et al., 2011). The archetypal CRLs, 
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which are built on CUL1, are named S phase kinase-associated protein 1 (SKP1)- Cullin1 
(CUL1)- F-box protein complexes (SCF complexes) and are the by far best characterized 
(Table 2 and Figure 5) (Feldman et al., 1997; Petroski and Deshaies, 2005). The modular 
composition of related CRLs is summarized in Table 2.  
Table	  2	  :	  Overview	  of	  Cullin-­‐RING	  Ligase	  Complex	  Components	  
BTB	  broad	  complex,	   tramtrack,	  bric-­‐a-­‐brac;	  SOCS	   suppressor	  of	   cytokine	   signaling;	  DDB1	  DNA	  damage	  binding	  protein-­‐1;	  
DCAF	  DDB1	  and	  CUL4	  associated	  factor;	  RBX	  ring-­‐box	  protein;	  SKP1	  S	  phase	  kinase-­‐associated	  protein-­‐1;	  APC	  adenomatosis	  
polyposis	  coli-­‐2.	  The	  SCF	  complex	  is	  indicated	  in	  blue.	  
	  
Cullin Adapter Substrate recognition subunit RING 
CUL1 SKP1 F-Box protein RBX1 
CUL2 Elongin C/B SOCS-box protein RBX1 
CUL3 BTB-domain protein RBX1 
CUL4A DDB1 DCAF RBX1 
CUL4B DDB1 DCAF RBX1 
CUL5 Elongin C/B SOCS-box protein RBX2 
Atypical and Cullin-related ligases 
CUL7*  SKP1 FBXW8 RBX1 
CUL9*/PARC ? ? RBX1 
APC2 ? CDC20 or CDH1 APC11 
*not conserved in nematodes 
1.2.3 SCF E3-Ubiquitin Ligase Complexes 
SCF complexes are assembled on a CUL1 scaffold that bridges the two essential biochemical 
functions (Figure 5): the CUL1 C-terminus binds the small RING domain protein RBX1 that 
recruits the E2 enzyme, while the N-terminus is linked to the F-box protein through a SKP1 
adapter. In humans there is only one adapter protein, SKP-1, whereas the C. elegans genome 
encodes 21 skp-1 related genes (skr) (Yamanaka et al., 2002). Eight of the skr genes were 
found to interact with C. elegans cul-1, of which skr-1 and -2 show the closest homology to 
human SKP-1 (Yamanaka et al., 2002; Nayak et al., 2002). Importantly, target specificity of 
SCF complexes is ensured by the F-box protein, which functions as SRS that directly binds 
the substrate (Skowyra et al., 1997). 
Figure	  5	  Schematic	  Structure	  of	  SCF	  E3-­‐Ubiquitin	  Ligase	  Complexes	  
Schematic	   representation	   of	   a	   CUL1-­‐based	   SCF	   E3-­‐ubiquitin	   ligase	  
complex:	   E2	   enzyme	   and	   substrate	   (SUB)	   get	   closely	   linked	   to	  
facilitate	   ubiquitin	   transfer.	   A	   ring	   finger	   containing	   protein	   (e.g.	  
RBX1)	   recruits	   the	   E2	   enzymes,	   while	   the	   F-­‐box	   protein	   binds	   the	  
substrate.	  SKR1	  functions	  as	  adapter	  to	  attach	  the	  F-­‐box	  protein	  to	  














In addition to their substrate specificity, CLRs are themselves regulated in abundance and 
activity: First, multiple SCF complexes have been shown to have autocatalytic ubiquitination 
activity targeting the F-box protein for degradation, in particular in the absence of substrates, 
which can have shielding function (Yen and Elledge, 2008; Galan and Peter, 1999; Li et al., 
2004). Second, SCF complexes and most other CRLs (except for CUL7-based) can be 
activated by neddylation, whereby the small ubiquitin-like protein Nedd8 gets covalently 
linked to a specific Lys residue of the Cullin scaffold itself (Hori et al., 1999; Pan et al., 
2004). This modification induces a conformational change that brings the E2 enzyme in 
closer proximity to the F-box protein-bound substrate and thus facilitates the ubiquitin 
transfer (Duda et al., 2008). Like ubiquitination, neddylation is catalyzed by an enzymatic 
triad, whereby Cullin functions as its own E3 ligase (Kamura et al., 1999). Nedd8 can be 
removed from Cullins via the COP9 signalosome, a large multisubunit comlex (Cope and 
Deshaies, 2003). Third, the conserved Cullin-associated and neddylation-dissociated protein-1 
(CAND1) can bind unneddylated Cullins by competing with the adapter/SRS to sequester the 
complex in an inactive and disassembled state ( Liu et al., 2002; Zheng et al., 2002). Cycles 
of SCF complex assembly and disassembly can prevent autoubiquitination of the F-box 
protein and enable binding of alternative SRS to the core scaffold (Pierce et al., 2013). Thus, 
neddylation and deneddylation act in concert with CAND1 to modulate SCF complex 
specificity and activity. Finally, additional levels of SCF complex regulation have more 
recently been uncovered, including allosteric regulation by small molecules, inhibition by 
pseudosubstrates, and substrate competition (Deshaies and Joazeiro, 2009).  
1.2.4 F-box Proteins – the Key to Substrate Recognition 
F-box proteins function as the substrate-recognition components of SCF complexes, thus 
conferring substrate-specificity to the UPS. Across species, a variety of F-box proteins can 
bind to the core SCF scaffold, each targeting multiple substrates, thus enabling SCF 
complexes to specifically label hundreds of proteins for subsequent degradation (Jin et al., 
2004; Skaar et al., 2009a; 2009b). The human genome encodes ‘only’ 69 F-box proteins, 
whereas the number of predicted F-box proteins in the nematode exceeds 500 (Skaar et al., 
2009b; Thomas, 2006). However only a handful of C. elegans F-box proteins are conserved 
across all major taxa (Table 3). The F-box domain describes a conserved 40 amino acid 
stretch that was termed after its presence in cyclin F/FBXO1 and that mediates binding to the 
SKP1 adapter and therefore the core scaffold (Bai et al., 1996). F-box proteins can be 
categorized into three classes depending on the presence of homology domains besides the F-
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box (Jin et al., 2004): FBXW proteins contain WD40 repeats (12 members in humans), FBXL 
proteins contain Leu-rich repeats (21 members in humans), and all other F-box proteins are 
referred to as F-box only (FBXO). However, FBXO proteins also contain conserved 
recognizable domains that they do not share with multiple other F-box proteins, but which 
have been shown to be involved in direct substrate binding (D'Angiolella et al., 2012; Duan et 
al., 2012). Therefore the term FBXO more recently refers to F-box and other domains. 
In response to certain triggers, for example during cell cycle coordination, F-box proteins 
must rapidly and specifically bind their target to promote its ubiquitination. Thereby substrate 
recognition generally requires prior post-translational modification of the target, which makes 
substrate recruitment the ultimate regulatory level of SCF complex-mediated ubiquitination. 
In the canonical model F-box proteins have a high affinity for short, defined degradation 
motifs termed degrons, predominantly when they are phosphorylated (phosphodegrons) 
(Ravid and Hochstrasser, 2008). Prime examples include β-TRCP/FBXW1 and FBXW7, 
which recognize specific phosphodegrons of their targets through the WD40 repeats (Wu et 
al., 2003; Hao et al., 2007). Besides phosphodegrons multiple regulatory mechanisms of 
substrate-recognition have emerged: F-box proteins can bind unmodified degrons, 
glycosylated degrons, require cofactors or small molecules for degron binding, or even detect 
larger domain structures (Skaar et al., 2013). Together with the regulation of the SCF core 
scaffold described above, substrate recruitment confers temporal and context-dependent 
specificity to SCF-complex mediated protein degradation. 
Physiologically, F-box protein-substrate modules affect a wide range of cellular processes in 
health and disease states, including cell death and survival, cell differentiation as well as 
developmental timing (Skaar et al., 2013). However F-box proteins are predominantly studied 
in the context of cell proliferation, as they target multiple cell cycle regulators. Not 
surprisingly dysregulation of F-box proteins such as truncation or hyperactivation has been 
closely linked to the onset of tumorigenesis by aberrantly modulating levels of substrates with 
oncogenic or tumor suppressive activity. Examples include β-TRCP, FBXL7, and SKP2. The 
latter is an oncogene that when overexpressed degrades the CDK inhibitor and tumor 
suppressor p27/Kip1. In contrast FBXL7 is found to be inactivated in numerous tumor tissues 
(Welcker and Clurman, 2008; Frescas and Pagano, 2008). In addition to their key role in 
tumorigenesis, F-box proteins such as β-TRCP, FBXL3, and FBXL21 govern circadian 
rhythms by degrading PER1 and 2 as well as CRY1 and 2, which constitute major regulators 
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of the core circadian clock system (Busino et al., 2007; Yoo et al., 2013; Shirogane et al., 
2005).  
In C. elegans only a few F-box proteins have been carefully investigated, which led to the 
discovery of several conserved F-box protein-substrate modules (Table 3). Most conserved F-
box proteins, including mec-15/FBXW9, sel-10/FBXW7, lin-23/β-TRCP, and fsn-1/FBXO45 
contribute to the regulation of axon guidance and synapsis dynamics in the nematode (Ding et 
al., 2007; Sun et al., 2013; Liao et al., 2004; Mehta et al., 2004; Segref and Hoppe, 2009). 
Furthermore, lin-23 was shown to affect cell cycle progression, while fsn-1 regulates germ 
cell apoptosis through CEP-1/p53 (Kipreos et al., 2000; Gao et al., 2008). Taken together, 
these findings highlight the diversity of F-box protein regulated processes across species and 
exemplifies their context and time-specific mode of action. However, although multiple 
orphan F-box proteins have been associated with biological processes particularly in disease 
states, their cognate proteolytic substrate remain elusive. 
Table	  3:	  Conserved	  C.	  elegans	  F-­‐box	  Proteins	  and	  Substrates	  Identified	  
Conserved	  C.	  elegans	  F-­‐box	  proteins	  and	  identified	  substrates	  are	  shown.	  Substrates	  depicted	  in	  grey	  yet	  require	  additional	  
experimental	  evidence.	  If	  conserved,	  also	  confirmed	  mammalian	  substrates	  are	  listed.	  For	  additional	  mammalian	  substrates	  
see	  (Skaar	  et	  al.,	  2009b).	  References:	  1	  Jin	  et	  al.,	  2004;	  2	  Thomas	  et	  al.,	  2006;	  3	  Shaye	  et	  al.,	  2011	  
 
C. elegans 
gene Substrates (C. elegans) Closest human homolog 
Selected substrates 
(mammals) 
C10E2.2  (FBXO30, FBXO40)3  
T28B11.1  ZCCHC102  
mec-15  FBXW91,2,3  
dre-1 
CED-9/BCL2 
(Chiorazzi et al., 2013) 
FBXO111,2,3 
BCL2 
(Chiorazzi et al., 2013) 
sel-10 
LIN-12/Notch 
(Hubbard et al., 1997); 
LIN-45/BRAF 
(la Cova and Greenwald, 2012) 
FBXW71,2,3 
Notch1 




(Dreier et al., 2005) 
(β-TRCP, FBXW11) 1,2,  
β-Catenin 
(Latres et al., 1999) 




C02F5.7   FBXL21,2,3  
C14B1.3   
(NCCRP1, FBXO10, FBXO27, 
FBXO2, FBXO44, FBXO6) 1,2  
fsn-1 
SCD-1/ALK 
(Liao et al., 2004) 
CEP-1/p53 
(Gao et al., 2008) 
FBXO452,3 
p73 
(Peschiaroli et al., 
2009) 
mfb-1 1,2,3  (FBXO25, FBXO32) 1,2,3  
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1.2.5 F-box Protein-Substrate Pair Identification 
In the 15 years of research on SCF complexes more than 100 substrates have been identified 
by distinct experimental approaches. However, many studies demonstrated that the F-box 
protein-substrate interaction is very transient and target identification still remains one of the 
most important challenges in the SCF complex field. 
The combination of a wealth of genetic and biochemical approaches in yeast led to the 
discovery of the first SCFCDC4/FBXW7 complex including the associated E2 ligase and the first 
substrate Sic1/p27Kip1 (Willems et al., 1996; Bai et al., 1996; Skowyra et al., 1997; Feldman 
et al., 1997; Mathias et al., 1996). Typically, involvement of an SCF complex in the turnover 
of an unstable protein was examined genetically, by either using temperature-sensitive SCF-
complex mutants, RNAi/shRNA depletion, or by overexpressing a dominant negative form of 
CUL1 (DN-CUL1) (Koepp et al., 2001; Donzelli et al., 2002; Jin et al., 2005). DN-CUL1 
lacks the C-terminus and thus the ability to recruit the E2 ligase, but retains its interaction 
with the SKP1 adapter, ultimately stabilizing the target protein (Jin et al., 2005). Biochemical 
approaches using libraries of F-box expression constructs in yeast two-hybrid systems were 
generally applied to identify the cognate F-box protein (Drury et al., 1997; Thomas et al., 
1995). In these assays, F-box deletion mutants have been successfully used to identify binding 
partners as they sequester the target protein from the degradation machinery (Margottin et al., 
1998). Also in C. elegans a genetic approach based on an EMS mutagenesis screen for 
reversion of sel-10//FBXW7 egg-laying defects resulted in the discovery of a highly 
conserved F-box substrate lin-12/Notch (Hubbard et al., 1997; Sundaram and Greenwald, 
1993). More recently, GFP fusion libraries allowed an unbiased approach to identify 
mammalian F-box substrates by expressing a library of ORFs fused to GFP in a wild type and 
F-box mutant background screening for GFP accumulation (Benanti et al., 2007; Yen and 
Elledge, 2008). Pagano’s group modified a conventional pull-down assay by adding ubiquitin 
conjugating components and tagged-ubiquitin to immunopurified SCF complexes to then 
recover proteins that incorporated the tagged ubiquitin and identify them by mass 
spectrometry (Peschiaroli et al., 2006). Still today F-box protein purification followed by 
mass spectrometry combined with the use of DN-CUL-1, proteasome inhibition, or F-box 
deletion mutants is the standard technique to identify F-box substrates, but it remains a 
challenging task.  
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1.3 DRE-1/FBXO11 – Connecting Selective Degradation to 
Developmental Timing Control 
1.3.1 DRE-1 
dre-1 encodes one of a handful of C. elegans F-box proteins that are conserved across all 
major taxa (Table 3) and it was shown to function in a SCF E3-ubiquitin ligase complex 
(Fielenbach et al., 2007; Shaye and Greenwald, 2011). Besides the N-terminal F-box domain 
DRE-1 contains no WD40 or Leu-rich domains, but three CASH (carbohydrate binding and 
sugar hydrolysis) domains situated in a region of 18 predicted β-sheets (Figure 6). 
Furthermore, this region is predicted to harbor protein arginine methyl transferase activity, 
although this could not be confirmed experimentally (Cook et al., 2006; Fielenbach et al., 
2007). Finally, at the C-terminus DRE-1 contains a zinc-finger motif homologous to ZnF-
UBR, which is associated with the N-end rule of substrate recognition (Figure 6) (Kwon et 
al., 1998; Tasaki et al., 2005). Thereby a proteins half-life was found to be dependent on the 
N-terminal amino acid, which can induce UPS-dependent protein degradation after its 
detection by N-recognins (Bartel et al., 1990; Bachmair et al., 1986; Dougan et al., 2012). 
 
Figure	  6:	  DRE-­‐1	  Protein	  is	  Evolutionary	  Conserved	  
Domain	  structure,	  mutations	  and	  multiple	  sequence	  alignment	  of	  C.	  elegans	  DRE-­‐1	  and	  human	  FBXO11	  showing	  sequence	  
similarity	   of	   homologous	   domains.	   F-­‐box	   domain,	   red;	   carbohydrate	   binding	   and	   sugar	   hydrolysis	   (CASH)	   domains,	   dark	  
green;	  zinc	   finger,	   light	  green.	  C.	  elegans	  DRE-­‐1	   (NP_504661);	  Homo	  sapiens	  FBXO11	   (NP_079409).	  Figure	  modified	   from	  
(Fielenbach	  et	  al.,	  2007).	  
	  
dre-1 was identified in a daf-12(rh61rh411) null mutant enhancer screen for daf-12 redundant 
functions in gonadal heterochrony (Fielenbach et al., 2007). As mentioned above, daf-
12(rh61rh411) null mutants show a near WT-like gonad migration pattern, while daf-
12(rh61) LBD mutants display strong gonadal migration defects, pointing toward potential 
daf-12 coactivators to act redundantly with daf-12 in gonadal heterochrony (Antebi et al., 
1998; 2000). dre-1(dh99);daf-12(rh61rh411) double mutants, but neither single mutant, give 
rise to a penetrant synthetic gonadal migration defect (Fielenbach et al., 2007). Similarly dre-
1;lin-29 and daf-12;lin-29 mutants unveil a strong synthetic migration defect, in which both 








H. sapiens FBXO11 (59%)
39% 71% 84% 68% 70%
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as a repetition of L2-specific gonadal programs with concomitant prevention of L3-programs 
and indicates a global redundant function of dre-1 in gonadal heterochrony. 
On their own, dre-1 hypomorphic mutants also display heterochronic phenotypes in 
epidermal tissue: seam cells fuse and form adult alae precociously in L3 larvae, a full stage 
ahead of schedule, suggesting that dre-1(+) specifies late larval programs (Fielenbach et al., 
2007). Conversely a subset of seam cells display adult alae gaps, which have been reported in 
various retarded heterochronic mutants (Slack et al., 2000). As both precocious and retarded 
phenotypes of dre-1 hypomorphic mutants are not fully penetrant, dre-1 is assigned a 
modulatory function at the larval-to-adult transition in the epidermis. This was supported by 
genetic epistasis experiments, which place dre-1 upstream of lin-29 and downstream or 
parallel to the let-7 microRNA (Fielenbach et al., 2007). Interestingly, dre-1 null mutants fail 
to hatch or arrest in the L1 stage, often displaying molting defects, which places dre-1 in line 
with lin-42/Period and nhr-25/SF1 as regulators of both developmental timing and the molt 
cycle (Fielenbach et al., 2007). Consistent with its diverse phenotypes, dre-1 is expressed 
throughout development in a variety of tissues including hypodermis and epidermal seams, 
dtcs, the anchor cell, and multiple neurons in head, tail, ventral cord and periphery 
(Fielenbach et al., 2007). More recently, dre-1 was shown to be expressed in the tail-spike 
cell and required for its programmed death several hours after birth (Chiorazzi et al., 2013; 
Sulston et al., 1983). Here, dre-1 functions through ced-9/BCL2, presumably by directly 
regulating its protein turnover (Chiorazzi et al., 2013). However, the dre-1 substrate(s) 
regulating C. elegans developmental timing and molting still remain to be elucidated. 
1.3.2 FBXO11 
C. elegans dre-1 shares 59% sequence homology with its human homolog FBXO11 
(Figure 6). In mice, FBXO11 protein is detected from embryonic day 9.5 and expressed in a 
wide range of tissues during development such as heart, muscle, liver, lung, palatal epithelia, 
adrenal gland, kidney, osteoblasts, spleen, bone marrow, hematopoietic cells, skin, and the 
middle ear (Hardisty-Hughes et al., 2006). Homozygous mutation of Fbxo11 results in facial 
clefting, cleft palate defects, and perinatal lethality as observed in Mutt and Jeff mutant mice, 
which were identified in ENU mutagenesis screens for deafness (Hardisty et al., 2003; 
Hardisty-Hughes et al., 2006). Furthermore, FBXO11 haploinsufficient mice develop chronic 
otitis media, an inflammation of the middle ear that affects about 15% of young children 
(Bluestone and Klein, 2001; Hardisty-Hughes et al., 2006). Interestingly, also in humans 
FBXO11 SNPs have been correlated with the onset of this hearing impairment (Segade et al., 
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2006; Rye et al., 2011). Finally, FBXO11 loss of function contributes to the pathogenesis of 
diffuse large B cell lymphomas and FBXO11 mutations are frequently found in other cancers, 
such as colon, neck, ovary, lung, and head tumors (Richter et al., 2012; Yoshida et al., 2011; 
Stransky et al., 2011; Kan et al., 2010). In particular, FBXO11 functions as tumor suppressor 
in B cells by controlling the stability of the oncoprotein BCL6, which was the first FBXO11 
substrate to be identified (Duan et al., 2012). However, the substrate(s) causative for 




1.4 Aim of Thesis 
Developmental progression is orchestrated by the collective action of microRNAs, 
transcriptional, translational, and post-translational regulators that integrate environmental 
cues and translate them into molecular traits. In C. elegans, these temporal selectors are 
termed heterochronic genes and they time cellular fates in a highly tissue-specific manner. In 
particular in epidermal seam cells three microRNA-mediated switches regulate developmental 
progression, which are largely regulated by food availability and general environmental 
conditions in part transduced through the nuclear hormone receptor DAF-12. Originally 
identified as daf-12 enhancer in gonadal heterochrony, the highly conserved F-box protein 
DRE-1 was shown to regulate the larval-to-adult transition in the epidermis (Fielenbach et al., 
2007). F-box proteins function as substrate-recognition components of SCF E3-ubiquitin 
ligase complexes, thus conferring substrate specificity to the UPS. Interestingly, also the 
mammalian homolog of DRE-1, FBXO11 has been linked to developmental alterations in 
mice and men, including facial clefting and otitis media. Moreover, it was recently shown to 
be a tumor suppressor by controlling BCL6 turnover in lymphocytes. Despite extensive 
research on the about 70 SCF complexes in humans, many F-box proteins remain orphan 
receptors or the discovered targets cannot fully explain their cellular and organism-wide 
functions. The temporal control of protein abundance and activity is largely mediated by the 
UPS and naturally essential for the control of developmental progression. In particular 
oscillating or transiently peaking proteins underlie a quick and precise degradation process. 
Two of the over 30 heterochronic genes, LIN-41 and DRE-1 encode proteins that harbor 
ubiquitin ligase activity. However, besides controversial work on mammalian LIN-41, which 
might target mammalian Argonaute proteins, the cognate substrates regulating developmental 
timing and cellular differentiation remain largely elusive. 
During my doctorate I aimed to identify novel substrate(s) of the SCFDRE-1/FBXO11 complex that 
coordinate developmental progression to shed light on the mechanisms of post-translational 
control of biological timing. I expected to find heterochronic genes that, if unknown, would 
be characterized with regard to their function in C. elegans maturation to further deepen our 
understanding of regulatory developmental timing circuits 
 








In parallel and simultaneous approaches, the group of Michele Pagano and our group 
identified two conserved substrates of the SCFDRE-1/FBXO11 E3-ubiquitin ligase complex, CDT2 
and BLMP-1. 
2.1 CDT2 – a Cell Cycle Regulator Targeted by DRE-1/FBXO11 
2.1.1 Identification of CDT2 as FBXO11 Substrate by the Pagano 
Laboratory 
After identification of the first FBXO11 substrate BCL6 (Duan et al., 2012), Pagano and 
coworkers aimed to identify novel substrates of FBXO11 in an unbiased fashion to further 
elucidate its physiological functions. Therefore, they expressed FLAG-HA-tagged FBXO11 
or a tagged version of the paralog FBXO10 as control in HEK293T cells and stabilized 
potential substrates by either coexpressing a DN-CUL1(1-385) or by inhibiting the 
proteasome (Rossi et al., 2013). Immunopurified SCF complexes were analyzed by 
multidimensional protein identification technology (MudPIT) (Florens and Washburn, 2006). 
CDT2 peptides were present specifically in the FBXO11 purifications that were treated with 
DN-CUL1 or proteasome inhibitor (Rossi et al., 2013). Likewise, in a parallel approach using 
siRNA-based screening, the Dutta group found FBXO11 to be a major regulator of CDT2 
stability (Abbas et al., 2013a). 
CDT2 (Cdc10-dependent transcript 2) encodes a highly conserved DBB1 (DNA damage-
binding protein 1) and CUL4 associated protein that functions as substrate recognition 
component of a CUL4A-based CRL. CRL4CDT2 has been shown to be a major regulator of cell 
cycle progression and the DNA-repair machinery by targeting the replication initiation factor 
CDT1 (Cdc10-dependent transcript 1), the CDK inhibitor p21, and the histone 4 
methyltransferase (H4K20) Set8 for proteasomal degradation (Abbas et al., 2010; Abbas and 
Dutta, 2011; Terai et al., 2010; Abbas et al., 2008; Centore et al., 2010; Kim et al., 2008; 
Jørgensen et al., 2011). In particular, CRL4CDT2 ubiquitinates its targets during S phase and in 
response to DNA damage in a PCNA-dependent manner to promote cell cycle progression, 
prevent aberrant re-replication, and induce DNA repair mechanisms (Abbas and Dutta, 2011). 
As described above, SRS stability of E3 ligases is frequently controlled by autoubiquitination 
(Galan and Peter, 1999; Yen and Elledge, 2008), which was recently also demonstrated for 
CDT2 (Abbas et al., 2013a). However, through extensive biochemical analysis, both Rossi et 
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al. and Abbas et al. independently showed CDT2 stability to be additionally controlled by the 
SCFFBXO11 complex (Figure 7) (Rossi et al., 2013; Abbas et al., 2013a). Interestingly, Pagano 
and colleagues found CDK-mediated Thr464 phosphorylation of CDT2 in proliferating cells 
to prevent FBXO11-dependent CDT2 ubiquitination and degradation (Rossi et al., 2013). 
This finding is in contrast to the paradigm of phosphorylation-dependent substrate recognition 
by F-box proteins and describes a novel mechanism of substrate recruitment to SCF-
complexes (Skaar et al., 2013). Physiologically, serum starvation or TGF-β treatment inhibits 
CDKs and promotes exit from the cell cycle via FBXO11-dependent degradation of then 
unphosphorylated CDT2. Consistently, FBXO11 depletion delays cell cycle exit through 
stabilized CDT2 (Figure 7) (Rossi et al., 2013). Furthermore, FBXO11 restrains TGF-β 
responses within a cell via CDT2 degradation and stabilization of its target Set8, which in 
turn prevents accumulation of the TGF-β downstream effector PhosphoSMAD2 by an 
unknown mechanism (Figure 7) (Abbas et al., 2013a; 2013b). Consistently, PhosphoSMAD2 
levels have been found to be aberrantly elevated in epithelia of homozygous Fbxo11 Jeff 
mutant mice (Tateossian et al., 2009). 
 
Figure	  7:	  FBXO11	  Regulates	  CDT2-­‐Dependent	  Processes	  by	  Controlling	  its	  Turnover	  
Model	  of	  FBXO11/CDT2	  function	   in	  mammals:	  FBXO11	  triggers	  CDT2	  degradation	  via	  the	  proteasome	  and	  thus	   interferes	  
with	  CDT2-­‐dependent	  processes	  such	  as	  cell	  cycle	  progression,	  TGF-­‐β	  signaling,	  and	  DNA	  repair	  mechanisms.	  Notably	  CDT2	  
itself	  is	  part	  of	  a	  CRL	  complex	  and	  controls	  the	  proteasomal	  turnover	  of	  multiple	  substrates	  including	  Set8,	  CDT1	  and	  p21,	  
which	  are	  key	  mediators	  of	  CDT2-­‐dependent	  processes.	  CDT2	  phosphorylation	  by	  cyclin-­‐dependent	  kinases	  (CDKs)	  prevents	  
the	  CDT2-­‐FBXO11	  interaction	  and	  stabilizes	  CDT2.	  
 
2.1.2 dre-1 and cdt-2 Genetically Interact in C. elegans 
Since both FBXO11 and CDT2 are highly conserved in C. elegans, and also their physical 
association was shown to be conserved (Rossi et al., 2013), I used C. elegans as a model to 
validate some of the major findings in vivo. During terminal differentiation C. elegans seam 
cells fuse, exit the cell cycle, and synthesize a continuous cuticular structure called adult alae. 
dre-1 mutants show various alterations in seam cell fates including precocious seam cell 






















heterochronic mutants, such as let-7, where individual cells fail to exit the cell cycle (Slack et 
al., 2000). Furthermore, dre-1;daf-12 mutants exhibit a synthetic gonadal migration defect in 
which both dtcs fail to reflex and continue migrating straight into head and tail (Fielenbach et 
al., 2007). Given that DRE-1 functions as substrate recognition component of a SCF complex, 
we hypothesized elevated substrate levels to cause dre-1 mutant developmental alterations. If 
CDT-2 were a cognate substrate, its depletion should ameliorate such phenotypes. 
 
Figure	   8:	   cdt-­‐2	   Depletion	   Suppresses	   dre-­‐
1(dh99)	  Mutant	  Alae	  Gap	  Phenotype	  
(A)	   Representative	   DIC	   images	   of	   dre-­‐1(dh99)	  
mutant	   young	   adult	   animals	   grown	   on	   L4440	  
empty	  vector	  control	  or	  cdt-­‐2	  RNAi.	  Scale	  bar	  =	  
10	   µm.	   (B)	   cdt-­‐2	   depletion	   restores	   complete	  
alae	   formation	   in	   dre-­‐1(dh99)	   mutants.	  




Knockdown of cdt-2 by RNAi was confirmed by qRT-PCR and by a significant increase in 
nuclei size of blast cells, such as the seams (Kim et al., 2008). Importantly, cdt-2 depletion 
strikingly reduced the appearance of gaps in the adult alae of dre-1(dh99) mutants from 56% 
to 13% (Figure 8). Surprisingly, the precocious seam cell fusion, as well as the synthetic 
gonadal migration defects of dre-1 mutants were fully cdt-2 independent (Figure 9), 
indicating that dre-1 and cdt-2 only interact for the process of adult alae formation. On its 
own, cdt-2 depletion did not show overt heterochronic phenotypes in the seam or gonad.  
	  
	  
Figure	  9:	  cdt-­‐2	  Depletion	  does	  not	  Affect	  Related	  dre-­‐1	  Mutant	  Phenotypes	  
(A)	  Representative	  fluorescence	  images	  of	  seam	  cell	  adherence	  junctions	  as	  visualized	  by	  ajm-­‐1::gfp	  in	  WT	  and	  dre-­‐1(dh99)	  
L3	   larvae	   grown	   on	   L4440	   empty	   vector	   control	   or	   cdt-­‐2	   RNAi.	   Arrowheads	   indicate	   seam-­‐seam	   boundaries.	   (B)	   cdt-­‐2	  
depletion	  does	  not	  affect	  dre-­‐1(dh99)	  mutant	  precocious	  seam	  cell	  fusion	  in	  L3	  larvae.	  Mean+SEM	  (n=3,	  ≥20	  worms	  each).	  
(C)	  Representative	  DIC	  images	  of	  WT	  and	  dre-­‐1(dh99);daf-­‐12(rh61rh411)	  young	  adult	  worms	  grown	  on	  L4440	  empty	  vector	  
control	  or	  cdt-­‐2	   RNAi,	   showing	  one	  gonadal	   arm.	  Arrowheads	   indicate	  position	  of	   the	  dtc.	   v	  =	   vulva.	   (D)	  cdt-­‐2	  depletion	  
does	  not	  suppress	  dre-­‐1(dh99);daf-­‐12(rh61rh411)	  gonadal	  migration	  defects.	  Mean+SEM	  (n=3,	  ≥40	  gonadal	  arms	  each).	  
	  
To further investigate the cellular fate underlying cdt-2 dependent alae gap formation, I 
analyzed CKI-1::GFP expression in seam cells of dre-1 mutant animals. cki-1 encodes a 



































































































homolog of the mammalian cyclin-dependent kinase inhibitor p27/Kip1 that promotes 
cessation from the cell-cycle in C. elegans and that is highly expressed in arresting cells 
(Fukuyama et al., 2003; Hong et al., 1998). I followed CKI-1::GFP expression throughout 
larval development and found it to be strongly expressed in all seam cells of WT young adult 
worms right after cell cycle exit and adult alae synthesis. Conversely, CKI-1::GFP expression 
was not visible in the region of the alae gaps in dre-1(dh99) mutants (n>15), although 
neighboring seam cells were strongly CKI-1::GFP positive (Figure 10). Next, I also analyzed 
CDT2 levels upon dre-1 depletion using a full-length cdt-2::gfp fusion construct (Poulin and 
Ahringer, 2010). CDT-2::GFP was very dynamic in the seam and hypodermal cells peaking 
prior to cell divisions (data not shown). However, I could not observe increased accumulation 
or altered expression of CDT-2::GFP upon dre-1 depletion by RNAi (data not shown). It is 
possible that changes in CDT-2 levels might only be observable during a narrow time window 
or there may be functional redundancy for CDT-2 turnover in C. elegans. Nevertheless, the 
observation of genetic suppression, and the coexpression of dre-1 and cdt-2 in the seams, 
argues for an important functional interaction. 
Figure	   10:	   CKI-­‐1::GFP	   is	   Absent	   from	  
Seam	  Cells	  Underneath	  the	  Alae	  Gaps	  
Representative	   DIC	   and	   fluorescence	  
images	  of	  WT	  and	  dre-­‐1(dh99)	  mutant	  
young	   adult	   animals	   expressing	   CKI-­‐
1::GFP	  (maIs105),	  a	  marker	  of	  arresting	  
cells.	   Arrowheads	   indicate	   seam	   (se)	  
nuclei	   (left	   panel)	   and	   the	   area	   of	   an	  




Taken together, my findings suggest that alae gaps in dre-1 mutants could arise from a failure 
of cell cycle exit in seam cells, which might be induced by aberrantly regulated CDT-2 levels. 
The observed genetic interaction in C. elegans is consistent with the situation in mammals 
and supports the notion that FBXO11-mediated degradation of CDT2 controls cell cycle exit 













2.2 BLMP-1/BLIMP-1 - a Novel DRE-1/FBXO11 Target 
2.2.1 blmp-1 and nhr-25 Suppress dre-1 Epidermal Heterochrony 
Similar to our genetic approach with the candidate interactor cdt-2, we reasoned that client 
substrates aberrantly accumulate in dre-1 mutants and cause developmental timing alterations 
in epidermis and gonad. If so, then knockdown of such substrates should suppress dre-1 
mutant defects. Thus, I performed an RNAi-based suppressor screen in dre-1(dh99) 
hypomorphic mutants that was initially focused on transcription factors and a handful of 
heterochronic gene candidates. I identified the Zn-finger transcription factor BLMP-1 and the 
nuclear hormone receptor NHR-25 as potent suppressors of dre-1 heterochronic phenotypes 
in the epidermis and therefore as potential substrate candidates.  
The predicted C. elegans BLMP-1 protein contains an N-terminal SET domain, a proline rich 
domain, and 5 paired-domain Zn fingers at the C-terminus (Andersen and Horvitz, 2007; 
Tunyaplin et al., 2000). An existing deletion allele tm548 lacks part of exon 3 leading to a 
frameshift that disrupts the SET domain and all subsequent Zn fingers, suggesting it is null. In 
a previously published genome-wide RNAi screen in C. elegans, blmp-1 was found to affect 
male tail tip morphogenesis as its depletion results in precocious retraction of the male tail tip 
(Nelson et al., 2011). Moreover, blmp-1 was shown to modulate adult lifespan and cuticle 
morphogenesis, but altogether its function in the nematode is poorly understood (Samuelson 
et al., 2007; Greer et al., 2010; Zhang et al., 2012). In contrast, mammalian BLIMP-1 is 
extensively studied in different cellular contexts: BLIMP1 is necessary and sufficient to drive 
terminal differentiation of B cells into antibody-secreting plasma cells and also governs 
various cell fate decisions, including primordial germ cell specification and skin 
differentiation, generally working as a transcriptional repressor (Horsley et al., 2006; Ohinata 
et al., 2005; Turner et al., 1994; Shapiro-Shelef et al., 2003). Importantly, C. elegans BLMP-1 
and mammalian BLIMP-1 show striking domain conservation, with 43% similarity in the 
SET domain and 70% similarity in the Zn fingers (Tunyaplin et al., 2000).  
I found both blmp-1 and nhr-25 loss of function to suppress dre-1 phenotypes in the 
epidermis. In dre-1 partial loss-of-function mutants, such as dre-1(dh99), seam cells undergo 
precocious terminal differentiation in L3, a full stage ahead of schedule. Using the adherens 
junction marker ajm-1:gfp, I observed that RNAi-mediated knockdown of blmp-1 reduced 
dre-1(dh99) precocious seam cell fusion from 90% to 15% of the animals (Figure 11). 
Results 
38 
Similarly, only 7.5% of dre-1(dh99);blmp-1(tm548) double mutant animals showed 
precocious seam cell fusion in L3 larvae (Figure 11). 
 
Figure	  11:	  blmp-­‐1	  and	  nhr-­‐25	  Suppress	  dre-­‐1(dh99)	  Precocious	  Seam	  Cell	  Fusion	  
(A)	  Representative	  fluorescence	  images	  of	  seam	  cell	  adherence	  junctions	  as	  visualized	  by	  ajm-­‐1::gfp	  in	  WT	  and	  dre-­‐1(dh99)	  
L3	  larvae	  grown	  on	  L4440	  empty	  vector	  control	  or	  blmp-­‐1	  RNAi.	  Arrowheads	  indicate	  seam-­‐seam	  boundaries.	  Scale	  bar	  =	  
10	  µm.	   (B)	  blmp-­‐1	   and	  nhr-­‐25	   RNAi	   suppress	  dre-­‐1(dh99)	  precocious	   seam	   cell	   fusion	   in	   L3	   larvae.	   ***p<0.001	   (Fisher’s	  
exact).	  Mean+95%CI	  (n>30).	  
	  
Notably, blmp-1 mutants themselves displayed heterochronic phenotypes: Surprisingly they 
showed no alteration in seam cell division and fusion patterns (data not shown), but as 
reported previously in a different context, blmp-1 mutants exhibited incomplete adult alae 
formation, a phenotype reminiscent of retarded mutants such as let-7 (Figure 12) (Slack et al., 
2000; Zhang et al., 2012). Notably, incomplete alae formation was rescued by introducing a 
fosmid-based blmp-1::gfp translational fusion construct (wgIs109, (Sarov et al., 2012)), 
demonstrating that the phenotype arises from lesions in blmp-1 (Figure 12B). Of note, the 
poor alae formation phenotype precluded the analysis of dre-1 mutant alae gap appearance 


















































Figure	  12:	  blmp-­‐1	  Promotes	  Terminal	  Differentiation	  in	  the	  Hypodermis	  
(A)	   Representative	   DIC	   images	   of	   young	   adult	   WT	   and	   blmp-­‐1(tm548)	  mutant	   worms.	   Arrowheads	   indicate	   seam	   cell	  
positions,	   the	   origin	   of	   adult	   alae	   synthesis.	   (B)	   blmp-­‐1(tm548)	   and	   dre-­‐1(dh99);blmp-­‐1(tm548)	   mutants	   show	   poor	  
formation	  of	  adult	  alae	   (n>20).	   (C)	  Seam	  cell	   lineages	   (V1-­‐V4,	  V6)	   from	  WT	  worms	  and	  various	  mutants	  as	   inferred	   from	  
inspection.	  Terminal	  differentiation	  is	   indicated	  by	  fusion	  of	  the	  seams	  (eye-­‐shaped	  cells)	  and	  adult	  alae	  formation	  (three	  
horizontal	   bars).	   dre-­‐1	   mutants	   exhibit	   precocious	   seam	   cell	   terminal	   differentiation,	   whereas	   blmp-­‐1	   and	   the	   double	  
mutants	  show	  incomplete	  formation	  of	  adult	  alae	  (three	  dashed	  horizontal	  bars).	  
 
Besides blmp-1, also knockdown of the nuclear hormone receptor nhr-25 using RNAi 
substantially reduced dre-1 precocious seam cell fusion from 90% to 21.5% of the animals 
(Figure 11B). Of note, nhr-25 depletion reportedly induces retarded seam cell fusion in WT 
worms and prevents precocious adult alae formation in several precocious mutants (Hada et 
al., 2010). Taken together, complete terminal differentiation of epidermal stem cells depends 
on both blmp-1 and nhr-25 and both transcriptional regulators constitute potential targets of 
the SCFDRE-1 ubiquitin ligase. 
2.2.2  blmp-1 Suppresses dre-1 Gonadal Heterochrony 
We next asked whether blmp-1 and nhr-25 also influenced dre-1 developmental timing 
phenotypes in the gonad. In WT hermaphrodites, dtcs guide gonadal migration to form two 







































































weak retarded gonadal migration phenotype, combinations with other heterochronic loci, such 
as daf-12/FXR/LXR/VDR or the lin-29/EGR null mutants, unveil a strong synthetic retarded 
phenotype in which both gonadal arms entirely fail to reflex (mig). 
Strikingly, RNAi-mediated depletion of blmp-1 suppressed the strong retarded phenotype of 
dre-1(dh99);daf-12(rh61rh411) mutants, restoring the dorsal turn in more than 80% of the 
animals (Figure 13). In contrast, nhr-25 knockdown failed to ameliorate the gonadal 
migration defect (Figure 13B). To investigate specificity of blmp-1-mediated mig 
suppression, the effect of blmp-1 reduction was analyzed in related mig mutants. blmp-1 
depletion also restored gonadal reflection in dre-1(dh99);lin-29(n546) mutants, whereas 
gonadal migration defects in daf-12(rh61rh411);lin-29(n546) and the strong heterochronic 
daf-12 allele rh61 remained unaffected (Figure 13B). These observations reveal that blmp-1 
depletion specifically suppresses gonadal heterochronic phenotypes arising from dre-1, and 
not daf-12 or lin-29 lesions, again suggesting that dre-1 and blmp-1 work in a unified 
pathway.  
 
Figure	  13:	  blmp-­‐1,	  but	  not	  nhr-­‐25	  Depletion	  Specifically	  Suppresses	  dre-­‐1	  Synthetic	  Gonadal	  Migration	  Defects	  
(A)	  Representative	  DIC	  images	  of	  WT	  and	  dre-­‐1(dh99);daf-­‐12(rh61rh411)	  young	  adult	  worms	  grown	  on	  L4440	  empty	  vector	  
control	  or	  blmp-­‐1	  RNAi,	   respectively,	   showing	  one	  gonadal	  arm	  each.	  Arrowheads	   indicate	  position	  of	   the	  dtc.	  v	  =	  vulva.	  
Scale	  bar	  =	  10	  µm.	  (B)	  blmp-­‐1	  depletion	  specifically	  suppresses	  gonadal	  migration	  defects	  of	  dre-­‐1(dh99);daf-­‐12(rh61rh411)	  
and	   dre-­‐1(dh99);lin-­‐29(n546)	   mutants,	   but	   does	   not	   affect	   daf-­‐12(rh61rh411);lin-­‐29(n546)	   and	   the	   strong	   heterochronic	  
daf-­‐12	  allele	  rh61.	  ***p<0.001	  (ANOVA).	  Mean+SEM	  (n=3,	  40	  gonadal	  arms	  each).	  
 
To test whether blmp-1 regulates WT gonadal morphogenesis I analyzed dtc migration in 
blmp-1(tm548) mutant animals. Consistent with a role in gonadal developmental timing, 
blmp-1 mutants showed precocious gonadal migration: dtcs navigated the first turn dorsally 2-
3 hours ahead of schedule, but often failed the second turn and continued migration toward 
head and tail (Figure 14). Again, these phenotypes were rescued by the full-length blmp-
1::gfp transgene (Figure 14B). Notably, blmp-1(lf) early gonadal migration defects prevailed 
in dre-1(dh99);daf-12(rh61rh411) mutants grown on blmp-1 RNAi, consistent with blmp-1 








































































Figure	  14:	  blmp-­‐1(+)	  Impedes	  Dorsal	  Migration	  of	  the	  Gonad	  
(A) Representative DIC images of 27 hrs post-hatching WT and blmp-1 mutant larvae staged by vulval precursor cells 
(arrowheads, upper panel). Dtcs migrate precociously in the blmp-1(tm548) mutant (arrowheads, lower panel). Scale bars = 
10 µm. (B) In blmp-1(tm548) mutants, as well as WT and dre-1(dh99);daf-12(rh61rh411) mutants grown on blmp-1 RNAi 
dtcs turn dorsally ahead of time. ***<0.001 (ANOVA). Mean±SD. ns = not significant. nd = not determined. (C) Gonad 
migration program of WT worms and various mutants as inferred from inspection. Arrowheads indicate positions of the dtcs. 
	  
Taken together, these results show that dre-1/blmp-1 also function together to coordinate 
temporal patterning of gonadal outgrowth. Because blmp-1 and not nhr-25 suppressed dre-1 
phenotypes in multiple tissues, we focused our further analyses on blmp-1. 
2.2.3 blmp-1 Works at a Late Step in the Seam Cell Heterochronic Circuit 
To further elucidate the role of blmp-1 in the seam cell heterochronic gene network I 
performed genetic epistasis and synergy experiments with known heterochronic loci that 
regulate the larval-to-adult transition. First, I tested blmp-1 knockdown in a variety of 
precocious heterochronic mutants (Figure 15). Amongst them, hbl-1/Hunchback, lin-
42/Period, lin-41/Trim71, and sop-2/PcG-like specify L4 programs by directly or indirectly 
preventing lin-29/EGR expression and thus the adult fate. Accordingly, loss-of-function 

































































































cells fuse and synthesize adult alae already in L3 larvae, similar to dre-1 mutants. Notably, 
knockdown of blmp-1 variously suppressed precocious seam cell phenotypes of these 
mutants, suggesting it acts downstream or parallel to these components (Figure 15). 
Moreover, blmp-1 retarded or incomplete adult alae formation even strongly prevailed over 
hbl-1(ve18), lin-42(n1089) and lin-41i precocious phenotypes, possibly closely linking these 
genes in a pathway (Figure 15A and 15C). By comparison, suppression of temperature-
sensitive hypomorphic sop-2(bx91) mutant phenotypes at semi-permissive temperatures was 
relatively weak, indicating blmp-1 might work upstream or in parallel to sop-2 (Figure 15A). 
However, these results have to be interpreted with caution, since not all alleles used were null.  
 
Figure	  15:	  blmp-­‐1	  Interacts	  with	  Precocious	  Heterochronic	  Loci	  in	  the	  Epidermis	  
(A)	  Epistasis	  experiments	  of	  blmp-­‐1(tm548)/blmp-­‐1i	  with	  precocious	  heterochronic	   loci	  hbl-­‐1(ve18),	   lin-­‐41i,	   lin-­‐42(n1089),	  
and	   sop-­‐2(bx91).	   (n>20).	   L4440	   empty	   vector	   functions	   as	   control.	   Partial	   seam	   fusion	   refers	   to	   an	   incomplete	   seam	  
syncytium	   with	   leftover	   unfused	   seam	   cells.	   Partial	   alae	   formation	   refers	   to	   poorly	   formed	   or	   incomplete	   adult	   alae.	  
Temperature-­‐sensitive	  sop-­‐2(bx91)	  mutants	  were	  observed	  after	  shifting	  L1	   larvae	   from	  15°C	   to	  23°C.	   (B)	  Representative	  
pictures	  of	  seam	  cell	  adherence	  junctions	  as	  visualized	  by	  ajm-­‐1::gfp	  in	  hbl-­‐1(ve18)	  L3	  larvae	  grown	  on	  L4440	  empty	  vector	  
control	   or	   blmp-­‐1	   RNAi.	   Arrowheads	   indicate	   seam-­‐seam	   boundaries.	   (C)	   Representative	   DIC	   images	   of	  WT	  worms	   and	  
selected	   precocious	   heterochronic	   mutants	   showing	   adult	   alae	   formation	   under	   control	   (L4440)	   and	   blmp-­‐1	   depleted	  
conditions	  at	  the	  early	  L4	  or	  young	  adult	  (yA)	  stage.	  Arrowheads	  indicate	  position	  of	  the	  seam	  syncytium.	  
hbl-1 blmp-1i (yA)
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Next I examined blmp-1 genetic synergy with various retarded heterochronic mutants 
working at the larval-to-adult transition (Figure 16). hbl-1 and lin-41 are downregulated post-
transcriptionally by let-7/let-7s microRNAs, leading to derepression of lin-29/EGR, which 
then triggers the adult fate. Thus let-7 and lin-29 loss of function cause retarded phenotypes: 
let-7 mutants display incomplete seam cell fusion and poor or no adult alae formation; in lin-
29 mutants both events fail entirely. RNAi mediated knockdown of blmp-1 in temperature-
sensitive let-7(n2853ts) mutants slightly enhanced the let-7 retarded adult alae formation and 
the bursting phenotype at a semi-permissive temperature (Figure 16A-C). No enhancement 
was detected for lin-29(n546) as its retarded phenotypes are fully penetrant (Figure 16A 
and 16B). The transcriptional cofactor mab-10/NAB cooperates with lin-29/EGR to specify 
the adult seam fate. Loss-of-function mutations of mab-10 do not alter seam cell fusion and 
adult alae formation, but subsets of seam cells undergo an extra nuclear division after they 
fuse into the seam syncytium (Harris and Horvitz, 2011). blmp-1 depletion enhanced the 
penetrance of the extra nuclear division phenotype of mab-10(e1248) (Figure 16D and 16E) 
and corresponding animals rarely formed adult alae (Figure 16A and 16B), indicating that 




Figure	  16:	  blmp-­‐1	  Interacts	  with	  Retarded	  Heterochronic	  Loci	  in	  the	  Epidermis	  
(A)	   Synergy	   experiments	   of	   blmp-­‐1(RNAi)	   with	   retarded	   	   heterochronic	   loci	   let-­‐7(n2853ts),	   lin-­‐29(n546),	   and	   mab-­‐
10(e1248).	   (n>20).	  L4440	  empty	  vector	   functions	  as	  control.	  Partial	   seam	  fusion	  refers	   to	  an	   incomplete	  seam	  syncytium	  
with	   leftover	  unfused	   seam	  cells.	   Partial	   alae	   formation	   refers	   to	  poorly	   formed	  or	   incomplete	  adult	   alae.	   Temperature-­‐
sensitive	  let-­‐7(n2853ts)	  mutants	  were	  observed	  after	  shifting	  L1	  larvae	  from	  15°C	  to	  20°C.	  (B)	  Representative	  DIC	  images	  of	  
WT	  animals	  and	  retarded	  heterochronic	  mutants	  showing	  adult	  alae	  formation	  under	  control	  (L4440)	  and	  blmp-­‐1	  depleted	  
conditions	  at	  the	  young	  adult	  (yA)	  stage.	  Arrowheads	  indicate	  position	  of	  the	  seam	  syncytium.	  (C)	  blmp-­‐1	  depletion	  slightly	  
enhances	  let-­‐7(n2853ts)	  bursting	  phenotype	  at	  semi-­‐permissive	  temperatures	  (20°C).	  Mean+SD	  (n=3,	  >50	  worms	  each).	  (D)	  
blmp-­‐1	  knockdown	  increases	  the	  number	  of	  seam	  cells	  that	  undergo	  an	  extra	  division	  after	  the	  larval-­‐to-­‐adult	  transition	  in	  
mab-­‐10(e1248)	  mutants.	  The	  number	  of	  seam	  cells	  was	  scored	  in	  worms	  carrying	  1-­‐5	  eggs	  using	  the	  scm-­‐1::gfp	  marker.	  The	  
number	  of	  theoretically	  present	  seam	  cells	  per	  side	  (16)	  was	  subtracted	  from	  the	  results	  to	  get	  the	  number	  of	  cells	  with	  
extra	  divisions.	  ***p<0.001	  (ANOVA).	  Mean+SD	  (n≥17).	  (E)	  Representative	  fluorescence	  image	  of	  a	  mab-­‐10(e1248)	  mutant	  
young	  adult	  worm	  grown	  on	  blmp-­‐1	  RNAi	  expressing	  scm-­‐1::gfp	  in	  seam	  cell	  nuclei.	  
Scale	  bar	  =	  10	  µm.	  
	  
Altogether, these analyses reveal a broad role for blmp-1 as a developmental timing gene 
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2.2.4 dre-1/blmp-1 Regulate C. elegans Life History 
The genetic interactions described above reveal that dre-1 and blmp-1 act in opposition for 
developmental timing events in epidermis and gonad. Interestingly, I found both dre-1 and 
blmp-1 to also regulate entry into dauer diapause. Under unfavorable environmental 
conditions, such as food scarcity and heat, C. elegans can enter this alternate third larval 
stage, characterized by stress resistance, longevity, and multiple metabolic and morphological 
changes including the synthesis of a thick stress and desiccation resistant cuticle. In particular, 
blmp-1 mutants were defective in dauer formation (Daf-d), as even under dauer inducing 
conditions (27°C, low cholesterol) they did not enter the alternate larval stage (Figure 17A). 
However, they arrested development as L3 or L4 larvae appearing unable to shed their cuticle. 
Also starvation induced a similar phenotype, but not dauer formation in blmp-1 mutants (data 
not shown). Conversely, dre-1 mutants constitutively formed dauer larvae (Daf-c) under 
stress conditions, albeit at low levels, suggesting the two genes normally promote and prevent 
dauer formation, respectively (Figure 17A). Consistent with my previous data, the blmp-1 
mutant phenotype (Daf-d) prevailed in the double mutant (Figure 17A). blmp-1 depletion was 
also epistatic to canonical Daf-c loci daf-2/InsR, daf-7/TGF-β, and daf-9/CYP27A1, placing 
blmp-1 downstream of Insulin/IGF, TGF-β, and steroidal signaling at a late step in the dauer 
signaling pathways in close proximity to the key regulator of the dauer decision daf-12 
(Figures 1, 17B, and 17C). 
	  
	  
Figure	  17:	  dre-­‐1	  and	  blmp-­‐1	  Show	  Opposite	  Phenotypes	  for	  Dauer	  Formation	  
(A)	  Dauer	  formation	  of	  WT,	  dre-­‐1(dh99),	  blmp-­‐1(tm548)	  and	  dre-­‐1(dh99);blmp-­‐1(tm548)	  animals	  scored	  on	  plates	   lacking	  
cholesterol	  at	  27°C.	  *p<0.05,	  ***p<0.001	  (ANOVA).	  Mean+SEM	  (n≥8,	  >100	  worms	  each).	  (B)	  Dauer	  formation	  of	  WT,	  daf-­‐
2(e1368),	  daf-­‐7(e1372)	  and	  daf-­‐9(dh6)	  animals	  scored	  on	  regular	  NGM	  plates	  at	  25°C.	  In	  the	  latter	  three	  genotypes,	  blmp-­‐1	  
depletion	   led	   to	   L3/L4	   arrest	  without	   dauer	   alae	   and	   SDS	   resistance.	   ***p<0.001	   (ANOVA).	  Mean+SEM	   (n=3,	   15	  worms	  
each).	  (C)	  Representative	  DIC	  images	  of	  daf-­‐2(e1368)	  mutants	  on	  L4440	  empty	  vector	  control	  or	  blmp-­‐1	  RNAi.	  Arrowheads	  
indicate	  dauer	  alae.	  Scale	  bar	  =	  10	  µm.	  
	  
In addition to dauer formation blmp-1 and dre-1 affected organismal life span (Figure 18A). 



















































previous reports (Figure 18A) (Samuelson et al., 2007), dre-1 depletion resulted in a modest, 
but reproducible lifespan increase (Figure 18A). Interestingly a completely parallel approach 
in our lab identified blmp-1 as a modulator of germline longevity. Upon loss of germline 
precursor cells C. elegans lifespan is dramatically increased (Hsin and Kenyon, 1999). 
Multiple important players in germline longevity have been identified, including a functional 
somatic gonad, as well as key transcriptional regulators such as daf-16/FOXO, daf-
12/FXR/LXR/VDR, nhr-80/HNF-4, and pha-4/FOXA (Hsin and Kenyon, 1999; Lapierre et 
al., 2011; Goudeau et al., 2011; Antebi, 2013). Similar to these key factors, my colleagues 
found blmp-1 depletion to abrogate glp-1/Notch mutant longevity, mutants, which lack the 
germline at non-permissive temperatures (Nakamura, Karalay, and Antebi, unpublished; 
Austin and Kimble, 1987; Arantes-Oliveira et al., 2002). I reproduced this lifespan phenotype 
together with Dr. Shuhei Nakamura in germ cell precursor-ablated animals, which lived 
significantly longer than mock-ablated controls, but only in the presence of functional blmp-
1(+) (Figure 18B). However, blmp-1 mutation led to general sickness as it also significantly 
shortened WT lifespan. Moreover, blmp-1 RNAi treatment from L4 onwards did not 
completely suppress the lifespan extension upon germline loss induced by germ cell precursor 
ablation (Figure 18C). Therefore the role of blmp-1 in germline longevity was not further 
investigated in this study.  
 
Figure	  18:	  dre-­‐1	  and	  blmp-­‐1	  Modulate	  Longevity	  
(A)	   Lifespan	   analysis:	   WT	   animals	   were	   grown	   on	   RNAi	   from	   the	   L4	   stage	   as	   indicated.	   Dashed	   lines	   represent	   an	  
independent	   repeat	  of	   the	  experiment.	   First	   given	  p	   value	   corresponds	   to	   the	  experiment	  displayed	  with	   solid	   lines	   (log	  
rank	  (Mantel-­‐Cox)	  test).	  (B)	  Lifespan	  analysis:	  Germ	  cell	  precursors	  Z2	  and	  Z3	  of	  WT	  animals	  and	  blmp-­‐1(tm548)	  mutants	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functioned	  as	  control	  (mock).	  (C)	  Lifespan	  analysis:	  After	  germ	  cell	  precursor	  ablation	  WT	  animals	  were	  recovered	  on	  OP50	  
bacteria	   and	   transferred	   to	   RNAi	   plates	   at	   the	   L4	   stage	   as	   indicated.	   Lifespan	   analysis	  was	   performed	   together	  with	  Dr.	  
Shuhei	  Nakamura.	  
 
Taken together, dre-1 and blmp-1 not only regulate developmental timing in epidermis and 
gonad, but also work in opposite ways for the life history traits of dauer formation and 
longevity in C. elegans. 
2.2.5 BLMP-1 Overexpression Enhances dre-1 Phenotypes 
As blmp-1 loss of function variously suppressed dre-1 mutant phenotypes, I examined 
whether its overexpression can recapitulate or enhance dre-1 mutant developmental 
alterations. Surprisingly, BLMP-1::GFP overexpression did not evoke dre-1 related 
phenotypes such as precocious seam cell fusion in a WT background (data not shown). 
However, multiple dre-1 phenotypes were strongly enhanced: first, the blmp-1 overexpressor 
provoked strong retarded gonadal migration defects when grown on dre-1 RNAi 
(Figure 19A). Second, it substantially enhanced molting defects of dre-1 depleted worms 
(Figure 19B and 19C). Third, it was synthetic lethal in a dre-1(dh99) mutant background, 
similar to dre-1 null mutants, and could only be recovered in a weaker dre-1 allele dre-
1(dh279). In sum, blmp-1 overexpression cannot fully recapitulate, but significantly enhance 
dre-1 mutant phenotypes.  
 
Figure	  19:	  blmp-­‐1	  Overexpression	  Enhances	  dre-­‐1	  Phenotypes	  
(A)	  blmp-­‐1	   overexpression	   (OE)	  using	   an	   integrated	  blmp-­‐1::gfp	   transgene	   (wgIs109,	   Sarov	  et	   al.,	   2012)	   induces	   gonadal	  
migration	   defects	   in	   dre-­‐1	   depleted	   worms.	   **p<0.01	   (ANOVA).	   Mean+SEM	   (n=3,	   40	   gonadal	   arms	   each).	   (B)	  
Representative	  DIC	  images	  of	  molting	  defects	  observed	  in	  blmp-­‐1	  OE	  worms	  grown	  on	  dre-­‐1	  RNAi.	  Scale	  bar	  =	  10	  µm.	  (C)	  




























































2.2.6 The SCFDRE-1 Complex Degrades BLMP-1 via the Proteasome 
The genetic epistasis experiments described above place blmp-1 downstream of dre-1, 
supporting the idea that BLMP-1 could be a substrate of the SCFDRE-1 E3-ubiquitin ligase. To 
directly test this hypothesis, I examined the effect of dre-1 depletion on BLMP-1 protein 
levels.  
 
Figure	  20:	  BLMP-­‐1::GFP	  and	  NHR-­‐25::GFP	  Overlap	  with	  DRE-­‐1::GFP	  Expression,	  but	  NHR-­‐25::GFP	  is	  dre-­‐1	  Independent	  
(A)	   Representative	  DIC	   and	   fluorescence	   images	   showing	   overlapping	   expression	   patterns	   of	   DRE-­‐1-­‐,	   BLMP-­‐1-­‐	   and	  NHR-­‐
25::GFP	   in	   seam	  (se)	  and	  hypodermal	   (hyp)	  nuclei	  of	   L4	   larvae.	   (B)	  NHR-­‐25::GFP	  expression	   in	   seam	  cells	  varies	  with	   the	  
molt	  cycle	  (indicated	  by	  the	  dashed	  line),	  but	  does	  not	  depend	  on	  dre-­‐1.	  Each	  dot	  represents	  mean	  GFP	  intensity	  in	  >5	  seam	  
cells	  of	  a	  worm.	  Developmental	  age	  is	  given	  in	  hours	  (h)	  post-­‐hatching.	  
	  
First, BLMP-1::GFP and also NHR-25::GFP showed overlapping expression with DRE-
1::GFP in seam and hypodermal cells as well as the dtcs (Figure 20A). NHR-25::GFP 
expression oscillated with the molt cycle, but showed no obvious dre-1 dependence during 
L2-to-L4 larval stages, indicating that NHR-25 indeed is not a primary target of the SCFDRE-1 
complex (Figure 20B). Second, in contrast to NHR-25, I found that knockdown of dre-1 
resulted in a striking 7-8-fold increase in BLMP-1::GFP levels in seam and hypodermal cells 
(Figure 21A and 21B). Interestingly, BLMP-1::GFP levels were only moderately elevated in a 
weak dre-1(dh279) mutant background and could not be analyzed in dre-1(dh99) mutants due 
to synthetic lethality (Figure 21B and 21E). Third, knockdown of other SCF complex 
components, such as the scaffold cul-1 and the skr-1 adapter also led to a pronounced 
accumulation of BLMP-1::GFP, whereas knockdown of related molecules, such as cul-4, skr-
2 and skr-3, had little or no effect (Figure 21B and 21E). Finally, to test whether the UPS 
mediates BLMP-1 proteolysis, I inhibited the proteasome using the synthetic inhibitor 
bortezomib or rpn-8 RNAi, which depletes a subunit of the proteasomal 19S cap (Segref et 
al., 2011). Both treatments significantly increased BLMP-1::GFP levels in seam and 

















































Figure	  21:	  BLMP-­‐1::GFP	  Levels	  are	  Regulated	  by	  the	  SCFDRE-­‐1	  Complex	  and	  the	  Proteasome	  
(A)	  Representative	  DIC	  and	  fluorescence	  images	  of	  BLMP-­‐1::GFP	  expressing	  L4	  larvae	  grown	  on	  L4440	  empty	  vector	  control	  
or	   dre-­‐1	   RNAi.	   (B)	   BLMP-­‐1::GFP	   levels	   in	   seam	   and	   hypodermal	   cells	   are	   significantly	   increased	   upon	   dre-­‐1	   and	   cul-­‐1	  
depletion.	   ***p<0.001	   (ANOVA).	  Mean+SEM	   (n≥3,	   ≥10	   cells	   of	   5	  worms	   each).	   (C)	   Representative	   DIC	   and	   fluorescence	  
images	  of	  BLMP-­‐1::GFP	  expressing	  L4	  larvae	  treated	  with	  100	  µM	  bortezomib	  or	  DMSO	  control.	  (D)	  Proteasome	  inhibition	  
(bortezomib	  and	  rpn-­‐8	  RNAi)	  increases	  BLMP-­‐1::GFP	  levels	  in	  seam	  and	  hypodermal	  cells.	  **p<0.01,	  ***p<0.001	  (ANOVA).	  
Mean+SEM	  (n≥3,	  ≥10	  cells	  of	  5	  worms	  each).	  (E)	  Representative	  fluorescence	  images	  showing	  BLMP-­‐1::GFP	  expression	  in	  
seam	  and	  hypodermal	  nuclei	  upon	  various	  RNAi	  treatments	  and	  in	  dre-­‐1(dh279)	  mutants.	  
se	  =	  seam	  cell.	  hyp	  =	  hypodermal	  cell.	  Scale	  bars	  =	  10	  µm.	  
 
I next analyzed endogenous BLMP-1 levels by western blotting to visualize the amount of 
native protein (Figure 22). In accord with my blmp-1::gfp transgene results, dre-1 depletion 
and proteasome inhibition by rpn-8 RNAi both resulted in a significant increase in 
endogenous BLMP-1 protein (Figure 22). Consistent with the genetic data, BLMP-1 levels 




































































































































































Figure	  22:	  Endogenous	  BLMP-­‐1	  Levels	  Depend	  on	  dre-­‐1	  and	  the	  Proteasome	  
(A)	  Western	   blot	   analysis	   of	   BLMP-­‐1	   protein	   levels	   in	  WT,	  dre-­‐1(dh99)	   and	   blmp-­‐1(tm548)	   L4	   larvae	   after	   various	   RNAi	  
treatments	  from	  egg.	  The	  asterisk	  marks	  a	  nonspecific	  band.	  The	  arrow	  points	  to	  the	  BLMP-­‐1	  band.	  (B)	  Quantification	  of	  
western	  blot	  analyses.	  *P<0.05,	  **P<0.01,	  ***P<0.001	  (ANOVA).	  Mean	  +SD	  (n=5).	  
 
Conversely, blmp-1 mRNA levels were unchanged upon dre-1 depletion or proteasome 
inhibition as analyzed by qRT-PCR (Figure 23). Altogether, these results strongly support the 
notion that the SCFDRE-1 complex post-transcriptionally regulates BLMP-1 through 
proteasome-mediated degradation. Furthermore, they indicate that DRE-1 C-terminal residues 
might not be of major importance for mediating BLMP-1 degradation, since the dre-1(dh279) 
allele, which leads to a C-terminal dre-1 truncation, only marginally elevates BLMP-1 levels 
(Figure 21B and 21E). 
 
Figure	   23:	   blmp-­‐1	   mRNA	   Levels	   are	   Largely	   Independent	   of	   dre-­‐1	   and	   the	  
Proteasome	  	  
qRT-­‐PCR	  analysis	  of	  WT	  L4	  larvae	  treated	  with	  the	  indicated	  RNAis	  starting	  at	  the	  








If BLMP-1 were a direct substrate of DRE-1, then the two proteins would be predicted to 
physically interact. To test this, I performed coimmunoprecipitation experiments in worms 
expressing full-length DRE-1::GFP under its native promoter. Importantly, 
immunoprecipitation of DRE-1::GFP specifically coprecipitated a small fraction of 
endogenous BLMP-1 (< 1% of input), whereas a NHR-25::GFP control did not (Figure 24A). 
NHR-25::GFP was used as control due to its largely overlapping expression pattern and its 
similar expression intensity compared to DRE-1::GFP. Consistently, when expressed in 
HEK293T cells FLAG-HA-tagged DRE-1 specifically coprecipitated with 6xHis-tagged C. 









































































(Figure 24B). Thereby coprecipitation of DRE-1 and BLMP-1 required proteasome 
inhibition, pointing to a very transient interaction.  
 
Figure	  24:	  DRE-­‐1	  Physically	  Interacts	  with	  BLMP-­‐1	  
(A) L3 larvae expressing integrated DRE-1::GFP or NHR-25::GFP as control were grown from egg stage onwards on L4440 
empty vector control or blmp-1 RNAi expressing bacteria, respectively and utilized for anti-GFP immunoprecipitation (IP). 
Lysates and IP were analyzed by SDS-PAGE and immunoblotting. (B)	  His-DRE-1 coprecipitates with FLAG-HA-tagged 
(F/H) BLMP-1 when cotransfected in HEK293T cells treated with 15 µM MG132. F/H-RFP and -LIN-29 serve as negative 
controls.  
	  
Furthermore, I found DRE-1 expression in mammalian cells to destabilize coexpressed 
BLMP-1 protein after blocking nascent protein synthesis by cycloheximide (CHX) treatment 
(Figure 25). In these assays BLMP-1 stability was rescued by proteasome inhibition, 
supporting the in vivo findings. However, we failed to detect ubiquitinated BLMP-1 of higher 
molecular weight in C. elegans as well as in cell-based assays (collaboration with the group 
of Michele Pagano at NYU), but such species might be of low abundance or unstable in vivo, 
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Figure	   25:	   BLMP-­‐1	   is	   Degraded	   via	   the	  
Proteasome	  
HEK293T	   cells	   were	   transfected	   with	   His-­‐
BLMP-­‐1	   and	   -­‐LIN-­‐29	   in	   combination	   with	  
FLAG-­‐HA-­‐DRE-­‐1.	   Transfected	   cells	   were	  
treated	   with	   cycloheximide	   (CHX)	   or	   CHX	   +	  
15	  µM	  MG132	  for	  the	  indicated	  time	  intervals	  
prior	   to	  harvesting	   and	  analysis	   by	   SDS-­‐PAGE	  
and	  immunoblotting.	  
 
2.2.7 BLMP-1 is Dynamically Regulated in a Tissue-Specific Manner 
Having established BLMP-1 as a DRE-1 substrate for proteolysis, we sought to better 
understand the temporal dynamics of BLMP-1 regulation in vivo. The genetic studies 
described above reveal that blmp-1 acts at an intermediate step in dtc migration, but promotes 
terminal differentiation in C. elegans hypodermis. To clarify the tissue-specific regulation of 
developmental timing by DRE-1/BLMP-1, I followed BLMP-1::GFP levels in these tissues 
throughout larval development.  
In dtcs BLMP-1::GFP was expressed from mid-L2, when gonadal outgrowth initiates toward 
head and tail (Figure 26A and 26B). By mid-L3 (28-30 hours of developmental age), just 
prior to the dorsal gonadal turn, BLMP-1::GFP levels in the dtcs dropped dramatically 
(Figure 26A and 26B). Correlatively, DRE-1::GFP levels in the dtcs steadily increased from 
L2-to-L4 larval stages (Figure 26C). In contrast, when worms were fed dre-1 RNAi, BLMP-
1::GFP levels persisted to later ages and the dtcs frequently failed the dorsal turn (Figure 26A 
and 26B). Altogether, these data strongly suggest that timely DRE-1-mediated BLMP-1 
degradation permits the gonadal turn, while high BLMP-1 levels in gonadal dtcs impede this 
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Figure	  26:	  DRE-­‐1	  Degrades	  BLMP-­‐1	  to	  Initiate	  the	  Dorsal	  Gonadal	  Turn	  
(A)	   BLMP-­‐1::GFP	   levels	   in	   the	   dtcs	   were	   assessed	   in	   ≥5	   worms	   per	   grouped	   developmental	   age.	   ***p<0.001	   (ANOVA).	  
Mean+SD.	   (B)	  Representative	  DIC	   images	  of	  age-­‐matched	  L3	   larvae	  with	  zoom	  in	  on	  BLMP-­‐1::GFP	  expression	   in	  the	  dtcs.	  
Black	  box	  indicates	  the	  area	  enlarged	  in	  the	  fluorescence	  image.	  White	  circle	  roughly	  marks	  the	  dtc	  nucleus.	  Scale	  bars	  =	  10	  
µm.	  (C)	  DRE-­‐1::GFP	  levels	  were	  assessed	  in	  dtcs	  of	  two	  integrated	  lines	  (A	  and	  B).	  Developmental	  age	  is	  given	  in	  hours	  (h)	  
post-­‐hatching.	  Solid	   lines	  represent	   linear	  regression	  fits	  for	   illustration.	  Each	  dot	  represents	  GFP	  intensity	   in	  one	  dtc.	  (D)	  
Model	  for	  dre-­‐1/blmp-­‐1	  action	  in	  gonadal	  tissue:	  BLMP-­‐1	  is	  downregulated	  in	  a	  dre-­‐1-­‐dependent	  manner	  in	  mid-­‐L3	  to	  allow	  
the	  dorsal	  gonadal	  turn.	  In	  dre-­‐1	  or	  dre-­‐1/daf-­‐12	  mutants	  BLMP-­‐1	  levels	  persist	  to	  later	  ages,	  leading	  to	  retarded	  migration	  
defects,	   whereas	   the	   dorsal	   turn	   is	   preceded	   in	   the	   absence	   of	   BLMP-­‐1.	   Double-­‐slashes	   indicate	   the	   end	   of	   data	  
assessment.	  
 
Surprisingly, in seam and hypodermal cells BLMP-1::GFP levels were largely constant 
throughout larval development except for a transient peak early in the L4 stage (Figure 27A). 
Interestingly, this peak coincides with the time of seam cell fusion, indicating this BLMP-1 
pulse might trigger the fusion event. Likewise, dre-1 knockdown provoked a strong increase 
of seam and hypodermal BLMP-1::GFP expression earlier in development, resulting in seam 
cell fusion as early as 28 hours of developmental age during the L3 stage (Figure 27A). These 
observations are consistent with a model in which increased BLMP-1 levels initiate terminal 
differentiation events in the seams. Unexpectedly, DRE-1::GFP levels in seam and 
hypodermis did not obviously change during this time, implying that other instructive 
components or cofactors, such as kinases or phosphatases may contribute toward BLMP-1 
regulation (Figure 27B). In sum, my data suggest that DRE-1 maintains a low steady state 
level of BLMP-1 to prevent precocious terminal differentiation in the epidermis (Figure 27C). 
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Figure	  27:	  DRE-­‐1	  Restrains	  BLMP-­‐1	  Levels	  to	  Prevent	  Terminal	  Differentiation	  in	  the	  Seams	  
(A)	  BLMP-­‐1::GFP	  levels	  in	  seam	  and	  hypodermal	  cells	  were	  assessed	  in	  ≥5	  worms	  per	  grouped	  developmental	  age.	  *p<0.05	  
(ANOVA).	  Mean+SEM.	  (B)	  DRE-­‐1::GFP	  levels	  in	  seam	  and	  hypodermal	  cells	  were	  analyzed	  in	  two	  integrated	  lines	  (A	  and	  B)	  .	  
Developmental	  age	  is	  given	  in	  hours	  (h)	  post-­‐hatching.	  Solid	  lines	  represent	  linear	  regression	  fits	  for	  illustration.	  Each	  dot	  
represents	  mean	  GFP	  intensity	  of	  >5	  seam	  cells	  of	  a	  worm.	   (C)	  Model	  for	  dre-­‐1/blmp-­‐1	  action	   in	  somatic	  tissue:	  Elevated	  
BLMP-­‐1	   levels	   contribute	   to	   seam	   cell	   terminal	   differentiation,	   leading	   to	   precocious	   terminal	   differentiation	   in	   dre-­‐1	  
mutants	  and	  consequentially	  impaired	  terminal	  differentiation	  in	  the	  absence	  of	  BLMP-­‐1.	  Double-­‐slashes	  indicate	  the	  end	  
of	  data	  assessment.	  
 
2.2.8 Screen for DRE-1/BLMP-1 Upstream Regulators 
As indicated above, additional layers of regulation might contribute to the timing of BLMP-1 
turnover particularly in the epidermis. As substrate phosphorylation is oftentimes key to 
substrate recognition by F-box proteins or, as recently shown, can have the exact opposite 
effect (Rossi et al., 2013; Skaar et al., 2013), we decided to screen through a RNAi library of 
kinases and phosphatases with regard to their effect on BLMP-1 protein abundance. Under 
my supervision a bachelor student, Caroline Hoppe, screened through a library of 393 kinases 
and 151 phosphatases using BLMP-1::GFP expression as direct readout. Surprisingly we 
found no striking upregulation of BLMP-1::GFP, but 5 candidates marginally increased 
BLMP-1::GFP levels in the hypodermis (Table 4). However, multiple RNAi treatments 
provoked a moderate reduction of BLMP-1::GFP levels, indicating the corresponding proteins 
to normally prevent BLMP-1 degradation (Table 4). As many of these candidates were tested 
only once, they are currently confirmed in an RNAi-sensitized rrf-3(pk1426) mutant 

























































































































Table	  4:	  Kinase	  and	  Phosphatase	  Candidates	  Found	  to	  Modulate	  BLMP-­‐1::GFP	  Levels	  
 
Kinase library Phosphatase library 
Gene Replicates Gene Replicates            BLMP-1::GFP down 
vps-34 1 W03F11.4 1            BLMP-1::GFP up 
mtk-1 1 ZK973.k 1 
cdk-9 1 ZK484.7 1 
Y47G6A_246.a 2 F22D6.9 1 
F46F5.2 2 R03D7.8 1 
vab-1 1 F52H3.6 1 
dkf-2 1 T20H9.6 1 
daf-1 2 C17H12.5 1 
pmk-3 1 cel-1 1 
C49C8.1 1 F53C3.13 1 
W03G9.5 1 T20B6.1 1 
plk-3 1 fem-2 1 
rskn-2 2 C55B7.3 1 










2.2.9 blmp-1 Expression Profiles – Seeking for Downstream Effectors 
We not only investigated upstream regulators of DRE-1/BLMP-1, but also aimed to identify 
cognate downstream effectors regulated by the transcription factor blmp-1. Therefore we 
performed RNA-sequencing analysis of blmp-1 mutant and WT animals harvested at the mid-
L3 stage. We identified 325 significantly up- and 303 downregulated genes (≥1.5-fold 
difference from WT, q-value<0.05), indicating that blmp-1 might not exclusively fulfills 
repressor functions in C. elegans (see Appendix). Differentially regulated genes included 
those enriched in the biological processes of molting and cuticle development, sugar and 
aminosugar metabolism, and protein modification (Figure 28A). The molting and cuticle-
related regulated genes were amongst others ptr-8, wrt-2, bed-3, nas-36, and collagens (e.g. 
col-7, col-91 and col-124). I further confirmed blmp-1-dependent regulation of these genes by 
qRT-PCR in L3 larvae and also young adult animals. Interestingly, all tested genes were 
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similarly regulated in both stages (Figure 28B). To initially test whether one target alone 
causes blmp-1 retarded seam phenotypes, I depleted multiple downregulated candidates by 
RNAi in a RNAi-sensitized rrf-3(pk1426) mutant background, since I saw no affect on alae 
formation in WT animals. wrt-2 and bed-3 depletion both altered adult alae formation, but 
only in a small fraction of worms, suggesting that multiple blmp-1 regulated genes act in 
concert to control adult alae synthesis (Figure 28C and 28D).  
 
Figure	  28:	  BLMP-­‐1	  Controls	  Epidermal	  Maturation	  via	  Transcriptional	  Changes	  in	  Molting-­‐	  and	  Cuticle	  Related	  Genes	  
(A) Summary of gene-ontology/biological processes derived from DAVID analysis (Huang et al., 2009) of differentially 
regulated genes (q<0.05, fold change >±1.5) in WT vs. blmp-1 mutant animals from RNA-sequencing datasets (n=3). 
ReviGO was used for visualization of the resulting GO term classes and its semantic similarity (Supek et al., 2011). Bubble 
color, size, and line widths respectively indicate significance of enrichment, frequency of GO term in underlying data sets, 
and degree of similarity. More intense colors indicate a higher significance of enrichment. (B) qRT-PCR analysis of blmp-1-
regulated molting and cuticle-related genes in L3 larvae and young adult worms. *P<0.05, **P<0.01, ***P<0.001 (t-test). 
Mean+SEM (n≥3). (C) bed-3 and wrt-2 depletion by RNAi hamper adult alae formation in only a small fraction of RNAi-
sensitive rrf-3(pk1426) mutant animals (n>15). (D) DIC images of young adult rrf-3(pk1426) mutant animals grown on 
L4440 empty vector control or wrt-2 RNAi. Arrowheads indicate seam cell positions, the origin of adult alae synthesis. Scale 
bar = 10 µm. 
 
In sum, these data strongly support the idea that blmp-1 is a key regulator of C. elegans 
epidermal terminal differentiation, by transcriptionally regulating a set of molting and cuticle-
related genes. 















molting cycle, collagen and cuticulin-based cuticle




























































































































2.2.10 The DRE-1/BLMP-1 Interaction is Conserved to Mammals  
Given the remarkable degree of conservation of both BLMP-1 and DRE-1, I next asked 
whether also human FBXO11 restrains human BLIMP-1 stability. Importantly, I found the 
regulation of BLMP-1 by DRE-1 to be evolutionary conserved. First, like the worm proteins, 
human BLIMP-1 specifically coprecipitated with human FBXO11 when coexpressed in 
cultured HEK293T cells, again only upon proteasome inhibition (Figure 29A and 29B). 
BLIMP-1 also weakly interacted with the closely related FBXO10, but not other controls 
(Figure 29A). Interestingly, the ability to bind BLIMP-1 was substantially reduced when the 
Q491L amino acid substitution identified in the Jeff mouse mutant was introduced into human 
Fbxo11, suggesting that the conserved region containing the point mutation may facilitate 
interaction (Figure 29A).  
 
Figure	  29:	  Human	  FBXO11	  Binds	  Human	  BLIMP-­‐1	  and	  Triggers	  its	  Ubiquitination	  
(A)	  Anti-­‐FLAG	  IP	  of	  human	  FLAG-­‐HA-­‐tagged	  (F/H)	  RFP,	  -­‐FBXO5,	  -­‐FBXO10,	  -­‐FBXO11	  and	  -­‐FBXO11(Q491L/Jeff)	  from	  HEK293T	  
cells	   treated	   with	   15	   µM	   MG132.	   Human	   His-­‐BLIMP-­‐1	   was	   coexpressed.	   Quantification	   of	   RFP/F-­‐box-­‐protein	   binding	  
intensity	   to	  BLIMP-­‐1	  was	  normalized	  to	  BLIMP-­‐1	   input	  and	  FBXO11-­‐BLIMP-­‐1	  association.	  ***p<0.001	   (ANOVA).	  Mean+SD	  
(n=5).	  nd	  =	  not	  detectable.	  (B)	  Human	  His-­‐BLIMP-­‐1	  coprecipitates	  with	  coexpressed	  F/H-­‐FBXO11	  from	  HEK293T	  cells	  only	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FLAG-­‐tagged	   FBXO11	   or	   -­‐FBXO11(F-­‐boxMUT),	   and	   an	   empty	   vector	   as	   indicated.	   After	   immunopurification	  with	   anti-­‐FLAG	  
resin,	  in	  vitro	  ubiquitination	  of	  BLIMP-­‐1	  was	  performed	  in	  the	  presence	  of	  E1	  and	  E2	  enzymes.	  Where	  indicated,	  ubiquitin	  
was	  added.	  Samples	  were	  analyzed	  by	  SDS-­‐PAGE	  and	  immunoblotting	  (left	  panel).	  Immunoblots	  of	  whole-­‐cell	  extracts	  and	  
immunoprecipitations	  are	  shown	  in	  the	  right	  panel.	  
 
Second, in collaboration with Dr. Lukas Cermak from the Pagano laboratory at NYU, we 
could show that immunopurified FBXO11 promoted BLIMP-1 ubiquitination in vitro 
(Figure 29C). To this end, Dr. Cermak performed in vitro ubiquitination assays after 
coexpression of tagged FBXO11 and BLIMP-1 and immunopurification of SCFDRE-1 
complexes from HEK293T cells. Notably, the appearance of BLMP-1 higher molecular 
weight species in these assays necessitated a functional F-box domain, which tethers FBXO11 
to the SCF complex: F-box domain mutation (F-boxMUT/V98A, C99A, F102A) abolished 
binding to the SKP1 adapter protein and consistently prevented BLIMP-1 ubiquitination 




Figure	  30:	  The	  SCFFBXO11	  Complex	  Triggers	  Human	  BLIMP-­‐1	  Degradation	  via	  the	  Proteasome	  
(A+B)	  FBXO11	  promotes	  BLIMP-­‐1	  degradation.	  Human	  BLIMP-­‐1	  stability	  was	  assessed	  in	  HEK293T	  cells	  transfected	  with	  His-­‐
BLIMP-­‐1	   and	   -­‐RFP	   in	   combination	  with	   either	   Flag-­‐HA(F/H)-­‐tagged	  RFP,	   -­‐FBXO11	   ±	  DN-­‐CUL1(1-­‐452),	   -­‐FBXO11(ΔF-­‐box),	   -­‐
FBXO11(Q491L/Jeff),	  FBXO5,	  or	  FBXO10.	  Cells	  were	  treated	  with	  cycloheximide	  (CHX)	  or	  CHX	  ±	  15µM	  MG132	  for	  0,	  1,	  2	  or	  4	  
hrs	   as	   indicated	   prior	   to	   harvesting	   and	   analysis	   by	   SDS-­‐PAGE	   and	   immunoblotting.	   (C)	   Human	   BLIMP-­‐1	   stability	   was	  
quantified	   from	   ≥3	   independent	   experiments	   (see	   A+B)	   and	   normalized	   to	   BLIMP-­‐1	   levels	   at	   0	   hrs	   CHX	   treatment	   and	  
coexpressed	  His-­‐RFP.	  Mean+SD	  (n≥3).	  
	  
A







0 1 2 4 0 1 2 4





















































































Third, like for the C. elegans counterparts, CHX treated cells showed progressive proteolysis 
of transfected human BLIMP-1 upon cotransfection of FBXO11, which strongly depended on 
a functional proteasome (Figure 30A and 30C). Rates of human BLIMP-1 proteolysis were 
significantly reduced by deletion of the FBXO11 F-box domain (ΔF-box) or by introducing 
the amino acid substitution FBXO11/Q491L (Figure 30A and 30C). Furthermore, inclusion of 
a deletion mutant, dominant negative form of the SCF scaffold CUL1, but not other dominant 
negative Cullins, prevented FBXO11-dependent BLIMP-1 degradation (Figures 30B, 30C 
and 31). In accord with a low BLIMP-1 binding affinity, also FBXO10 overexpression 
slightly destabilized BLIMP-1 after CHX treatment, indicating that FBXO10 might also 
harbor a minor capability to target BLIMP-1 (Figure 30B and 30C).  
 
Figure	  31:	  Specifically	  DN-­‐CUL1,	  but	  not	  other	  DN-­‐CULs,	  
Prevents	  FBXO11-­‐Dependent	  BLIMP-­‐1	  Turnover	  
HEK293T	   cells	  were	   transfected	  with	  His-­‐BLIMP-­‐1	  and	   -­‐
RFP	  in	  combination	  with	  F/H-­‐tagged	  FBXO11	  ±	  FLAG-­‐DN-­‐
CUL1(1-­‐452),	  -­‐CUL2(1-­‐427),	  or	  -­‐CUL3(1-­‐418).	  Transfected	  
cells	  were	   treated	  with	  CHX	   for	   0	   or	   4	   hrs	   as	   indicated	  







Finally, in agreement with accelerated BLIMP-1 degradation Dr. Lukas Cermak found that 
short hairpin RNA (shRNA)-mediated depletion of FBXO11 in ARP1 multiple myeloma cells 
using two different shRNAs, led to stabilization of endogenous BLIMP-1 in the presence of 
CHX (Figure 32). ARP1 cells were used as BLIMP-1 plays a critical role in B cell maturation 
and also because it was one of few cell lines that showed detectable BLIMP-1 protein levels 



























Figure	  32:	  FBXO11	  Restrains	  Endogenous	  BLIMP-­‐1	  Levels	  in	  ARP1	  Multiple	  Myeloma	  Cells	  
(Performed	  by	   L.	   Cermak)	  Stability	  of	  endogenous	  BLIMP-­‐1	  was	  analyzed	   in	  ARP1	  multiple	  myeloma	  cells	   infected	  	  with	  	  
either	  	  viruses	  	  expressing	  two	  	  different	  	  FBXO11	  shRNAs	  or	  	  an	  	  empty	  	  virus	  	  (CTRL),	  	  and	  	  selected	  	  for	  	  72	  hrs.	  Cells	  were	  
then	  treated	  with	  CHX	  for	  0,	  1	  or	  2	  hrs	  as	  indicated	  and	  protein	  extracts	  were	  analyzed	  by	  SDS-­‐PAGE	  and	  immunoblotting.	  
 
Altogether, these experiments demonstrate that SCFFBXO11 mediates ubiquitin-mediated 
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3.1 DRE-1 Substrates in C. elegans 
CED-9/BCL2 was so far the only predicted substrate of DRE-1 in C. elegans, a hypothesis 
solely based on genetic interactions (Chiorazzi et al., 2013). In this work, I validated CDT-2 
as a genetic interactor of dre-1 in vivo in C. elegans and discovered the zinc-finger 
transcriptional repressor BLMP-1 as a novel target of the highly conserved SCFDRE-1 E3-
ubiquitin ligase. My findings indicate that dre-1 and cdt-2 interact genetically to regulate the 
timing of cell cycle exit, while I found that dre-1/blmp-1 work together to not only regulate 
developmental timing in the epidermis and gonad, but also affect molting, dauer diapause 
formation and adult lifespan in C. elegans. Remarkably, our data demonstrate that the dre-
1/blmp-1 interaction is conserved in human cells, suggesting that these two proteins might act 
together to control related processes across species. 
Prof. Michele Pagano and colleagues identified a novel substrate of the SCFFBXO11 complex, 
CDT2, which was known to control cell cycle progression and DNA damage responses 
(Abbas et al., 2013b; Abbas et al., 2013a; Rossi et al., 2013). As the two C. elegans 
counterparts, CDT-2 and DRE-1, specifically interacted in cultured cells, I used the nematode 
to validate the relation in vivo. My data show that cdt-2 genetically interacts with dre-1 for the 
process of adult alae formation, but not seam cell fusion or gonadal migration. Further my 
findings indicate that dre-1 mutant alae gaps could arise from a cdt-2-dependent failure in cell 
cycle exit, as a marker of arresting cells, CKI-1::GFP, is exclusively absent underneath the 
alae gaps in mature worms. Since on its own, cdt-2 depletion did not lead to overt 
heterochronic phenotypes in epidermis or gonad, it was not further studied with regard to 
heterochronic interactions. Taken together, my results support the notion that DRE-
1/FBXO11 targets CDT-2/CDT2 across species, but they also clearly indicate that distinct 
DRE-1/FBXO11 substrates must accumulate to mediate the diverse developmental 
phenotypes of dre-1 mutants.  
Multiple lines of evidence argue that BLMP-1 constitutes a novel, and the first biochemically 
evidenced target of the SCFDRE-1 complex in C. elegans. First, DRE-1 and BLMP-1 interact in 
vivo and when coexpressed in cultured cells. Second, BLMP-1::GFP and endogenous BLMP-
1 levels are strongly elevated upon dre-1 depletion, reduction of other SCFDRE-1 complex 
components and inhibition of the proteasome. Third, although we failed to detect BLMP-1 
ubiquitinated species in vivo and in vitro assays, BLMP-1 protein is substantially destabilized 
upon coexpression of DRE-1 in cell culture. Finally, dre-1 and blmp-1 show strong genetic 
interactions in epidermis and gonad: blmp-1 is epistatic to dre-1 heterochronic phenotypes in 
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both seam cell differentiation and gonadal migration, strongly suggesting that blmp-1 acts 
downstream of blmp-1 in a unified pathway. Interestingly, this genetic interaction also further 
extends to the life history traits of dauer formation and longevity. These data are in accord 
with my finding that blmp-1 overexpression exacerbates dre-1 mutant phenotypes, indicating 
that dre-1 developmental alterations largely arise from increased BLMP-1 activity. Taken 
together, my findings demonstrate that BLMP-1 is specifically targeted for degradation by the 
SCFDRE-1 complex.  
3.2 The DRE-1/BLMP-1 Module Coordinates C. elegans Life 
History 
DRE-1 and BLMP-1 work as a module to regulate several aspects of C. elegans life history 
(Figure 33). In particular, my studies establish dre-1/blmp-1 as key regulators of epidermal 
and gonadal developmental timing. Our previous work demonstrated that dre-1 loss of 
function induces precocious seam cell fusion and synthetic retarded gonadal migration 
defects. Here, I discovered blmp-1 depletion to efficiently suppress both phenotypes. On its 
own, blmp-1 mutation leads to phenotypes opposite to dre-1, namely retarded terminal 
differentiation of the seam cells (e.g. poor alae formation) on the one hand and precocious 
migration of gonadal dtcs on the other hand. The obtained phenotypes nicely correlate with 
BLMP-1::GFP levels in the corresponding tissues. While BLMP-1::GFP levels are shut down 
in the dtc in a dre-1 dependent manner right before the dorsal gonadal turn, they transiently 
peak at the time of the seam cell fusion event in the epidermis. These findings suggest that 
high BLMP-1 levels in the gonad prevent its full maturation, whereas hypodermal BLMP-1 
triggers epidermal terminal differentiation (Figure 33). Thus blmp-1, similar to its mammalian 
counterpart, mediates terminal differentiation in some tissues, but also controls intermediate 





Figure	  33:	  DRE-­‐1/BLMP-­‐1	  Coordinate	  C.	  elegans	  Developmental	  Timing	  and	  Other	  Life	  History	  Traits	  
Model	   of	   DRE-­‐1/BLMP-­‐1	   function	   in	   C.	   elegans:	   The	   SCFDRE-­‐1	   E3-­‐ubiquitin	   ligase	   complex	   controls	   BLMP-­‐1	   protein	  
abundance	   via	   proteasomal	   degradation.	   Thereby	   dre-­‐1-­‐dependent	   BLMP-­‐1	   regulation	   not	   only	   times	   epidermal	  
maturation	  and	  dorsal	   gonadal	  migration,	  but	  also	  affects	  other	   life	  history	   traits	   such	  as	  entry	   into	  dauer	  diapause	  and	  
adult	  longevity.	  
 
Importantly, blmp-1 genetically interacts with multiple heterochronic loci that govern the 
larval-to-adult transition. blmp-1 loss of function enhances retarded (let-7, mab-10/NAB) and 
suppresses precocious (lin-41/Trim71, lin-42/Period, hbl-1/Hunchback, sop-2/PcG-like) 
heterochronic mutants for phenotypes in the epidermal seam cells. Similarly also dre-1 was 
shown to act at the larval-to-adult transition, enhancing impenentrant hbl-1 and lin-41 
precocious phenotypes and partially suppressing let-7 retarded terminal seam differentiation 
(Fielenbach et al., 2007). Altogether, these data indicate that dre-1/blmp-1 could work in 
parallel to both hbl-1 and lin-41, acting downstream of let-7 (Figure 34). Furthermore lin-29 
was shown to be epistatic to dre-1 (Fielenbach et al., 2007), suggesting that the dre-1/blmp-1 
module acts upstream or parallel to lin-29 (Figure 34). The fact that lin-29 expression was 
found to be preceded in only a minor fraction of dre-1 mutants (less than 10%) might argue 
that dre-1 acts both through and independent of lin-29, maybe by regulating distinct targets 
(Fielenbach et al., 2007). As blmp-1 mutation did not regulate lin-29 expression according to 
our RNA-sequencing data sets, blmp-1 might act largely parallel to lin-29 (Figure 34).  
Taken together, these genetic interactions firmly place the dre-1/blmp-1 module in general 
and the new heterochronic gene blmp-1 in particular within the heterochronic circuit 
controlling late larval development (Figure 34). As not all alleles used were null and ts alleles 
were observed at semi-permissive temperatures, further analyses are required to ultimately 
place dre-1/blmp-1 within the seam cell heterochronic network. Understanding how these 
genetic interactions translate into molecular regulatory events should also be interesting to 


















Figure	  34:	  dre-­‐1/blmp-­‐1	  Act	  at	  a	  Late	  Step	  in	  the	  C.	  elegans	  Heterochronic	  Seam	  Circuitry	  
Genetic	   epistasis	   and	   synergy	   experiments	   place	   both	   dre-­‐1	   and	   blmp-­‐1	   at	   a	   late	   step	   in	   the	   seam	   cell	   heterochronic	  
network.	  My	  data	  and	  previous	  results	  indicate	  that	  the	  dre-­‐1/blmp-­‐1	  module	  acts	  downstream	  of	  the	  let-­‐7	  microRNA	  and	  
mostly	  upstream	  of	  lin-­‐29,	  but	  it	  might	  also	  have	  parallel	  functions	  to	  this	  key	  terminal	  maturation	  factor.	  
 
3.3 Evolutionary Conserved Functions of DRE-1/BLMP-1 
Importantly, the DRE-1/BLMP-1 interaction is conserved to mammals. First, I found human 
BLIMP-1 to specifically coprecipitate with FBXO11 and at low levels with FBXO11’s 
paralog FBXO10. Second, FBXO11 promotes BLIMP-1 ubiquitination in vitro in a manner 
that strongly depends on FBXO11’s association to the SCF complex via its F-box domain. 
Third, functional FBXO11 strongly destabilizes human BLIMP-1 upon cotransfection and 
blockage of nascent protein synthesis in cultured cells. Conversely, shRNA mediated 
depletion of FBOX11 in the ARP1 multiple myeloma cell line leads to stabilization of 
endogenous BLIMP-1. Altogether, these data demonstrate that the interaction and degradation 
function of DRE-1/BLMP-1 is evolutionarily conserved (Figure 35).  
Interestingly, many of C. elegans heterochronic genes governing seam cell development are 
remarkably conserved and have mammalian counterparts that regulate skin stem cell 
homeostasis, such as blmp-1/BLIMP-1 itself, daf-12/FXR/LXR/VDR, lin-4/mir-125b, let-7, 
lin-42/Period, and others (Cianferotti et al., 2007; Horsley et al., 2006; Janich et al., 2011; 
Magnúsdóttir et al., 2007; Zhang et al., 2011). In particular, BLIMP-1 specifies a stem cell 
population in the sebaceous gland and triggers keratinocyte terminal differentiation in the 
epidermis, a transition from the granular to the cornified layers, which form the outer barrier 
toward the environment (Magnúsdóttir et al., 2007; Horsley et al., 2006). Therein, BLIMP-1 
and the vitamin D receptor were shown to be downregulated by the microRNA lin-4/mir125b 




























in skin stem cells to prevent their differentiation. Together with previous reports, my data 
show that C. elegans blmp-1 specifies terminal differentiation in the epidermis and that this 
regulation could stem from blmp-1-dependent transcriptional changes in molting and cuticle-
related genes (Zhang et al., 2012). Moreover, dauer epistasis experiments place blmp-1 at a 
late step in the dauer signaling network, in close proximity to DAF-12/FXR/LXR/VDR, thus 
bearing remarkable similarity to the situation in the mammalian skin. Interestingly, FBXO11 
too is expressed in the skin (Hardisty-Hughes et al., 2006; Dr. Sarah Wickström, personal 
communication), suggesting FBXO11 might modulate BLIMP-1-dependent skin maturation 
by controlling its stability (Figure 35). 
Although BLIMP-1 is described as a key maturation factor in mammals, our findings in the 
nematode might add further perspectives to BLIMP-1 function. In C. elegans, DRE-1/BLMP-
1 not only orchestrate developmental timing, but also affect organism-wide fates such as 
molting, dauer diapause, and adult longevity. Previously, dre-1 was shown to be required for 
programmed death of the tail-spike cell and blmp-1 was uncovered as regulator of the male 
tail tip morphogenesis (Chiorazzi et al., 2013; Nelson et al., 2011). Altogether, the rich 
signaling circuits governing C. elegans developmental timing, molting, dauer formation, 
longevity, and apoptosis might add novel aspects to BLIMP-1 function in mammalian stem 
cells and maturation. Therein, FBXO11/BLIMP-1 might not only function as switch 
regulating cellular differentiation, but could also be viewed as a developmental timing module 
that specifies distinct states of differentiation in a tissue-specific fashion.  
Indeed, the notion that DRE-1/BLMP-1 comprise a conserved functional module may have 
several implications in mammals (Figure 35). Among others, BLIMP-1 specifies primordial 
germ cell fates by repressing somatic transcriptional programs (Ohinata et al., 2005; 2009). 
More recently, it has been shown to not only specify pluripotent cell fates, but also to have the 
potential to partially reprogram somatic cells (Nagamatsu et al., 2011). Furthermore, BLIMP-
1 is a key regulator of forelimb development, pharyngeal and heart morphogenesis, as well as 
T cell differentiation (Martins and Calame, 2008; Vincent et al., 2005). Interestingly, 
FBXO11 too is expressed in a variety of BLIMP-1 target tissues including the heart during 
morphogenesis as well as hematopoietic cells (Hardisty-Hughes et al., 2006). By inference, 
FBXO11 could work in tandem with BLIMP-1 in at least some of these contexts by 
controlling its turnover (Figure 35).  
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Despite its remarkable evolutionary conservation rather little is known about FBXO11 
function in mammals. Its loss of function results in perinatal lethality paired with strong 
developmental abnormalities during facial morphogenesis in Jeff mutant mice (Hardisty-
Hughes et al., 2006). Moreover, in mice and men Fbxo11 mutation has been closely linked to 
the onset of otitis media, a chronic inflammation of the inner ear. My results indicate that 
aberrantly elevated BLIMP-1 levels could mediate some of these malformations, since 
BLIMP-1 degradation is substantially impaired upon introduction of the Q491L/Jeff point 
mutation into human Fbxo11. Interestingly, although not shown mechanistically yet, also 
CDT2 misregulation could contribute to the development of these malformations. FBXO11-
dependent degradation of CDT2 stabilizes Set8, which in turn stimulates epithelial cell 
migration (Abbas et al., 2013a). Therefore, enhanced Set8 degradation in FBXO11 mutants 
might result in impaired epithelia cell migration, which has been linked to the development of 
cleft palates (Figure 7) (Johnston and Bronsky, 1995). Furthermore, Set8 is required to 
restrain TGF-β responses by triggering pSmad2 dephosphorylation via an unknown 
mechanism (Abbas et al., 2013a). Likewise, FBXO11 mutant mice show increased pSmad2 
levels, indicating altered TGF-β signaling, which could stem from a lack of CDT2 
degradation and thus reduced Set8 levels (Tateossian et al., 2009; Abbas et al., 2013a). These 
observations could directly link misregulated CDT2 to inflammatory responses (Yoshimura et 
al., 2010) that could to some measure contribute to the onset of chronic inner ear 
inflammation, whereas the function of potentially elevated BLIMP-1 or BCL6 levels in this 
context are yet unknown (Figure 35).  
In addition to the Jeff mutant mice phenotypes, Fbxo11 mutation has been found in a variety 
of cancers (Richter et al., 2012; Duan et al., 2012; Stransky et al., 2011; Kan et al., 2010; 
Yoshida et al., 2011). Recently, Duan et al. could show that FBXO11 plays a critical role in 
preventing tumorigenesis in the immune system by degrading BCL6 (Duan et al., 2012). 
FBXO11 loss results in aberrantly elevated BCL6 levels, a hallmark of many large B cell 
lymphomas (Basso and Dalla-Favera, 2012). In a healthy state, BCL6 maintains germinal 
center B cells, which constitute an intermediate step of B cell differentiation specialized for 
proliferation and affinity maturation (Crotty et al., 2010). Also BLIMP-1 plays a critical role 
during immune cell development. In contrast to its closely related Zn-finger protein BCL6, 
BLIMP-1 promotes terminal differentiation of B cells toward antibody-secreting cells (plasma 
cells) (Turner et al., 1994; Crotty et al., 2010). Thereby BCL6 and BLIMP-1 function as 
antagonistic self-reinforcing switch by driving cognate transcriptional programs. Also in T 
cells BCL6 and BLIMP-1 act antagonistically to control the memory and effector 
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differentiation of both helper and cytotoxic T cells (Crotty et al., 2010). In lymphocytes, 
BCL6 defines a cellular state of high proliferative capacity, while BLIMP-1 expressing 
lymphocytes exhibit low proliferative capacity and a highly active secretory machinery. 
Interestingly, BLIMP-1 mutation has been also linked to tumorigenesis (Hangaishi and 
Kurokawa, 2010): in a subclass of large B cell lymphomas (activated B cell type, ABC) 
BLIMP-1-controlled differentiation is frequently impaired by distinct mechanisms all 
ultimately preventing BLIMP-1 function (Mandelbaum et al., 2010). In contrast, elevated 
BLIMP-1 levels have been associated with tumorigenesis in T cell-derived tumors (Zhao et 
al., 2008). In sum, FBXO11 targets both BCL6 and BLIMP-1 (this work) for proteasomal 
degradation. However, how this proteolytic function is coordinated within healthy immune 
lineages and potentially impaired in tumorigenesis remains to be elucidated. One could 
speculate that FBXO11 adds an additional layer of regulation to the critical transcriptional 
coordination of lymphocyte maturation (Figure 35). Consequentially, FBXO11 dysfunction 
might result in a detrimental imbalance of BCL6/BLIMP-1 protein that might lead to the 
formation of malignant tumors. Interestingly, also FBXO10 degrades a tumor suppressor 
affecting the immune system, BCL2 (Chiorazzi et al., 2013), suggesting a general role for 
FBXO10/11 complexes in immunity and lymphoma formation. The fact that I found FBXO10 
to harbor a low capability to destabilize BLIMP-1 might indicate that FBXO10 and -11 even 
have partially redundant functions or that they are additionally regulated by modification or 
spatial separation. In particular, FBXO10 is predominantly expressed in the cytoplasm, while 
FBXO11 is largely nuclear, supporting the latter hypothesis (Chiorazzi et al., 2013).  
 
Figure	  35:	  FBXO11	  Could	  Modulate	  BLIMP-­‐1	  Dependent	  Processes	  in	  Mammals	  by	  Controlling	  BLIMP-­‐1	  Turnover	  
Model	  of	  FBXO11/BLIMP-­‐1	  function	  in	  mammals:	  FBXO11	  triggers	  BLIMP-­‐1	  degradation	  and	  could	  by	  inference	  play	  a	  key	  
role	   in	   BLIMP-­‐1	   dependent	   maturation	   processes	   such	   as	   B	   cell	   and	   epidermal	   maturation	   or	   primordial	   germ	   cell	  
specification.	   Similarly,	   BLIMP-­‐1	   might	   be	   involved	   in	   developmental	   alterations	   associated	   with	   FBXO11	   loss	   including	  
facial	  malformations.	  
 
Taken together, I discovered BLMP-1 as a substrate of the SCFDRE-1 complex, modulating 
developmental timing and other life history traits in C. elegans. Given the remarkable degree 



















FBXO11/BLIMP-1 module could similarly regulate metazoan cellular fate decisions across 
tissues.
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4.1 Significance 
The identification and characterization of F-box protein substrates still remains one of the 
biggest challenges in the field of ubiquitin-mediated proteolysis. Here, I used the model 
organism C. elegans to test in vivo functions of a newly identified F-box protein substrate, 
CDT2. Moreover, I uncovered a novel target of the F-box protein DRE-1 using a genetic 
approach in C. elegans. Importantly, I could closely link the obtained degradation function to 
developmental progression in epidermis and gonad, by monitoring the substrate abundance in 
vivo over time. My findings not only unraveled a novel DRE-1 substrate, but also establish 
blmp-1 as a new heterochronic gene. The remarkable conservation of heterochronic gene 
structure and function in general, and dre-1 as well as blmp-1 in particular, suggest that also 
FBXO11/BLIMP-1 work as a global switch controlling metazoan maturation in a variety of 
tissues. In sum, this work furthers our understanding of post-translational control of 
developmental timing and might give new insights into FBXO11 function in health and 
disease states, thus constituting a solid basis for groundbreaking future studies. 
4.2 Future Perspectives 
Based on this work one could imagine a variety of exciting follow-up studies. In this final 
section I will describe several potential future directions. 
4.2.1 Characterization of the FBXO11-Substrate Interaction Site  
A central question that arises from our work is what is the biochemical nature of the 
FBXO11-substrate interaction site? An emerging body of evidence from Pagano’s group and 
my study suggest that the CASH domains of FBXO11 mediate substrate binding. First, I 
found that FBXO11 Q491L mutation (Jeff) within the second CASH domain hampers 
BLIMP-1 binding and degradation. Second, I found a point mutation in the first CASH 
domain of C.elegans DRE-1 (dh99: G514S) to result in synthetic lethality upon BLMP-
1::GFP overexpression, while the blmp-1::gfp transgene could be recovered in the dre-
1(dh279) (Q824STOP) allele, which lacks only the C-terminal part of the last CASH domain 
and the ZnF-UBR-like domain. Finally, Pagano and colleagues recently showed that 
specifically FBXO11 mutations within the CASH domains impair BCL6 degradation (Duan 
et al., 2012). Altogether, these data indicate that CASH domains of FBXO11 bind distinct 
substrates, but the mechanism of substrate recognition, in particular for BLIMP-1 and BCL6, 
remains poorly understood. 
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To further understand the molecular details underlying substrate recognition by FBXO11, the 
FBXO11-BLIMP-1 interaction site should be characterized in more detail. The use of first 
deletion and then point mutated versions of BLIMP-1 in coimmunoprecipitation and protein 
stability assays could help to identify the degron and the ubiquitinated Lys residue(s) within 
BLIMP-1. Studies of the CDT2-FBXO11 interaction uncovered a novel mechanism of 
substrate recognition, whereby substrate phosphorylation prevents its ubiquitination (Rossi et 
al., 2013). Similar investigations with BLIMP-1 and the first identified FBXO11 substrate 
BCL6 might unravel whether this ‘phospho-inhibited degron’-recognition is shared by all 
known FBXO11 substrates. In particular, the specific recognition of BLIMP-1 and BCL6 
might be key to understand their potential regulation in the context of B cell maturation. 
Moreover, further molecular details on the FBXO11-substrate interaction site could unravel a 
specific degradation motif, that would allow identification of potential novel DRE-1/FBXO11 
substrates via a bioinformatics approach, as successfully applied for SEL-10/FBXW7 (la 
Cova and Greenwald, 2012). Finally, as shown for CDT2, such a specific degradation motif 
might further inform about enzymes involved in post-translational modification prior to 
ubiquitination such as kinases or phosphatases (Rossi et al., 2013). 
4.2.2 Investigation of Upstream Regulators 
Another key question is what are the critical upstream regulators of BLMP-1 protein stability? 
In particular my findings in C. elegans epidermis, where DRE-1 levels are rather constant 
while BLMP-1 levels show a transient peak, point to other instructive components or 
cofactors that contribute to BLMP-1 regulation. Their identification might further inform 
coordination of developmental progression across species. Interestingly mammalian BLIMP-1 
has recently been shown to be sumoylated by SUMO-1 at Lys816 (Shimshon et al., 2011; 
Ying et al., 2012). This modification is catalyzed by the E3 SUMO-protein ligase PIAS1 and 
was on the one hand reported to facilitate BLIMP-1’s proteolytic degradation and on the other 
hand shown to enhance BLIMP-1 dependent transcriptional repression during B cell 
maturation (Shimshon et al., 2011; Ying et al., 2012). How and whether BLIMP-1 
sumoylation affects FBXO11-dependent BLIMP-1 degradation remains to be elucidated. 
Notably, the affected Lys residue is not conserved in nematodes, indicating that another Lys 
or another yet unidentified type of BLMP-1 modification might contribute to the regulation of 
BLMP-1 function and stability in C. elegans (Tunyaplin et al., 2000).  
Although one might gain initial hints about additional BLMP-1 regulators from the 
characterization of the FBXO11-BLIMP-1 interaction site, a genetic approach in C. elegans 
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would certainly be very powerful. As already initiated in this study, one could screen 
phosphatase and kinase RNAi libraries for augmentation of BLMP-1::GFP levels in vivo, 
assuming phosphorylation to prevent or support substrate recognition and subsequent 
degradation. Alternatively, one could test a panel of kinase inhibitors for their potential to 
stabilize or destabilize BLMP-1/BLIMP-1 in vivo in C. elegans or in a cell-based system. 
This approach was successfully applied for the identification of kinases phosphorylating the 
FBXO11 substrate CDT2 (Rossi et al., 2013). In a more unbiased approach one could perform 
EMS mutagenesis in BLMP-1::GFP overexpressing worms looking for modulation of 
expression (Jorgensen and Mango, 2002). In general, EMS mutagenesis has certain 
advantages over RNAi-based screens, since it is not limited by the drawbacks associated with 
RNAi technology, such as targeting only coding sequences, incomplete knockdown rates 
resulting in many false negatives, and the inability to activate genes. However, this particular 
screen is difficult because of the weak BLMP-1::GFP signal, which does not allow high-
throughput analysis of BLMP-1 levels and would rely on visual screens under the compound 
microscope. Alternatively, one could screen for the appearance of molting or gonadal 
migration defects as blmp-1 overexpression provokes both defects upon additional dre-1 
depletion. Therefore one would expect to find mutations in dre-1 and other SCF complex 
components, as well as unknown modulators of BLMP-1 abundance including microRNAs, 
which were shown to target mammalian BLIMP-1 (Thiele et al., 2012; Zhang et al., 2011). 
Notably, this latter approach using synthetic phenotypes as readout assumes strongly elevated 
BLMP-1 levels to be causative for the molting and gonadal migration defects that I observed 
in blmp-1 overexpressors upon dre-1 depletion. However, these defects could also be a result 
of multiple elevated DRE-1 substrates combined with BLMP-1 overexpression. 
Besides BLMP-1, DRE-1 levels are also tightly controlled particularly in the dtcs where they 
increase during the L2-to-L4 larval stages. One could imagine dre-1 expression being induced 
or a repressor action to be released by the mid-L2 stage, when DRE-1 accumulates to trigger 
BLMP-1 degradation. Interestingly, dre-1 mRNA contains multiple microRNA target sites, 
indicating that microRNA-mediated repression might contribute to the regulation of dtc 
migration through dre-1/blmp-1 (Fielenbach et al., 2007). To test this hypothesis dre-1- and 
blmp-1::gfp reporter lines could be studied in microRNA mutant backgrounds that potentially 
target dre-1, including mir-2, mir-59, and mir-71 (Fielenbach et al., 2007).  
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4.2.3 Further Identification of Downstream Effectors 
Because BLMP-1 is a transcriptional regulator, a natural question arising from our studies is, 
what are the BLMP-1-regulated targets important for maturation? Through RNA-sequencing 
and qRT-PCR we showed BLMP-1 to target a set of molting and cuticle-related genes in C. 
elegans, consistent with a general role in the molt cycle and the synthesis of the adult cuticle 
(Zhang et al., 2012). In initial RNAi knockdown experiments with some of these targets, no 
candidate target depletion could fully recapitulate BLMP-1 epidermal differentiation defects, 
indicating that we have yet to further functionally identify specific genes that mediate BLMP-
1’s effects. In mammals, a variety of BLIMP-1 targets have been identified across tissues. For 
example BLIMP-1 resides at the c-myc promoter to block its transcription, thereby preventing 
proliferation during B cell maturation (Lin et al., 1997). Overall, BLIMP-1 is thought to 
switch-off whole gene expression programs such as mature B cell programs during B cell 
differentiation on the one hand and somatic programs during primordial germ cell 
specification on the other hand (Vincent et al., 2005; Ohinata et al., 2005; Shaffer et al., 
2002). However, how BLIMP-1 fulfills these highly context-specific functions remains 
poorly understood. In particular, germ cell development involves major epigenetic 
remodeling, which strongly relies on BLIMP-1 function (Surani et al., 2007). Although 
BLIMP-1 harbors a SET domain (a domain generally involved in Lys methylation), BLIMP-1 
itself bears no intrinsic enzymatic activity (Ancelin et al., 2006; Dillon et al., 2005). Instead, it 
cooperates with epigenetic regulators to control transcription and epigenetic remodeling (Su 
et al., 2009; Ancelin et al., 2006; Yu et al., 2000; Gyory et al., 2004; Surani et al., 2007). 
Therefore, a distinct set of cofactors present in different tissues might allow BLIMP-1 
context-specific action. Similar context-specific activities might hold for the distinct 
developmental fates triggered by BLMP-1 in C. elegans. Moreover, one could speculate that 
also in C. elegans epigenetic regulation, potentially through BLMP-1, directs developmental 
progression and differentiation. Thereby certain epigenetic traits might function as cellular 
memory reflecting the current developmental state. In this context dauer diapause signaling, 
including daf-12 and now also blmp-1, would be of special interest as progression through the 
dauer diapause to a certain extend erases developmental memory, since heterochronic mutants 
develop normally upon passage through dauer (Liu and Ambros, 1991; Euling and Ambros, 
1996). 
In sum, the identification and characterization of BLMP-1 downstream effectors in the 
nematode could help illuminate coordination of developmental timing in C. elegans and also 
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further elucidate the complex regulation of BLIMP-1 targets during cell fate specification in 
mammals. To this end, RNA-sequencing and ChIP-sequencing experiments should be 
repeated in young adult worms, where we obtained defects in adult alae synthesis, since our 
data from L3 larvae, as well as existing ChIP-sequencing data from L1 larvae (Niu et al., 
2011) might not fully reflect BLMP-1 targets during C. elegans maturation.  
In particular, terminal maturation of seam cells is ultimately induced by the Zn-finger 
transcription factor LIN-29 (Rougvie and Ambros, 1995). Despite BLMP-1 and LIN-29 being 
closely related Zn-finger proteins, LIN-29 is not directly regulated by DRE-1 (this work). 
Instead LIN-29 was shown to bind the NAB transcriptional cofactor MAB-10 via a motif 
similar to the R1 domain of mammalian NAB transcription factors EGR1-3 (Harris and 
Horvitz, 2011). Interestingly, C. elegans and also human BLMP-1/BLIMP-1 harbor an amino 
acid stretch very similar to the MAB-10 interaction site of LIN-29 (Figure 36). Thus BLMP-
1/BLIMP-1 might cooperate with NAB transcriptional cofactors such as mab-10 in C. 
elegans, which could be tested directly by coimmunopurification experiments.  
Figure	  36:	  BLMP-­‐1	  and	  BLIMP-­‐1	  Show	  Sequence	  Similarity	  
to	  the	  MAB-­‐10	  Interaction	  Site	  of	  LIN-­‐29.	  
Multiple	   sequence	   alignment	   of	   an	   amino	   acid	   stretch	  
within	  the	  R1	  domain	  of	  EGR1	  with	  the	  MAB-­‐10	  interaction	  
site	  of	   LIN-­‐29	  and	   related	  amino	  acid	   sequences	  within	  C.	  
elegans	  BLMP-­‐1	  and	  human	  BLIMP-­‐1.	  	  
 
In this context, it could also be elucidated whether BLMP-1 acts through LIN-29 or in a 
distinct branch to direct terminal differentiation in the epidermis, by studying LIN-29 
expression in a blmp-1 mutant background. 
Besides seam cell differentiation we found blmp-1 to direct cellular migration in C. elegans 
gonad, as its aberrant accumulation prevents dorso-ventral migratory events. The Dtcs, which 
lead gonad migration, are only two out of about 1000 cells of the worm, which may preclude 
identification of potential blmp-1 target genes from whole worm lysates. However, previous 
work from the group of Prof. Joseph Culotti found transcriptional upregulation of the netrin 
receptor unc-5/UNC5 to initiate the dorsal gonadal turn (Su et al., 2000), which by inference 
render it a potential blmp-1 target. As initial experiments using a unc-5::lacZ reporter gave 
inconclusive results, however, blmp-1 targets regulating dtc migration still remain elusive. 
Importantly, BLIMP-1 was shown to also affect cellular migration in mammals (Kurimoto et 
al., 2008), pointing out parallels between worms and humans and highlighting the importance 
of target gene analysis across species. Taken together, identification of blmp-1 targets and 
cofactors might help to further understand the regulation of developmental timing, dauer 
  EGR1: 281 TQQPSLTPLSTIKAFAT 297 
LIN-29: 390 PGFNMITPLENIQRYNG 406 
BLMP-1: 359 LGNFYASPLVDFKEFMR 375 
BLIMP-1: 266 LYRSNISPLTSEKDLDD 282 
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diapause, molting, and aging in C. elegans, and also give further insights into BLIMP-1 
regulated processes in mammals.  
4.2.4 Explore FBXO11 and BLIMP-1 Function During Tissue Maturation 
As extensively described above, dre-1 and blmp-1 function together to regulate 
developmental timing and other life history traits in C. elegans. Due to the remarkable degree 
of structural and functional conservation, one could speculate that the FBXO11/BLIMP-1 
module coordinates related processes in mammals. In mice, BLIMP-1 controls B cell 
maturation, limb formation, skin maturation, pharyngeal and heart morphogenesis, as well as 
gametogenesis (Turner et al., 1994; Robertson et al., 2007; Magnúsdóttir et al., 2007). 
Likewise, BLIMP-1 deficient embryos die during mid-gestation and exhibit strong 
developmental abnormalities including brachial arch, hemorrhage and placental defects as 
well as complete loss of primordial germ cells (Vincent et al., 2005). In zebrafish, BLIMP-1 
additionally specifies neural crest cells and drives anteroposterior axis formation, wherein 
similar BLIMP-1 requirements were not found in mice (Wilm and Solnica-Krezel, 2005;; 
Vincent et al., 2005). Surprisingly, BLMP-1 protein is not essential during C. elegans 
morphogenesis, indicating that BLIMP-1 functions and requirements expanded throughout 
evolution. However, the regulation of BLMP-1/BLIMP-1 protein by DRE-1/FBXO11 is 
highly conserved, supporting the notion that FBXO11 might govern multiple BLIMP-1-
mediated differentiation processes in mammals. To directly test this hypothesis, B cell or skin 
stem cell differentiation could be studied upon FBXO11 depletion or overexpression using an 
in vitro system (Stocker, 1977; Karasek, 1975).  
Like BLIMP-1, also FBXO11 deficiency is linked to a variety of developmental 
abnormalities, such as craniofacial and respiratory defects (Hardisty-Hughes et al., 2006). The 
etiology of craniofacial clefts is not yet fully understood, but they could arise from a failure in 
neural crest cell migration during embryogenesis (Chai and Maxson, 2006). Interestingly, 
comparable malformations have been observed in zebrafish lacking functional BLIMP-1 
(Robertson et al., 2007). Although one would rather expect an inverse correlation between 
FBXO11 and BLIMP-1, the fact that both were already associated with craniofacial 
development is striking and suggests that aberrant BLIMP-1 action might contribute to 
FBXO11 mutant phenotypes. This hypothesis is strongly supported by my finding that 
introduction of the FBXO11 Jeff mutation to human FBXO11 almost entirely abrogates its 
ability to degrade human BLIMP-1. Furthermore Blimp-1 was found to be expressed in 
related tissues (Chang et al., 2002). However, in vivo data from FBXO11 deficient mice 
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would be required to confirm elevation of BLIMP-1 protein. Therefore, one should first 
follow endogenous BLIMP-1 levels in specific tissues of Jeff mutant mice such as the skin or 
the palate shelves throughout development using a validated BLIMP-1 antibody (e.g. 3H2-E8 
(Chang et al., 2002)). Additionally, one should carefully observe skin morphology, primordial 
germ cell specification, and B cell maturation in these mice, processes, strongly depending on 
BLIMP-1. However, BLIMP-1 could in some contexts be redundantly regulated in vivo, 
which would mask FBXO11-dependent regulation. Similarly, also CDT2 and BCL6 levels 
should be analyzed in FBXO11 deficient mice, as they could as well contribute to the 
malformations and the onset of chronic inner ear inflammations observed in these mice 
(Hardisty-Hughes et al., 2006; Hardisty et al., 2003). In particular, CDT-2 constitutes an 
interesting candidate as its aberrant stabilization was shown to affect cellular migration and 
also TGF-β signaling, one of the key pathways mediating inflammation (Yoshimura et al., 
2010). Both might directly link to craniofacial abnormalities and the onset of otitis media, 
respectively. So far, elevated BCL6 levels are predominantly associated with tumorigenesis, 
but might also contribute to Jeff mutant mice developmental alterations (Duan et al., 2012). 
To dissect the effects of the different substrates with regard to craniofacial development or 
inner ear inflammation, one could make use of degradation-resistant mutant versions of the 
three substrates, such as CDT2(T464D) (Rossi et al., 2013). Expressing them in tissue-
specific contexts might recapitulate FBXO11 loss of function phenotypes, which would 
demonstrate a direct connection to the disease state. However, these experiments are 
restrained by the limited knowledge about the molecular details underlying BCL6 and 
BLIMP-1 degradation via FBXO11. Therefore the characterization of FBXO11-substrate 
interaction sites as described above also constitutes an important step toward the 
understanding of FBXO11 dysfunction in disease states.  
4.2.5 Identification of Additional DRE-1/FBXO11 Substrates 
The identification of F-box protein substrates significantly contributes to our understanding of 
specific protein turnover in health and disease states. Although many substrates have been 
identified within the last 15-20 years, dozens of F-box proteins remain orphan receptors or the 
identified substrates only poorly explain associated phenotypes. DRE-1/FBXO11 quite 
recently emerged as a crucial regulator of developmental progression and tumorigenesis 
(Hardisty-Hughes et al., 2006; Duan et al., 2012). Since then, two substrates were described 
in C. elegans, CDT-2 and BLMP-1, and three in mammals, CDT2, BLIMP-1, and BCL6. 
Interestingly, the closest C. elegans homolog of BCL6 also is BLMP-1, suggesting that 
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mammalian BLIMP-1 and BCL6, as well as C. elegans BLMP-1 evolved from a common 
precursor.  
In mice, FBXO11 knockout results in perinatal lethality and in C. elegans dre-1 null mutants 
arrest at the three-fold stage of embryogenesis or as L1 larvae, often displaying molting 
defects (Hardisty-Hughes et al., 2006; Fielenbach et al., 2007). Preliminary experiments in the 
nematode indicate that neither cdt-2 nor blmp-1 depletion can suppress this early lethality 
(data not shown). Thus one could speculate DRE-1 to target more than just the two substrates 
in the nematode, which has been demonstrated for a variety of F-box proteins in mammals 
(Skaar et al., 2009b). To identify additional DRE-1 targets, one could screen for suppressers 
of dre-1 larval lethality using a dre-1(hd60) deletion mutant carrying an extrachromosomal 
full-length dre-1 rescuing construct. The screen could be based on RNAi feeding libraries or 
EMS mutagenesis with positive hits being animals that survive despite loss of the rescuing 
transgene (Jorgensen and Mango, 2002; Kamath and Ahringer, 2003). As dre-1 affects all 
molts, possible substrates include known molting regulators such as nhr-23, nhr-25 or lin-42, 
which all oscillate with the molt cycle. My data indicate that NHR-25 protein levels are not 
dre-1 dependent and also preliminary investigations of a lin-42 full-length fusion to GFP 
showed no obvious dre-1 dependence. However multiple lin-42 isoforms exist, which would 
have to be tested individually to exclude their regulation by dre-1 (Tennessen et al., 2006). 
Furthermore, the screen might uncover novel regulators at the interface of molting and 
developmental timing, as seen for blmp-1. Interestingly, although blmp-1 depletion failed to 
suppress larval lethality, we found blmp-1 and dre-1 to genetically interact in molting 
regulation. Moreover, Drosophila Blimp-1 was reported to be induced by 20-hydroxiecdysone 
to repress nhr-25/FTZ-F1, indicating BLMP-1 might affect chronological age across molting 
species (Agawa et al., 2007). To this end, it could also be interesting to dissect blmp-1’s role 
within the molt cycle and to retest its ability to suppress dre-1 larval lethality in an RNAi-
sensitized background that allows RNAi function also in neuronal tissue, before setting up a 
genome-wide suppressor screen. Also cdt-2 should be retested in the synthesized background, 
since its depletion has previously been associated with molting defects (Frand et al., 2005). 
Taken together, F-box protein substrate identification remains challenging and where 
applicable C. elegans can be used as a tool to identify and characterize conserved substrate 
candidates. In particular, one could investigate the about ten highly conserved F-box proteins 
using genetic suppressor screens in the nematode (Table 3).  
Significance and Future Perspectives 
80 
4.2.6 Biological Control of Developmental Timing 
Pioneering work in C. elegans discovered a set of heterochronic genes regulating 
developmental timing in the nematode (Ambros and Horvitz, 1984; Chalfie et al., 1981). By 
now, a complex regulatory network of more than 30 players has ben built mainly on genetic 
epistasis that includes various conserved transcriptional, translational, and post-translational 
regulators (Resnick et al., 2010). Thereby the time-specific activation and degradation of 
regulatory factors is key to proper developmental progression. My work shows that temporal 
control of BLMP-1 protein levels directs maturation in the epidermis and gonad. Likewise, 
multiple conserved heterochronic factors are under strict temporal control, but the molecular 
mechanisms remain largely elusive. In particular, gene products regulating both molting and 
developmental timing, such as LIN-42, NHR-25, or NHR-23 oscillate with the molt cycle and 
must therefore be induced and degraded in a strongly coordinated fashion. To identify 
regulators of these proteins, EMS-based mutagenesis screens could be performed with loss of 
the oscillatory expression pattern as primary readout. Therefore, after mutagenesis of the P0 
worms expressing full-length ORF::GFP fusion constructs, a mixed population of F3 animals 
could be analyzed for loss of the oscillatory GFP pattern using a worm biosorter. Besides 
picking up mutations in general modulators of transcription and degradation one might 
identify novel specific regulators of these molting and developmental timing gene 
coordinators. In a first, more biased approach related to this study, one could also test whether 
the oscillation of LIN-42, NHR-25, and NHR-23 requires SCF complex mediated 
degradation. If so, the knockdown of one of the six C. elegans Cullins by RNAi should result 
in a stabilization of the target protein and a consequent loss of the oscillatory pattern 
(Kipreos, 2005; Yamanaka et al., 2002). In sum, such experiments might further inform 
biological control of developmental time on a molecular level. They could help to understand 
the interplay of developmental timing and the molting cycle, both tied to environmental cues. 
Due to the remarkable conservation of all players involved, one might also gain further 
insights into the regulation of circadian rhythms and developmental progression in mammals. 
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5.1 Nematology and Genetics 
5.1.1 Worm Maintenance 
Worms were grown on nematode growth medium (NGM: 2.5% serva agar, 0.225% bacto-
peptode, 0.3% NaCl (all w/v), 1 mM CaCl2 and MgSO4, 25 mM KPO4, 5 µg/ml cholesterol) 
seeded with E. coli bacteria OP50 at 20°C unless otherwise noted (Brenner, 1974). Strains 
used were outcrossed at least 3 times and N2 Bristol was used as wild type reference strain. 
Notably daf-9(rh6) was maintained on plates containing additional 100 nM DA in the agar to 
prevent constitutive dauer entry. 
5.1.2 Genotyping - PCR 
In addition to phenotypic analysis, PCR from single worm lysates using Taq polymerase 
followed by 1% agarose gel electrophoresis was applied for worm genotyping. Detection of 
dre-1(dh99) required digestion of the PCR fragment with BpmI (RFLP assay). 
PCR reaction: 
General PCR program:   
95°C 5 min 
	    	  
95°C 45 s 
30x ≈ 60°C 30 s 
72°C 60 s/kb 
  	  
72°C 10 min 
	    	  
Primers including resulting PCR products and phenotypes used for genotyping: 
Genotype Primer or Phenotype PCR Products 
blmp-1(tm548)I fwd: GATGAAGCTCCGGAAGAGTG rev: GACGCCCCAGTTTGTTTTTA 
wt: 1115 bp 
mut: 305 bp 
blmp-1(tm548)I dumpy  
dre-1(dh99)V fwd: TCATGCGAATCCCTACTTCC rev: AAAAGCTCACCTTCCAAGCA 
wt: 638 + 258 bp (BpmI digest) 
mut: 898 bp (BpmI digest) 
dre-1(dh99)V synmig on daf-12 RNAi  
dre-1(dh279)V synmig on daf-12 RNAi  
sop-2(bx91)II lethal at 25°C  hbl-1(ve18)X potruding vulva  mab-10(e1248)II mild potruding vulva, extra seam cells  
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BLMP-1::GFP* fwd: TCAACAGCAACACATGA rev: TCACCTTCACCCTCTCCACT 305 bp 
 
5.1.3 C. elegans Strains 
N2 (Bristol), AA3093 dre-1(dh99)V, AA3091 blmp-1(tm548)I, A2601 dre-1(dh99)V; blmp-
1(tm548)I, SU93 jcIs1IV [ajm-1::gfp; unc-29(+); rol-6(su1006)], AA820 dre-1(dh99)V; 
jcIs1IV, AA2557 blmp-1(tm548)I; jcIs1IV, AA2666 dre-1(dh99)V; blmp-1(tm548)I; jcIs1IV, 
AA3175 hbl-1(ve18)X; jcIs1IV, AA832 lin-42(n1089)II; jcIs1IV, AA3141 sop-2(bx91)II; 
jcIs1IV, JR667 unc-119(e2498::Tc1)III; wIs51 [scm::gfp; unc-119(+)], AA2558 blmp-
1(tm548)I; wIs51, AA3200 mab-10(e1248)II; wIs51, EM723 sop-2(bx91)II; him-5(e1490)V, 
MT7626 let-7(n2853ts)X, RG559 hbl-1(ve18)X, MT2257 lin-42(n1089)II, AA528 dre-
1(dh99)V; daf-12(rh61rh411)X, AA885 lin-29(n546)II; daf-12(rh61rh411)X, AA619 dre-
1(dh99)V; lin-29(n546)II, CB3518 mab-10(e1248)II; him-5(e1490)V, AA2734 unc-
119(ed3)III; wgIs109 [blmp-1p::ORF::gfp::3xFLAG; unc-119(+)] (Sarov et al., 2012), 
AA2602 blmp-1(tm548)I; wgIs109 [blmp-1p::ORF::gfp::3xFLAG; unc-119(+)], AA2821 
dre-1(dh279)V; wgIs109, OP356 unc-119(ed3)III; wgIs356 [nhr-25::TY1::EGFP::3xFLAG; 
unc-119(+)] (Sarov et al., 2012), AA2881 and 2882 dhIs876 [dre-1p::gfp::orf 3'UTR; 
coel::RFP] (integrated dhEx452; two lines) (Fielenbach et al., 2007), JA1501 pha-
1(e2123)III; weEx70 [cdt-2p::cdt-2::gfp::let858(3’UTR); pha-1(+)] (Poulin and Ahringer, 
2010), DR1572 daf-2(e1368)III, CB1372 daf-7(e1372)III, AA2863 daf-9(dh6)X, VT825 dpy-
20(e1282)IV; maIs113 [cki-1::gfp; dpy-20(+)], AA3009 dre-1(dh99)V; maIs113, AA1327 
rrf-3(pk1426)II  
 
Underlined strains were generated in this work by crossing or UV integration. 
5.1.4 UV Integration 
UV integration of extrachromsomal arrays was achieved by UV irradiation (0.03 Joule/cm2 on 
Viber Lourmat BLX-254 crosslinker) of L4 larvae that carry the corresponding transgene. 
Irradiated worms were kept in the dark for 24 hrs and the F2 and F3 generation was analyzed 
for stable integrands, which were then outcrossed to WT.  
5.1.5 RNAi Depletion and Drug Treatment 
RNAi-mediated knockdown was achieved by cultivating worms on HT115(DE3) bacteria 
expressing dsRNA of the target gene from an IPTG-inducible promoter (Kamath et al., 2001; 
Timmons and Fire, 1998). To induce dsRNA expression bacteria were seeded to NGM plates 
containing a final concentration of 1mM IPTG and 100 µg/µl ampicillin. RNAi clones were 
available from the Ahringer collection (Kamath and Ahringer, 2003), except for dre-1 RNAi, 
which we described previously (Fielenbach et al., 2007), and cdt-2 RNAi, which I obtained 
from the Vidal library (Rual et al., 2004). All clones were verified by sequencing using T7 
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primer after plasmid purification (MiniPrep, Qiagen). For knockdown experiments L4 larvae 
or eggs were moved to the RNAi plates and analyzed 2-3 days later as indicated.  
Proteasome inhibition using the drug bortezomib was achieved by transferring L3 larvae to a 
plate containing 100 µM bortezomib (in DMSO) on top of the OP50 bacteria lawn, for 6 h.  
5.1.6 Worm Synchronization  
To synchronize C. elegans populations gravid adult worms were washed from plates using 
M9 buffer (0.6% Na2HPO4, 0.3% KH2PO4, 0.5% NaCl (all w/v), 1 mM MgSO4). Somatic 
tissues were removed by adding 1 ratio of bleach solution (0.5 M KOH, 20% (v/v) NaClO) 
and vigorous shaking for 10 min. Remaining eggs were washed at least 3x in M9 before 
counting and distribution to seeded NGM plates. Notably bleach treated worms are still 
unsynchronized by about 8 hrs. For more precise synchronization worms were either 
synchronized by short egg-lay periods or newly hatched L1 larvae were carefully washed off 
from plates after bleach treatment or previous washing using M9 buffer, as eggs stick to the 
bacteria lawn. 
5.1.7 Microscopy and Phenotype Analysis 
General handling and observation of nematodes was performed on a Leica M80 
stereomicroscope. Heterochronic phenotypes were analyzed at specific larval stages as 
assessed by gonad morphology and vulval formation using Nomarski DIC and fluorescence 
microscopy on a Carl Zeiss Axio Imager Z1. Seam cell number (scm-1::gfp marker), seam 
cell fusion (ajm-1::gfp marker) and adult alae formation were scored each on one side of 
individual animals. Worms were anesthetized with 1 mM levamisole. GFP intensity in 
seam/hypodermal cells was leveled from 5-10 cells per animal, whereas for measurements in 
the dtc, one dtc per animal was analyzed. Fluorescence intensity was determined using the 
ImageJ software (http://rsbweb.nih.gov/ij/). 
5.1.8 Dauer Assays, Laser Microsurgery and Lifespan Analysis 
For dauer assays worms were synchronized by egg-lay on NGM plates lacking cholesterol 
seeded with OP50 bacteria or RNAi plates with HT115 bacteria. Dauer larvae were scored 
after 48 hrs (27°C) or 60 hrs (25°C).  
Ablation of germline precursor cells was achieved by laser microsurgery as described 
(Gerisch et al., 2001). In brief, L1 larvae were subdued to laser microsurgery on a Carl Zeiss 
Axio Imager Z1 right after hatching, whereby the germ cell precursors Z2 and Z3 were 
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ablated with a laser beam. Worms were immediately recovered in M9 medium using a mouth 
pipette. Success of the laser microsurgery was assessed 2-3 days later, when mock-ablated 
worms fully established a functional germline and laid eggs. 
Lifespan assays were performed at 20°C. Worms were synchronized by egg-lay and 
transferred to RNAi plates at the L4 stage. Worms undergoing internal hatching, bursting 
vulva or crawling off the plates were censored. 
5.2 Molecular Biology 
5.2.1 RNA Isolation and qRT-PCR 
For qRT-PCR analysis synchronized populations of about 1000 L3 larvae, 400 L4 larvae or 
200 adult worms were harvested in 200 µl QIAzol (Qiagen). After 3-4 freeze thaw cycles  
(N2(l)/37°C) Chloroform was added and the aqueous phase was used for total RNA extraction 
using the RNeasy Mini Kit (Qiagen) according to the manufacturer’s instructions. RNA 
quantity and quality was determined on a NanoDrop 2000c (peqLab). cDNA was 
subsequently generated from 100 ng RNA using the iScript cDNA Synthesis Kit (BioRad). 
qRT-PCR was performed with Power SYBR Green master mix (Applied Biosystems) on a 
ViiA 7 Real-Time PCR System (Applied Biosystems). Four technical replicates were pipetted 
on a 384-well plate either manually or by use of the JANUS automated workstation 
(PerkinElmer). Primers were validated by determination of standard- and melting curves. 
Data were analyzed for comparative CT values and normalized to ama-1, which served as 
internal control.  
qRT-PCR primer sequences: 
 
Gene Primer Sequence (5'-3') 
blmp-1 fwd ATCTTCCACACCGCCATCA 
 
rev TCGCACCTGACGCTGAAAC 
nas-36 fwd CAAATGTATGGGCAGATTGGG 
 
rev GGGCACGCTTTCAAATTACAG 
bed-3 fwd GCATGTTGGAAAGATTCGTGG 
 
rev GGCAGCTTGTTCAATAGTTGG 
wrt-2 fwd TGCATACGCCGATCATATTCC 
 
rev CAGTCCATCCGAAGCATTTTG 
ptr-8 fwd CGGCAGAAAATTCAGTCTAATCC 
 
rev TCCCATTGCTTAACTGTCTTCG 
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col-7 fwd CGGAATTGTGGTATTTGGAGC 
 
rev CATCCTGGTTTATCATTGAGTTCC 
col-124 fwd GACTTTCTCCACCATTGCAG 
 
rev GGGATACGGTTGACTTGAGAG 
col-91 fwd CGAGACTATGGAAACTTTTGACG 
 
rev GAGCTTGACAGTCTGGAAGAG 





50°C 2 min activation 95°C 10 min 
   
95°C 15 s 40x 60°C 1 min 
   
95°C 15 s melting 
curve 60°C 1 min 95°C 15 s 
 
5.2.2 RNA-Sequencing and Data Analysis (in part performed by Dr. 
Corinna Klein) 
Worms were synchronized by egg-lay (≈ 200 adults, 3 hrs) and collected in M9 at the mid-L3 
stage. Total RNA was extracted as described above, but RNA quality was additionally 
controlled on a Tape Station 2200 (Agilent Technologies). Libraries were prepared with the 
Illumina TruSeq RNA and DNA Sample Preparation Kit v2 and sequenced on an Illumina 
HiSeq 2000 sequencer at the Max Planck-Genome-Centre, Cologne. Three biological 
replicates per genotype with a library size in the range of 41-47 million reads were further 
analyzed by Dr. Corinna Klein (MPI bioinformatics facility). Sequences were trimmed at both 
ends with the FASTA/Q Trimmer of the FASTX-Toolkit 
(http://hannonlab.cshl.edu/fastx_toolkit by Hannon Lab), and then preprocessed reads were 
mapped to the genome with tophat2 (v2.0.7) (Kim et al., 2013) allowing only unique 
mapping. On average 96.1% of the reads could be aligned. Subsequently, differential gene 
expression analysis was performed with cuffdiff, which is part of the cufflinks package 
(v2.0.2) (Trapnell et al., 2010). Genes with a FPKM value >0.5 in at least one of the N2 and 
blmp-1 samples were considered expressed. Those with a q-value <0.05 and fold change 
>±1.5 were classified as differentially expressed. I then used DAVID analysis to identify 
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enriched gene-ontology/biological processes (Huang et al., 2009). ReviGO was used for 
visualization of the resulting GO term classes and its semantic similarity (Supek et al., 2011).  
5.2.3 Plasmid Construction and Molecular Cloning (performed by Dr. 
Christoph Geisen) 
Plasmids were constructed as follows: cDNAs for human FBXO11, FBXO10, FBXO5, 
PRDM1, C. elegans dre-1, blmp-1, lin-29 and Discosoma sp. DsRed1-derived mRFP 
(Campbell et al., 2002) were PCR amplified with specific primers from commercially 
available cDNA-clones (Open Biosystems/Thermo Scientific) or public repository plasmids 
(Addgene or Harvard PlasmID) and subcloned into plasmids derived from pcDNA3.1- 
(Invitrogen) carrying either a N-terminal 6xHis- or FLAG-HA-tag (RGS6xHis-pcDNA3.1- 
and FLAG-HA-pcDNA3.1-) and driving expression through the cytomegalovirus promoter. 
To generate RGS6xHis-pcDNA3.1- and FLAG-HA-pcDNA3.1- the following DNA 







The latter was only achieved after point mutation to generate a “FLAG – 5xGly – HA – 
5xGly – tag”, of FLAG- and the HA-tag. DN-Cullins were purchased from Addgene (15818-
15820, (Jin et al., 2005)).  
In general DH5α bacteria (Invitrogen) were used for subcloning and transformed by 40 s heat 
shock at 42°C. Plasmids were purified using Mini-, Midi- or HiSpeed Maxi kits (Qiagen) 
according to the manufacturer’s instructions. 
5.3 Biochemistry 
5.3.1 Antibodies 
The following antibodies were used in this study: BLMP-1 (rb, Novus Bio), GFP (ms, 
Clontech), α-Tubulin (ms, Sigma), HA (rat, Roche), His (ms, Qiagen and rb, Santa Cruz), 
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FLAG (ms and rb, SIGMA), PCNA (ms, Invitrogen), BLIMP-1 (rb, ab59369, Abcam and ms, 
3H2-E8, Novus Bio), FBXO11 (rb, NB100-59826, Novus Bio), and SKP1 (Pagano lab). 
5.3.2 C. elegans Biochemistry 
For western blot analysis synchronized L4 larvae were collected in M9 buffer, lysed in 2x 
SDS sample buffer (Biorad) and equal volumes were applied to SDS-PAGE and 
immunblotting. Band intensity was quantified with Adobe Photoshop. 
For immunoprecipitation (IP) assays eggs were isolated by bleach treatment. After a 3 hrs 
hatching-period L1 larvae were washed off with M9 buffer and transferred to RNAi plates. L3 
larvae were lysed in worm IP buffer (50 mM Tris/HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 
0.1% NP-40, protease and phosphatase inhibitor cocktail (Roche)) using a dounce 
homogenizer. Worm lysates were incubated with 40 µl GFP-Trap agarose beads (Chromotek) 
for 1 hr at 4°C and washed 5x with worm washing buffer (as worm IP buffer, but 300 mM 
NaCl and 0.75% NP-40). Precipitants were eluted with 2x SDS sample buffer (Biorad) and 
analyzed by SDS-PAGE and immunoblotting. 
5.3.3 Cell Culture and IP Experiments 
HEK293T cells were maintained in Dulbecco's Modified Eagle's Medium supplemented with 
10% fetal bovine serum (Gibco). Transfections were performed using Lipofectamine 2000 
(Invitrogen) according to the manufacturer’s instructions. For IP experiments (not prior to 
ubiquitination assay), cells were treated with 15 µM MG132 or DMSO control for 4 hrs prior 
to harvesting. Cells were lysed 20 hrs post-transfection in lysis buffer (50 mM Tris/HCl pH 
7.4, 120 mM NaCl, 0.5% NP-40, protease and phosphatase inhibitor cocktail (Roche)) and 
equal protein amounts (Bradford assay) were incubated with anti-FLAG-M2 resin (Sigma) for 
1 hr at 4°C. Precipitated proteins were eluted by competition with 150 ng/µl 3xFLAG peptide 
(Sigma) and analyzed by SDS-PAGE and immunoblotting. To study BLIMP-1 turnover, 
transfected cells were treated with 100 µg/ml cycloheximide (CHX, AppliChem) for the 
indicated time intervals 20 hrs post-transfection. Cells were lysed in lysis buffer and analyzed 
by SDS-PAGE and immunoblotting. Whole cell lysates and CHX treatment in ARP1 cells 
was performed by Dr. Lukas Cermak as described (Duan et al., 2012). 
5.3.4 Gene Silencing by shRNAs (performed by Dr. Lukas Cermak) 
Sequences of FBXO11 shRNAs were as follows:. #1: GAGTTTACATCTTTGGTGA, 
#2: CAATTGTTCGGCATAACAA. shRNA lentiviruses were produced as described (Phan et 
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al., 2007). ARP1 multiple myeloma cells were infected by re-suspension in virus-containing 
supernatants and centrifugation. 24 hrs after infection, cells were resuspended in fresh 
medium and selected with puromycin.  
5.3.5 In Vitro Ubiquitination (performed by Dr. Lukas Cermak) 
HEK293T cells were cotransfected with His-BLIMP-1 and FLAG-FBXO11 or -FBXO11(F-
boxMUT) and lysed using isotonic NP-40 buffer with Turbonuclease (Accelagen). Lysates were 
precleared with 0.40 mm filters and FLAG-tagged complexes were isolated using anti-FLAG-
M2 resin (Sigma). Complexes were eluted by competition with 3xFLAG peptide (Sigma). 
In vitro ubiquitination assays were performed in a volume of 30 µl containing 0.1 µM UBE1 
(Boston Biochem), 10 ng/ml Ubch3, 10 ng/ml Ubch5c, 1 µM ubiquitin aldehyde, ±2.5 µg/µl 
ubiquitin (Sigma), and either SCFFBXO11 or SCFFBXO11-Fbox-MUT complex in a ubiquitination buffer 
(50 mM Tris [pH 7.6], 2 mM ATP, 5 mM MgCl2, 0.6 mM DTT, okadaic acid 0.1 mM) for 
45 min at 37°C.  
5.4 Statistical Analysis 
Results are presented as mean+95%CI, SD or SEM as indicated. Statistical analyses were 
performed using one-way ANOVA with Tukey or Dunnett post test (ANOVA), Fisher’s 
Exact test, unpaired t test, or Mantel-Cox (Log Rank) method as indicated using GraphPad 
Prism (GraphPad software). 
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Table	  A1:	  Genes	  Regulated	  in	  blmp-­‐1(tm548)	  mutant	  Animals	  vs.	  WT	  Controls	  
Fold	  change	  represents	  mean	  of	  three	  biological	  replicates	  from	  RNA-­‐sequencing	  experiments	  of	  mid-­‐L3	  larvae.	  
 
Upregulated in blmp-1 vs. WT Downregulated in blmp-1 vs. WT 
Gene ID Gene Fold change q_value Gene ID Gene 
Fold 
change q_value 
K09C8.3 nas-10 110,81 1,02E-07 cTel54X.1 fbxa-6 245,31 6,03E-06 
Y39A3B.7  84,15 7,69E-04 T09D3.8  35,40 1,08E-07 
F59A6.10  58,87 3,71E-05 C24F3.6 col-124 17,59 0,00E+00 
ZK84.7 ins-20 38,28 6,37E-05 F15E11.12 pud-4 13,75 9,50E-04 
F12A10.7  36,23 3,94E-04 K02E2.8  13,18 0,00E+00 
C37A5.8 fipr-24 31,34 5,23E-03 F45D11.14  11,83 7,33E-08 
F32G8.3  29,64 2,96E-02 F38A5.5 nspb-3 11,14 1,97E-04 
C37A5.2 fipr-22 29,51 3,22E-04 F15E11.15 pud-3 10,60 5,13E-06 
Y102A5C.34 grd-17 26,02 1,13E-02 B0034.7  9,91 5,09E-05 
F22B3.7  16,52 1,21E-04 K02E2.2 grd-11 9,14 1,61E-13 
C27B7.9  15,17 8,54E-13 C04G6.2  8,65 0,00E+00 
T10B9.4 cyp-13A8 13,09 2,21E-06 F45D11.15  8,60 4,11E-07 
C37A5.4 fipr-23 12,18 6,01E-03 F45D11.16  8,05 3,47E-07 
F53B6.8 fipr-26 11,46 3,12E-02 Y5H2A.4  8,04 2,56E-06 
Y68A4A.13  11,26 8,21E-03 F38A5.12 nspb-2 7,61 2,77E-05 
F53H2.2 cnc-7 11,06 5,50E-07 F07E5.7  7,10 9,75E-07 
F08E10.7 scl-24 10,90 3,81E-02 F14D7.2  6,95 4,25E-02 
F07G11.9 imd-4 10,89 1,94E-05 K09C4.1  6,50 0,00E+00 
C49G7.7  10,23 2,50E-02 F59D8.1 vit-3 6,45 0,00E+00 
R13D7.11 cnc-9 9,14 2,49E-02 H02K04.1 clec-229 6,27 3,88E-10 
R09B5.9 cnc-4 8,65 0,00E+00 F59D8.2 vit-4 6,21 0,00E+00 
B0284.1  7,95 1,74E-07 Y5H2A.3 abu-4 6,06 1,62E-06 
R04D3.1 cyp-14A4 7,13 2,57E-07 C04G6.13  5,93 6,72E-03 
C08E8.3  6,97 1,51E-02 F17B5.6  5,33 4,30E-03 
F33H12.7  6,75 2,49E-07 R12E2.6  5,32 1,77E-02 
C45G7.3 ilys-3 6,19 4,55E-05 H06A10.1  5,32 7,33E-08 
B0284.2  5,92 3,81E-02 K10C2.8  5,14 2,49E-02 
D1065.3  5,89 8,02E-03 C04F6.1 vit-5 5,11 0,00E+00 
ZK783.5  5,80 2,20E-02 R09D1.11  5,02 1,56E-04 
C30B5.6  5,71 0,00E+00 C30H6.5  5,02 0,00E+00 
C49G7.1  5,69 3,29E-04 F23F1.2  4,96 4,62E-13 
B0205.14  5,61 1,30E-06 F56C3.9  4,83 1,51E-06 
F14D7.7  5,57 4,80E-03 H10E21.2  4,78 3,02E-03 
R09B5.3 cnc-2 5,55 3,77E-08 E02H4.4  4,59 7,98E-04 
Y46C8AL.2 clec-174 5,39 3,15E-04 F11D5.5  4,56 4,16E-02 
W09G12.8  5,31 7,17E-03 C54C8.4  4,49 2,91E-07 
Y38E10A.28  5,23 2,33E-02 C27D9.2  4,47 1,75E-02 
T24E12.5  5,21 5,52E-09 F36D1.8  4,32 3,45E-02 
Appendix 
109 
C04A11.5  5,21 2,07E-02 T02B5.1  4,24 1,03E-08 
F28G4.1 cyp-37B1 5,06 3,86E-03 C01F1.5  4,23 0,00E+00 
ZC513.14  5,05 2,43E-02 T19H5.6  4,21 2,00E-02 
C33G8.3  5,03 3,97E-03 Y51H4A.9 col-137 4,12 2,85E-03 
F13D12.3  4,98 0,00E+00 K03H9.3  4,07 9,84E-04 
Y41G9A.10  4,92 6,90E-12 K09F5.2 vit-1 4,05 0,00E+00 
F46C5.1  4,91 3,87E-03 W02B8.6 mltn-5 4,03 2,32E-04 
F53G12.7 col-45 4,85 4,93E-02 F11D5.7  4,01 5,48E-05 
C03G6.13 tag-293 4,79 6,32E-04 T14G12.6  3,97 1,06E-02 
C25F9.11 C25F9.11 4,77 3,73E-05 Y62H9A.3  3,96 1,09E-02 
T15B7.5 col-141 4,75 0,00E+00 C29F3.2 wrt-8 3,94 0,00E+00 
Y44E3B.2 tyr-5 4,59 1,10E-02 R09D1.6  3,92 2,78E-04 
ZC239.1  4,58 1,61E-13 F22E5.8  3,88 1,07E-02 
F12A10.1  4,57 1,09E-04 F59A1.9 fbxa-193 3,85 1,18E-02 
EEED8.12  4,54 5,23E-04 Y102A5C.16 clec-239 3,83 4,49E-04 
F15B9.1 far-3 4,44 1,15E-07 F11A5.8 oac-15 3,80 2,31E-03 
F35E2.5  4,36 2,41E-02 F47B7.4  3,77 3,83E-04 
F09C6.2 fbxa-44 4,35 1,78E-02 F31D4.6 try-4 3,77 2,71E-05 
F09E10.11 tts-1 4,35 1,01E-09 T22G5.6 lbp-8 3,59 1,42E-02 
C24B9.9 dod-3 4,33 1,09E-03 R05A10.6  3,51 2,32E-04 
F22B7.9  4,26 2,04E-11 Y37A1B.13 tor-2 3,48 1,27E-02 
C39B5.3 fbxa-62 4,23 2,62E-02 F38H12.3 nhr-181 3,42 4,58E-04 
W09G12.7  4,22 1,59E-07 R11G11.14 lipl-3 3,42 1,71E-02 
R05H10.1  4,21 8,54E-11 F38A1.14 clec-169 3,40 3,09E-07 
C15A11.7  4,21 0,00E+00 C54D1.2 clec-86 3,36 2,65E-03 
F14D7.10  4,20 1,69E-02 F56G4.1 oac-34 3,35 7,74E-07 
F55A12.6  4,17 1,53E-04 T09B4.7  3,33 2,10E-04 
K01A6.7  4,06 8,88E-03 F28G4.2  3,29 1,78E-02 
B0393.4  4,06 7,62E-06 R09D1.8  3,29 2,24E-02 
F43G9.6 fer-1 3,98 1,83E-08 F56H1.1 che-14 3,25 0,00E+00 
T28A11.3  3,97 1,44E-02 T03D3.1 ugt-53 3,24 2,18E-05 
C01G10.17  3,96 3,87E-03 Y62H9A.4  3,22 2,49E-02 
T21C9.8 ttr-23 3,80 1,41E-05 R52.9 math-37 3,20 3,74E-02 
F57A8.8 fipr-13 3,78 3,94E-02 K09C4.5  3,18 1,15E-09 
E03H4.10 clec-17 3,71 4,57E-08 B0507.8  3,13 2,45E-02 
C33G8.2  3,70 4,28E-10 M01B2.8  3,11 1,29E-02 
R08F11.3 cyp-33C8 3,69 0,00E+00 Y67A10A.1 oac-56 3,09 3,62E-03 
R02C2.7  3,68 3,29E-03 F52E10.5 ifa-3 3,08 6,83E-03 
C25F9.7 srw-86 3,62 4,91E-02 K02B9.1 meg-1 3,08 1,60E-02 
Y43C5A.3  3,61 3,05E-08 ZK813.1  3,08 7,98E-03 
C06B3.6  3,60 1,51E-06 B0507.10  3,07 5,11E-03 
ZK970.7  3,56 0,00E+00 F59F3.5 ver-4 3,07 5,24E-06 
T28A11.19  3,53 1,95E-02 ZK617.2 lips-6 3,02 0,00E+00 
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C45B2.8  3,49 2,96E-05 Y57G11B.5  3,01 2,45E-03 
Y69A2AR.12  3,49 3,49E-02 F52F10.4 oac-32 2,99 2,32E-04 
C17B7.10  3,47 9,76E-05 F10F2.3 lips-3 2,97 6,66E-08 
F21F3.3  3,41 3,98E-02 K01D12.8  2,97 2,63E-06 
C50C3.2  3,41 2,77E-05 Y45F10D.14  2,96 8,88E-03 
C01G5.4  3,41 1,18E-02 ZK666.6 clec-60 2,95 1,06E-02 
T06E4.5  3,40 8,84E-03 F47F6.3 oac-30 2,94 7,76E-09 
C17H1.7  3,40 2,70E-04 F58G4.6 str-146 2,92 2,38E-02 
Y37H2A.14  3,31 1,37E-12 F36H1.11  2,90 1,91E-02 
F48G7.8  3,30 2,83E-03 C25A8.4  2,88 3,90E-03 
R06B10.1  3,28 1,24E-03 C28H8.5  2,84 1,11E-08 
C13D9.8 ncx-9 3,27 4,08E-02 W06D12.1 cutl-4 2,83 5,81E-04 
F26D11.6  3,27 3,22E-02 K11G9.2  2,82 1,48E-05 
H20J04.1  3,23 4,13E-02 ZK813.3  2,82 2,10E-02 
C17B7.5  3,23 2,93E-04 F41A4.1 cutl-28 2,82 5,18E-09 
Y65B4BR.1  3,23 1,61E-02 T09F5.9 clec-47 2,80 2,07E-10 
F02C12.5 cyp-13B1 3,20 3,89E-07 T23F4.4 nas-27 2,79 1,84E-07 
Y39B6A.25  3,19 2,52E-02 C54C8.2  2,79 1,48E-05 
Y45F10D.6  3,19 3,44E-05 C29F3.5 clec-230 2,78 2,06E-09 
C25F9.12  3,18 4,77E-02 F11H8.3 col-8 2,75 3,15E-08 
C01G10.5  3,16 1,43E-02 Y19D10B.7  2,72 1,21E-06 
ZC168.2  3,15 1,85E-02 R04B3.1  2,70 5,33E-03 
C07E3.4  3,09 2,38E-02 C35A5.5  2,69 1,92E-03 
ZK484.7  3,09 2,52E-02 F15E11.13  2,69 1,29E-06 
C33F10.8  3,08 3,66E-02 F38A5.14 nspb-1 2,68 2,13E-02 
C38D9.2  3,08 2,08E-03 ZK1025.6 nhr-244 2,67 6,81E-03 
C49G7.5 irg-2 3,07 3,66E-02 F55G11.2  2,65 8,73E-08 
R10D12.9 swt-6 3,06 3,15E-02 H13N06.6 tbh-1 2,64 9,96E-03 
C09C7.1 zig-4 3,06 1,18E-10 Y11D7A.11 col-120 2,63 2,75E-04 
C26F1.2 cyp-32A1 3,03 6,90E-12 Y102A5C.17 clec-238 2,62 4,57E-03 
K04F1.9  3,02 1,70E-03 F15E11.14  2,59 1,62E-06 
K01A6.8  3,02 3,05E-02 Y62H9A.6  2,59 5,41E-03 
T26H5.9  3,01 7,53E-05 W02B12.13  2,56 7,34E-03 
C01G10.4  3,01 2,45E-02 F55B11.2  2,55 2,14E-02 
R08F11.4  2,99 2,84E-04 F15E11.1  2,55 1,62E-06 
C06G4.5 npr-17 2,96 7,96E-03 C44B12.1 perm-2 2,52 3,90E-04 
C38D4.7  2,94 1,60E-02 K11H12.11  2,50 2,88E-02 
F37A4.5  2,94 4,27E-04 R10H1.5 nas-23 2,49 1,65E-10 
F11E6.11  2,94 2,85E-03 C23H4.3  2,48 1,47E-08 
C45G7.2 ilys-2 2,92 3,17E-02 F08H9.5 clec-227 2,48 7,94E-03 
F54B8.3 fbxa-69 2,92 1,95E-02 C41H7.7 clec-3 2,47 8,39E-05 
T10B9.2 cyp-13A5 2,92 2,14E-04 W08G11.1  2,47 6,94E-05 
F25H5.8  2,92 3,79E-03 K07H8.6 vit-6 2,45 8,12E-09 
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Y5H2B.5 cyp-32B1 2,90 2,52E-04 F09C8.1  2,44 8,42E-03 
ZK896.1  2,88 2,16E-03 C44B7.5  2,43 3,88E-02 
F59E11.7  2,87 6,17E-05 F28G4.4  2,43 6,03E-03 
F01G10.5  2,87 1,84E-02 Y46G5A.36  2,38 4,43E-03 
C17B7.3  2,85 2,30E-02 C29F3.6 srx-58 2,37 1,34E-02 
Y41C4A.2 faah-6 2,85 8,62E-03 Y34F4.2  2,37 1,20E-02 
F01D4.8  2,83 2,12E-04 F52E4.6 wrt-2 2,37 3,86E-06 
Y43F8C.1 nlp-25 2,83 1,65E-04 T09H2.1 cyp-34A4 2,36 4,72E-02 
B0547.3 srd-14 2,80 2,09E-03 F21G4.3  2,35 3,44E-02 
F17E9.11 lys-10 2,80 1,04E-02 C39D10.7  2,34 1,62E-06 
C44B7.6  2,76 8,54E-08 ZK899.4 tba-8 2,33 9,45E-07 
Y80D3A.7 ptr-22 2,75 6,55E-04 C15A11.5 col-7 2,31 2,29E-03 
K12B6.8  2,74 5,83E-03 C02F5.14  2,31 5,36E-04 
T27F6.8  2,73 1,16E-08 C42D4.13  2,31 2,82E-02 
F20D1.5 arl-7 2,73 6,92E-03 F25H8.6 bed-3 2,31 7,40E-13 
F21C10.11  2,73 4,35E-02 C04F5.7 ugt-63 2,30 1,48E-05 
C50F7.5  2,71 1,62E-06 B0331.2  2,30 6,03E-03 
C34F11.8  2,70 2,26E-02 F38E11.1 hsp-12.3 2,26 3,28E-02 
C24G7.4  2,68 1,16E-04 F40F12.4 mam-7 2,26 2,83E-02 
C37H5.9 nas-9 2,67 5,83E-10 F49C5.12  2,24 2,00E-02 
K04E7.3 nas-33 2,64 9,73E-06 R09H10.7  2,23 2,65E-02 
Y105C5A.8  2,64 9,83E-07 K11E4.2  2,23 1,13E-04 
F35F10.7  2,63 3,88E-02 F49E12.1  2,20 1,70E-02 
C05E11.4 amt-1 2,62 7,54E-03 F13B12.4  2,20 1,74E-07 
Y71H2AM.16 pho-9 2,62 1,47E-07 ZC455.4 ugt-6 2,19 3,03E-08 
F43C9.1  2,62 2,14E-06 Y46G5A.22  2,19 4,29E-02 
Y58A7A.4  2,61 1,56E-08 Y62H9A.5  2,18 3,63E-02 
C08E8.4  2,59 2,14E-04 T25G12.7 dhs-30 2,17 2,38E-06 
M176.9  2,59 3,57E-02 F58B3.3 lys-6 2,17 2,52E-04 
F35F10.1  2,56 2,61E-05 C27C7.3 nhr-74 2,16 7,53E-05 
T22H9.3 wago-10 2,56 1,45E-03 T19H12.1 ugt-9 2,16 6,41E-04 
T01B11.4 ant-1.4 2,56 1,08E-03 ZK1193.1 col-19 2,15 4,56E-07 
C47A10.1 pgp-9 2,55 0,00E+00 C17C3.12 acdh-2 2,14 2,32E-04 
F35E12.5  2,55 3,81E-11 K08H10.6  2,14 3,69E-04 
C10C5.2  2,52 1,22E-03 T21D11.1  2,14 1,58E-03 
F46F2.5  2,50 5,22E-06 C15A11.6 col-62 2,13 8,05E-03 
F57H12.5  2,50 1,57E-02 ZK678.5 wrt-4 2,12 9,31E-12 
C33A12.19  2,50 1,06E-02 C32H11.6  2,12 1,10E-02 
F48F5.2  2,48 1,33E-02 F41E6.14 oac-29 2,11 1,77E-08 
Y113G7C.1  2,47 2,32E-04 D1054.11  2,11 4,15E-03 
T10H4.11 cyp-34A2 2,46 3,75E-05 F54C9.8 puf-5 2,09 3,94E-04 
Y58A7A.5  2,46 1,51E-02 C26C6.3 nas-36 2,09 3,79E-10 
C25H3.10  2,44 3,15E-04 C44B12.5 perm-4 2,09 2,35E-04 
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ZK75.1 ins-4 2,40 6,46E-03 F47B8.5  2,08 9,67E-03 
M162.5  2,40 1,60E-04 Y37E11B.7  2,06 1,16E-02 
K09D9.1  2,38 2,50E-02 K10C2.3  2,06 3,92E-05 
C31B8.8  2,37 1,67E-10 ZK1055.4  2,05 1,23E-02 
K01H12.2 ant-1.3 2,37 4,94E-03 C32H11.12 dod-24 2,04 7,89E-07 
C27D8.2  2,36 6,92E-03 R05G6.9  2,02 1,87E-03 
B0564.3  2,34 1,40E-03 F49E12.9  2,02 1,35E-05 
F54D10.2 fbxa-24 2,34 1,26E-02 C52B11.3 dop-4 2,02 8,88E-03 
W01F3.2  2,34 1,61E-07 F15H10.8  2,01 1,97E-03 
Y8A9A.2  2,33 6,09E-04 R12C12.10  2,01 1,19E-02 
C23H4.8  2,33 2,05E-02 E04F6.15  2,00 5,90E-03 
R13D7.7 gst-41 2,32 1,45E-02 Y40H7A.10  2,00 1,69E-02 
K08B4.3 ugt-19 2,30 4,49E-12 ZC513.2  1,97 2,09E-02 
Y49G5A.1  2,29 1,51E-02 C04F1.1  1,96 2,75E-03 
C54D10.10  2,29 2,29E-05 C41A3.1  1,96 1,32E-03 
C16E9.1  2,28 1,20E-05 F38A3.1 col-81 1,95 4,03E-06 
R11G11.7 pqn-60 2,27 1,07E-02 Y54G2A.10  1,95 1,45E-03 
F35E8.8 gst-38 2,27 4,64E-04 T22D1.11  1,95 1,97E-03 
Y39A1A.19 fmo-3 2,25 1,72E-11 C09B8.4  1,95 1,50E-02 
F14F7.3 cyp-13A12 2,25 5,38E-04 B0511.11  1,95 1,81E-02 
F23C8.7  2,25 4,96E-03 Y38A10A.2  1,95 2,76E-07 
C55C3.3  2,22 8,07E-03 ZC250.3 nstp-3 1,94 4,97E-04 
T13A10.11 sams-5 2,19 3,69E-02 F49E12.12  1,94 7,53E-05 
Y58A7A.3  2,19 1,97E-09 ZK829.3  1,93 2,27E-03 
B0213.17 nlp-34 2,19 7,24E-04 F55F3.4  1,92 1,75E-04 
Y95B8A.6  2,19 4,77E-08 D1054.10  1,92 4,91E-02 
Y48G8AL.11 haf-6 2,19 2,90E-05 F58B3.2 lys-5 1,91 7,94E-03 
F40H3.2  2,17 1,26E-03 C36A4.1 cyp-25A1 1,91 4,55E-02 
Y119D3B.18 fbxa-91 2,17 1,03E-02 K01A2.11 cbn-1 1,90 6,56E-04 
Y36E3A.2  2,17 2,41E-02 Y37A1A.2  1,90 6,29E-03 
Y119D3B.20 fbxa-92 2,16 1,79E-02 F17C11.3 col-153 1,89 1,87E-05 
W08E12.2  2,16 1,46E-05 K08B12.1  1,89 2,38E-02 
T19C3.9 ttr-7 2,16 3,43E-04 T05E7.1  1,88 9,68E-06 
Y51A2D.5 hmit-1.2 2,14 2,69E-07 Y53F4B.25  1,87 6,17E-05 
B0205.13  2,13 5,70E-05 ZC513.1  1,87 2,68E-02 
B0213.3 nlp-28 2,12 3,64E-02 F08H9.8 clec-54 1,87 2,23E-02 
C49G7.10  2,11 2,41E-03 ZC449.2  1,86 9,83E-03 
F20G2.5  2,11 3,81E-02 T06D8.10  1,86 3,63E-08 
T28D6.2 tba-7 2,10 1,71E-05 T02B5.3  1,85 8,86E-04 
F26G1.2  2,09 3,81E-02 F17B5.1  1,85 1,55E-02 
Y54F10BM.3  2,09 1,32E-02 C42D8.2 vit-2 1,85 7,93E-09 
Y95B8A.12  2,08 7,39E-03 K07C6.5 cyp-35A5 1,84 4,15E-03 
T05A7.1  2,07 2,71E-05 F09G8.5  1,84 2,23E-02 
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T23F1.6 pqn-71 2,05 4,55E-05 C32H11.11  1,84 7,59E-03 
K08D8.4  2,05 3,30E-04 C34F6.3 col-179 1,84 4,57E-03 
Y41G9A.5  2,05 3,94E-04 F32D1.11  1,83 6,20E-03 
B0228.1  2,03 2,16E-03 E03G2.4 col-186 1,83 1,58E-03 
T28B8.1  2,02 2,88E-03 E01G6.3  1,83 4,19E-03 
K07C5.7 ttll-15 2,02 6,72E-05 Y42A5A.2 lact-8 1,83 9,14E-05 
C40H1.1 cpb-1 1,99 1,34E-06 T07G12.3  1,82 3,47E-04 
T01D3.3  1,97 4,15E-03 Y69A2AR.5 daao-1 1,82 4,16E-02 
W03D2.1 pqn-75 1,96 3,39E-03 C17H12.8  1,82 2,39E-06 
C45B2.1  1,93 1,57E-02 Y71F9B.9  1,82 1,28E-02 
C45E1.4  1,93 8,84E-03 F25E5.2  1,81 4,21E-02 
F25E5.8  1,93 9,79E-04 C32H11.8  1,80 1,25E-02 
Y69H2.10  1,93 1,22E-02 C01H6.1 col-61 1,80 1,12E-02 
F44G3.2  1,92 2,86E-03 F45G2.5 bli-5 1,79 1,95E-02 
ZK507.4 dos-1 1,92 4,16E-02 F10A3.4  1,78 9,40E-04 
T25B9.7 ugt-54 1,91 2,65E-02 F38A1.5 clec-166 1,77 3,25E-03 
F49B2.6  1,91 1,21E-04 Y34B4A.10  1,77 6,18E-06 
B0238.12  1,90 1,32E-02 Y4C6B.6  1,77 3,14E-05 
K02E7.6  1,89 1,08E-03 F18F11.4  1,77 6,66E-04 
C53B7.3  1,89 2,03E-03 F08A8.2  1,76 7,24E-08 
F35B12.3  1,89 4,42E-02 F52D1.3 abu-12 1,75 1,30E-07 
B0213.4 nlp-29 1,89 3,21E-04 F18C5.5  1,75 1,59E-03 
T20D4.12  1,88 8,68E-04 K02D3.2  1,74 6,67E-03 
F55G11.5 dod-22 1,88 3,64E-02 F39D8.4 nas-13 1,73 2,38E-02 
T01B11.5 str-176 1,86 2,16E-03 Y42H9B.1 col-115 1,72 2,28E-02 
F57C12.1 nas-38 1,86 1,29E-09 ZK1025.4  1,72 1,81E-02 
F44F4.4 ptr-8 1,85 1,65E-08 Y46G5A.29  1,72 9,54E-06 
Y54G2A.11  1,85 7,03E-06 M18.1 col-129 1,72 1,24E-04 
Y54G11A.4  1,85 6,06E-03 F22E5.1  1,71 1,20E-02 
F54D1.4 nhr-7 1,85 8,48E-03 K07G5.1 crml-1 1,70 3,16E-06 
C44E12.1  1,85 1,18E-03 B0399.2 oac-1 1,69 5,43E-04 
T19H12.10 ugt-11 1,84 4,44E-02 C46H11.2  1,69 1,01E-03 
C31H2.4  1,83 2,11E-03 M03B6.3  1,69 1,65E-02 
B0303.7  1,83 2,40E-06 C06B3.3 cyp-35C1 1,69 5,45E-05 
C23H4.6  1,83 4,73E-02 H23N18.3 ugt-8 1,68 7,14E-03 
K02G10.7 aqp-8 1,82 1,62E-06 F54B11.11  1,68 1,67E-03 
C09F9.7  1,82 3,37E-02 ZC13.4 mab-7 1,68 8,80E-05 
E02H1.7 nhr-19 1,81 7,47E-03 Y38C1AB.1  1,68 1,24E-02 
R01E6.4 acr-12 1,81 6,07E-03 T19D7.3 lpr-7 1,68 3,68E-04 
C54D1.1 pgp-10 1,81 8,80E-05 F46B3.5 grd-2 1,67 2,27E-04 
F01E11.1 ugt-57 1,80 1,68E-03 F18A11.2  1,67 3,49E-03 
ZC123.4  1,79 3,86E-02 R11A5.7 suro-1 1,67 7,88E-04 
F16F9.2 dpy-6 1,79 6,80E-08 F26G1.6  1,67 7,22E-03 
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F47B7.7  1,79 4,69E-03 M02G9.2  1,66 3,93E-03 
C25D7.3 sdc-3 1,79 2,28E-07 F58G1.5 lips-9 1,66 8,02E-04 
B0222.5  1,78 7,57E-05 M01E10.2 dpy-1 1,66 3,08E-05 
T28H10.2  1,78 3,59E-03 F38A1.1 clec-170 1,66 1,58E-03 
R03A10.5  1,78 2,90E-03 Y18D10A.7 ptr-17 1,65 1,04E-02 
B0310.2  1,78 3,87E-03 T15B7.3 col-143 1,65 2,09E-02 
F47E1.2  1,78 6,67E-03 C02D5.1 acdh-6 1,65 2,41E-03 
Y19D10A.9 clec-209 1,76 2,10E-03 F49C12.7  1,65 3,44E-02 
R11F4.1  1,76 1,77E-06 C13C12.2  1,65 2,28E-03 
Y44A6C.1  1,76 1,39E-02 B0365.9  1,65 2,00E-02 
ZC373.7 col-176 1,75 2,54E-06 T22B7.7  1,64 2,09E-02 
T12B3.2  1,74 3,35E-03 C12D5.9  1,64 4,91E-02 
T02B11.4  1,74 1,63E-02 C05E7.2  1,63 7,99E-04 
F14F9.4  1,73 1,16E-02 W07A12.7 rhy-1 1,63 1,06E-02 
F10G2.3 clec-7 1,73 4,91E-02 F09G8.6 col-91 1,63 9,83E-05 
M7.3 bcc-1 1,73 6,55E-04 F55G11.8  1,62 2,19E-02 
C14F11.5 hsp-43 1,72 2,47E-03 Y11D7A.5  1,62 3,52E-02 
F56A4.2  1,71 3,87E-03 T03G6.1  1,62 4,64E-04 
T08A9.11 ttr-59 1,70 2,78E-03 D1014.5  1,62 8,09E-04 
C13E3.1  1,70 1,04E-02 T16G1.2  1,61 1,22E-02 
T20B3.1  1,70 2,12E-04 C07A12.5 spr-3 1,61 3,65E-02 
F21C10.8 pqn-31 1,69 2,36E-03 K01B6.3  1,61 3,35E-02 
T10E9.4  1,68 2,96E-02 F19H8.4 mltn-9 1,61 3,26E-04 
T28F3.4  1,68 2,08E-04 ZC449.1  1,60 4,33E-03 
W09D12.1  1,67 1,62E-04 C14A4.9  1,60 1,18E-02 
F10D2.11 ugt-41 1,66 1,67E-03 R11E3.4 set-15 1,59 1,22E-02 
C54D10.1 cdr-2 1,66 5,36E-04 Y18H1A.13 col-46 1,59 4,41E-02 
B0213.5 nlp-30 1,66 1,25E-02 C05C9.1  1,59 3,03E-02 
F47G3.1  1,65 5,42E-04 F41F3.4 col-139 1,59 1,96E-03 
F14H12.3  1,64 1,10E-02 W04G3.3 lpr-4 1,58 2,10E-04 
Y66D12A.12 ztf-29 1,63 6,72E-03 T05H4.7  1,58 3,17E-02 
Y69A2AR.32  1,63 3,81E-02 F12F6.9 col-128 1,58 1,39E-02 
Y113G7B.14  1,63 1,25E-02 F11G11.11 col-20 1,58 4,49E-03 
T03F6.4  1,62 1,70E-02 T18H9.1 grd-6 1,58 5,70E-05 
F42A8.1  1,62 4,77E-02 F01D5.10  1,58 1,10E-02 
Y54E10A.4 fog-1 1,62 2,64E-03 F40F9.5  1,56 4,57E-03 
K08A2.5 nhr-88 1,61 2,44E-02 ZK377.1 wrt-6 1,55 7,70E-04 
E04F6.6  1,60 8,38E-03 C32D5.12  1,55 4,58E-02 
F48C1.1 aman-3 1,60 4,64E-04 T04H1.6 lrx-1 1,54 1,95E-02 
D1005.3 cebp-1 1,60 1,98E-03 F55A11.7  1,54 1,18E-02 
Y51H7C.13  1,60 2,45E-02 F08H9.6 clec-57 1,54 9,91E-03 
C09F9.3 glna-1 1,60 3,81E-02 C34F6.2 col-178 1,53 1,91E-02 
C25E10.5  1,60 6,51E-03 C17G1.6 nas-37 1,53 1,23E-03 
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Y69H2.3  1,60 1,27E-04 T08B1.6 acs-3 1,53 1,92E-02 
R13A5.3 ttr-32 1,60 3,55E-02 F30A10.2  1,53 1,56E-02 
R13A5.6 ttr-8 1,59 2,33E-02 Y45G12C.2 gst-10 1,53 9,36E-03 
D1005.2  1,59 1,22E-02 C41D7.2 ptr-3 1,53 4,94E-03 
C07A9.9  1,59 3,46E-02 T17H7.7  1,53 1,06E-03 
F55G11.4  1,59 8,84E-03 F07H5.8  1,52 1,63E-02 
Y75B8A.3  1,59 2,67E-03 Y113G7B.12  1,52 1,00E-03 
Y73F8A.21 nhr-5 1,58 3,67E-02     
ZC410.1 nhr-11 1,58 3,98E-02     
Y48G1BL.2 atm-1 1,58 9,91E-03     
F22F7.7  1,57 3,35E-02     
C05D11.7  1,56 1,28E-02     
F26D12.1 fkh-7 1,55 1,35E-02     
B0285.9 ckb-2 1,55 2,46E-03     
F08F3.7 cyp-14A5 1,55 1,59E-03     
T26H2.9 nhr-79 1,55 2,28E-02     
C30F2.3  1,55 1,88E-02     
F31F7.1  1,55 1,48E-02     
Y70G10A.3  1,55 1,69E-03     
Y49E10.4  1,54 1,47E-02     
F57H12.6  1,54 9,56E-03     
T04A11.4  1,53 2,78E-02     
F47A4.5  1,53 1,08E-03     
Y48G9A.4 frl-1 1,53 5,85E-04     
F58E6.1 sta-2 1,53 3,46E-02     
C02C2.1 tyr-1 1,51 1,08E-03     
F18E9.3  1,51 1,19E-03     
Y73F4A.2  1,51 4,87E-02     
T15B7.4 col-142 1,50 2,18E-03     
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